*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1bzy_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 133 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 134 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 137 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 165 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 13.34 89.40 45.53 11.81 89.79 44.14 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 9.14 89.42 48.04 8.93 88.63 46.06 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 11.51 80.72 44.41 10.38 78.98 44.80 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 13.35 79.17 49.96 8.00 78.73 47.28 10.86 -51.86 -2.39 9.09 -50.05 2.40 1bzy_c00 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c00 naa= 4 ULMN 4 1bzy_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 B 133 GLU C 18 GLU.? 10.63 O3' AMP A 901 B 134 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 137 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 165 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -0.78 112.03 42.85 0.95 111.50 41.80 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 2.83 112.32 46.21 3.45 112.93 44.27 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 1.33 120.54 41.38 2.37 122.32 41.83 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo -1.54 122.74 46.23 4.22 122.84 44.60 10.86 -51.86 -2.39 9.09 -50.05 2.40 1bzy_c01 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c01 naa= 4 ULMN 4 1bzy_c02 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 133 GLU C 18 GLU.? 10.63 O3' AMP A 901 C 134 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 137 ASP C 20 ASP.? 6.67 O5' AMP A 901 C 165 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 0.15 90.11 85.87 1.29 91.36 87.12 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 4.00 91.31 83.02 4.55 90.96 85.06 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 5.10 82.97 88.07 6.79 81.71 87.85 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 4.16 80.06 82.93 9.22 82.34 85.00 10.86 -51.86 -2.39 9.09 -50.05 2.40 1bzy_c02 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c02 naa= 4 ULMN 4 1bzy_c03 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 D 133 GLU C 18 GLU.? 10.63 O3' AMP A 901 D 134 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 137 ASP C 20 ASP.? 6.67 O5' AMP A 901 D 165 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 4.48 116.39 84.65 3.07 115.42 85.88 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 1.16 114.72 81.44 0.30 115.35 83.28 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -0.72 123.60 84.94 -2.32 124.82 84.32 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 1.15 125.85 79.67 -4.25 124.18 81.47 10.86 -51.86 -2.39 9.09 -50.05 2.40 1bzy_c03 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_c03 naa= 4 ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 A 208 GLU A 84 GLU~? 14.99 N1 AMP A 901 A 246 HIS A 81 HIS~? 14.35 N6 AMP A 901 B 109 TYR B 15 TYR^? -4.78 N3 AMP B 903s B 197 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 42.05 62.45 76.31 40.18 63.04 75.45 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 37.14 61.56 73.28 37.00 63.65 73.26 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 50.22 35.25 75.17 48.69 37.57 74.89 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 45.03 37.30 75.10 44.89 38.23 76.98 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1cqj_c00 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 1 hits 1cqj_c00 naa= 4 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 D 208 GLU A 84 GLU~? 14.99 N1 AMP A 901 D 246 HIS A 81 HIS~? 14.35 N6 AMP A 901 E 109 TYR B 15 TYR^? -4.78 N3 AMP B 903s E 197 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -2.91 18.30 76.21 -1.08 17.82 77.32 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 2.87 18.34 77.03 2.47 16.92 78.50 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo -1.67 35.94 53.83 -0.91 34.37 56.05 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 1.76 35.71 58.20 0.46 36.19 59.80 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1cqj_c01 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 1 hits 1cqj_c01 naa= 4 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1020 THR A 100 THR^? 7.88 N6 AMP B 902 A1034 TYR A 15 TYR^? -4.88 N3 AMP B 902s A1100 THR B 104 THR^? 8.91 N1 AMP B 902 B3294 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 40.94 131.25 89.60 39.24 130.12 90.27 5.53 -27.13 -23.05 7.17 -26.10 -22.11 coo 35.38 132.08 89.27 36.78 129.74 88.76 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 43.56 124.16 89.51 42.17 124.73 91.05 11.98 -26.45 -24.97 10.79 -26.06 -23.21 coo 33.89 125.64 85.55 35.54 126.95 85.33 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1020 THR B 100 THR^? 7.69 N1 AMP B 903 A1034 TYR B 15 TYR^? -4.78 N3 AMP B 903s A1100 THR C 104 THR^? 9.22 N1 AMP B 903 B3294 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 40.94 131.25 89.60 39.24 130.12 90.27 21.14 -26.34 -16.07 20.32 -28.16 -15.18 coo 35.38 132.08 89.27 36.78 129.74 88.76 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 43.56 124.16 89.51 42.17 124.73 91.05 21.16 -30.50 -20.95 20.80 -30.35 -18.84 coo 33.89 125.64 85.55 35.54 126.95 85.33 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1020 THR C 100 THR^? 7.96 N1 AMP A 901 A1034 TYR C 15 TYR^? 4.73 N3 AMP A 901 A1100 THR A 104 THR.? 9.25 N1 AMP A 901 B3294 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 40.94 131.25 89.60 39.24 130.12 90.27 14.11 -41.21 -19.38 12.34 -40.02 -18.95 coo 35.38 132.08 89.27 36.78 129.74 88.76 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo 43.56 124.16 89.51 42.17 124.73 91.05 13.23 -37.26 -24.51 12.15 -37.84 -22.73 coo 33.89 125.64 85.55 35.54 126.95 85.33 6.13 -35.02 -17.20 7.93 -35.29 -16.18 1djo_c00 source 1djo GLUTAMINASE-ASPARAGINASE : 3 hits 1djo_c00 naa= 4 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1294 GLU B 75 GLU^? -4.88 C2 AMP B 902s B3020 THR A 100 THR^? 7.88 N6 AMP B 902 B3034 TYR A 15 TYR^? -4.88 N3 AMP B 902s B3100 THR B 104 THR^? 8.91 N1 AMP B 902 coo 42.18 93.40 84.96 40.44 92.19 85.03 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 35.69 87.89 89.88 37.41 89.09 90.33 5.53 -27.13 -23.05 7.17 -26.10 -22.11 coo 40.98 87.08 88.86 39.63 89.46 88.41 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 33.09 94.86 90.18 34.63 94.22 91.55 11.98 -26.45 -24.97 10.79 -26.06 -23.21 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1294 GLU C 75 GLU^? -5.53 C2 AMP B 903s B3020 THR B 100 THR^? 7.69 N1 AMP B 903 B3034 TYR B 15 TYR^? -4.78 N3 AMP B 903s B3100 THR C 104 THR^? 9.22 N1 AMP B 903 coo 42.18 93.40 84.96 40.44 92.19 85.03 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 35.69 87.89 89.88 37.41 89.09 90.33 21.14 -26.34 -16.07 20.32 -28.16 -15.18 coo 40.98 87.08 88.86 39.63 89.46 88.41 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 33.09 94.86 90.18 34.63 94.22 91.55 21.16 -30.50 -20.95 20.80 -30.35 -18.84 1djo_c01 source 1djo GLUTAMINASE-ASPARAGINASE : 2 hits 1djo_c01 naa= 4 ULMN 4 1eix_c04 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 A 44 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 71 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 73 LYS C 54 LYS.? 9.50 O1P AMP A 901 A 76 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 19.59 28.23 101.92 19.95 24.94 105.61 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 23.19 26.70 106.03 22.83 25.75 107.86 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 27.86 26.05 110.45 22.68 24.67 109.97 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 36.95 24.59 112.32 38.04 22.87 111.77 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1eix_c04 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 1 hits 1eix_c04 naa= 4 ULMN 4 1eix_c05 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 B 44 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 71 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 73 LYS C 54 LYS.? 9.50 O1P AMP A 901 B 76 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 42.51 16.13 104.66 41.59 19.58 107.89 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 38.06 17.61 107.95 37.94 18.87 109.63 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 32.65 18.53 110.98 37.67 20.13 111.67 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 23.32 19.98 111.00 22.38 21.72 110.29 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1eix_c05 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 1 hits 1eix_c05 naa= 4 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 C 44 LYS C 95 LYS.? 12.30 O2P AMP A 901 C 71 ASP C 96 ASP.? -4.92 O1P AMP A 901s C 73 LYS C 54 LYS.? 9.50 O1P AMP A 901 C 76 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 36.80 44.62 62.45 37.50 45.99 67.26 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 41.24 46.44 65.36 41.30 47.43 67.22 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 46.67 48.87 67.69 41.63 48.86 69.39 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 56.00 48.26 68.98 57.09 46.84 70.05 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1eix_c06 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 1 hits 1eix_c06 naa= 4 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 D 44 LYS C 95 LYS.? 12.30 O2P AMP A 901 D 71 ASP C 96 ASP.? -4.92 O1P AMP A 901s D 73 LYS C 54 LYS.? 9.50 O1P AMP A 901 D 76 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 59.78 36.42 71.82 59.95 40.97 70.58 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 56.16 40.71 72.48 56.48 42.77 72.42 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 51.52 44.76 73.92 56.76 45.26 72.14 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 42.33 47.14 73.59 41.23 47.55 71.88 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1eix_c07 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 1 hits 1eix_c07 naa= 4 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 146 GLU A 18 GLU.? 10.44 O3' AMP B 902 A 147 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 150 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 178 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 A 146 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 147 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 150 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 178 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 10.86 -51.86 -2.39 9.09 -50.05 2.40 1fsg_c00 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_c00 naa= 4 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 146 GLU A 18 GLU.? 10.44 O3' AMP B 902 C 147 ASP A 69 ASP.? 5.85 O1P AMP B 902 C 150 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 178 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 21.13 43.45 27.66 22.75 42.66 28.81 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 23.59 40.44 23.80 23.75 39.21 25.49 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 15.48 36.57 28.52 14.54 34.69 28.40 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 12.35 37.47 23.73 15.50 32.82 25.71 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 C 146 GLU C 18 GLU.? 10.63 O3' AMP A 901 C 147 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 150 ASP C 20 ASP.? 6.67 O5' AMP A 901 C 178 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 21.13 43.45 27.66 22.75 42.66 28.81 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 23.59 40.44 23.80 23.75 39.21 25.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 15.48 36.57 28.52 14.54 34.69 28.40 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 12.35 37.47 23.73 15.50 32.82 25.71 10.86 -51.86 -2.39 9.09 -50.05 2.40 1fsg_c01 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 278 ARG A 36 ARG~? 10.98 O3P AMP A 901 A 298 GLU A 33 GLU~? 17.47 O3P AMP A 901 A 348 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -11.50 -38.64 -15.48 -13.24 -37.71 -14.68 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 278 ARG B 36 ARG~? 10.26 O2P AMP B 902 A 298 GLU B 33 GLU~? 17.08 O2' AMP B 902 A 348 ASP B 78 ASP^? 6.36 N6 AMP B 902 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 11.91 -10.56 -3.68 12.98 -9.62 -2.13 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 12.15 -16.83 -20.34 11.30 -14.93 -20.75 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 2 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 36 ARG~? 10.98 O3P AMP A 901 B 278 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 298 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 348 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -19.09 15.00 16.26 -16.38 15.21 14.84 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -19.42 16.58 21.15 -18.01 16.20 19.59 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -3.61 14.95 13.27 -5.31 15.62 12.23 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 278 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 298 GLU B 33 GLU~? 17.08 O2' AMP B 902 B 348 ASP B 78 ASP^? 6.36 N6 AMP B 902 coo -8.10 23.98 3.08 -8.58 21.04 2.27 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -19.09 15.00 16.26 -16.38 15.21 14.84 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo -19.42 16.58 21.15 -18.01 16.20 19.59 11.91 -10.56 -3.68 12.98 -9.62 -2.13 coo -3.61 14.95 13.27 -5.31 15.62 12.23 12.15 -16.83 -20.34 11.30 -14.93 -20.75 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 B 170 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 278 ARG C 36 ARG~? 10.59 O3P AMP B 903 B 298 GLU C 33 GLU~? 17.24 O2' AMP B 903 B 348 ASP C 78 ASP^? 6.25 N6 AMP B 903 coo -8.10 23.98 3.08 -8.58 21.04 2.27 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -19.09 15.00 16.26 -16.38 15.21 14.84 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo -19.42 16.58 21.15 -18.01 16.20 19.59 23.08 -46.28 0.12 22.30 -47.65 1.53 coo -3.61 14.95 13.27 -5.31 15.62 12.23 26.09 -37.43 -14.21 28.04 -37.58 -13.32 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 3 hits 1i8t_c03 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 11 GLY A 39 GLY.? 10.43 N6 AMP A 901 A 45 GLY A 42 GLY.? -3.55 C6 AMP A 901s A 217 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 23.95 20.41 42.64 25.99 15.22 44.13 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 21.78 10.35 42.81 21.85 10.58 42.04 -5.22 -44.24 -23.53 -5.00 -43.48 -23.51 coo 27.49 8.11 39.28 26.75 8.17 38.90 0.97 -42.40 -18.34 1.06 -41.78 -18.91 coo 29.45 15.15 50.79 25.80 14.13 47.92 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 2 4 # 2 A 8 LYS B 21 LYS^? 13.50 O2P AMP B 903 A 11 GLY B 17 GLY^? 5.09 O5' AMP B 903 A 45 GLY B 97 GLY.? -3.32 O1P AMP B 903s A 217 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 23.95 20.41 42.64 25.99 15.22 44.13 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 21.78 10.35 42.81 21.85 10.58 42.04 19.45 -25.97 -0.73 19.21 -25.21 -1.05 coo 27.49 8.11 39.28 26.75 8.17 38.90 24.07 -25.86 -6.22 24.84 -25.72 -6.62 coo 29.45 15.15 50.79 25.80 14.13 47.92 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 3 4 # 3 A 8 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 11 GLY B 39 GLY.? 11.12 N6 AMP B 902 A 45 GLY B 42 GLY.? 4.07 C5 AMP B 902 A 217 LYS B 85 LYS~? 13.55 N6 AMP B 902 coo 23.95 20.41 42.64 25.99 15.22 44.13 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 21.78 10.35 42.81 21.85 10.58 42.04 10.13 -8.80 -15.73 10.67 -9.39 -15.59 coo 27.49 8.11 39.28 26.75 8.17 38.90 7.37 -16.61 -14.90 8.15 -16.78 -15.17 coo 29.45 15.15 50.79 25.80 14.13 47.92 20.32 -12.07 -18.16 16.10 -8.70 -17.98 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 4 4 # 4 A 8 LYS C 21 LYS^? 15.49 O2P AMP A 901 A 11 GLY C 17 GLY^? 5.58 O3' AMP A 901 A 45 GLY C 97 GLY.? 4.38 O4' AMP A 901 A 217 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 23.95 20.41 42.64 25.99 15.22 44.13 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 21.78 10.35 42.81 21.85 10.58 42.04 6.37 -45.83 -6.76 7.18 -45.84 -6.57 coo 27.49 8.11 39.28 26.75 8.17 38.90 8.33 -47.69 -13.78 8.41 -48.09 -14.57 coo 29.45 15.15 50.79 25.80 14.13 47.92 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 5 4 # 5 A 8 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 11 GLY C 39 GLY~? 10.70 N6 AMP B 903 A 45 GLY C 42 GLY^? -3.50 C6 AMP B 903s A 217 LYS C 85 LYS~? 15.28 N6 AMP B 903 coo 23.95 20.41 42.64 25.99 15.22 44.13 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 21.78 10.35 42.81 21.85 10.58 42.04 30.44 -41.32 -6.97 29.76 -41.50 -7.38 coo 27.49 8.11 39.28 26.75 8.17 38.90 24.43 -35.52 -7.75 24.29 -36.09 -8.36 coo 29.45 15.15 50.79 25.80 14.13 47.92 26.67 -46.79 -15.77 32.41 -44.78 -16.80 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 5 hits 1oh9_c00 naa= 4 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU B 18 GLU.? 10.73 O3' AMP B 903 A 60 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 175 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 46.10 28.27 19.27 45.48 26.99 20.84 14.19 -24.84 2.24 12.77 -26.14 3.06 coo 56.42 28.06 12.93 55.01 27.92 14.50 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 45.02 22.04 15.38 46.16 24.00 13.76 13.87 -20.58 -2.07 11.87 -21.01 -0.16 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 1 hits 1a50_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS C 34 LYS~? 17.13 N6 AMP B 903 141 HIS C 6 HIS.? 9.51 N6 AMP B 903 333 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo 69.56 26.03 31.04 72.53 30.39 31.84 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 85.95 39.62 33.57 84.70 40.34 35.09 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 87.31 36.08 32.89 89.57 36.58 34.95 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 1 hits 1aa6_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 22 TRP^? 15.49 O3P AMP B 902 223 ASP A 20 ASP.? 5.75 O3P AMP B 902 258 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 127.19 33.46 26.14 126.78 36.79 28.15 -13.78 -29.18 -17.67 -13.35 -26.19 -20.20 coo 126.95 41.66 23.38 128.48 40.72 24.51 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 138.83 37.95 25.17 133.50 36.37 26.52 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 22 TRP^? 14.95 O2P AMP B 903 223 ASP B 20 ASP.? 4.50 O2P AMP B 903 258 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 127.19 33.46 26.14 126.78 36.79 28.15 21.53 -11.97 -1.43 25.21 -12.76 -2.62 coo 126.95 41.66 23.38 128.48 40.72 24.51 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 138.83 37.95 25.17 133.50 36.37 26.52 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP C 22 TRP^? 16.70 O5' AMP A 901 223 ASP C 20 ASP.? 6.67 O5' AMP A 901 258 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 127.19 33.46 26.14 126.78 36.79 28.15 17.49 -53.71 -3.88 16.62 -55.87 -7.05 coo 126.95 41.66 23.38 128.48 40.72 24.51 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 138.83 37.95 25.17 133.50 36.37 26.52 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 3 hits 1aam_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN C 19 ASN.? 10.79 O3' AMP A 901 63 ARG C 65 ARG.? -3.67 O5' AMP A 901s 255 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 42.10 13.02 11.14 41.85 11.12 10.23 4.38 -48.28 -1.80 3.20 -46.97 -0.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 38.40 3.83 10.26 40.02 6.30 9.25 6.08 -38.28 -1.54 7.50 -37.49 1.03 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 262 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 312 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 38.54 36.60 66.38 37.88 34.77 67.15 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 30.62 37.23 61.07 30.08 35.73 62.49 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 262 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 312 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 29.33 36.13 69.70 30.07 34.20 70.11 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 30.62 37.23 61.07 30.08 35.73 62.49 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 262 HIS A 81 HIS~? 14.35 N6 AMP A 901 B 312 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 29.35 31.42 99.15 28.72 33.09 98.04 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 20.42 28.25 99.26 20.25 29.62 97.63 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 81 HIS~? 14.35 N6 AMP A 901 B 262 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 312 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 23.86 29.50 91.20 24.12 31.58 91.00 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 20.42 28.25 99.26 20.25 29.62 97.63 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 6 HIS.? 9.49 N6 AMP A 901 320 HIS A 81 HIS~? 14.35 N6 AMP A 901 375 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 81 HIS~? 14.35 N6 AMP A 901 320 HIS A 6 HIS.? 9.49 N6 AMP A 901 375 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 2.95 -40.37 -24.73 1.78 -42.09 -25.10 1al6_c00 source 1al6 CITRATE SYNTHASE : 2 hits 1al6_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 20 ASP.? 5.75 O3P AMP B 902 214 ASP B 20 ASP.? 4.50 O2P AMP B 903 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 20 ASP.? 5.75 O3P AMP B 902 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 96 ASP.? 4.70 O3P AMP B 902 214 ASP B 20 ASP.? 4.50 O2P AMP B 903 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 96 ASP.? 4.70 O3P AMP B 902 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 96 ASP.? 4.70 O3P AMP B 902 214 ASP C 69 ASP.? 6.83 O3' AMP A 901 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 96 ASP.? -3.09 O1P AMP B 903s 214 ASP C 69 ASP.? 6.83 O3' AMP A 901 289 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 96 ASP.? -4.92 O1P AMP A 901s 214 ASP A 69 ASP.? 5.85 O1P AMP B 902 289 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 26.86 59.76 46.36 25.42 58.23 45.92 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 96 ASP.? -4.92 O1P AMP A 901s 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 289 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 26.86 59.76 46.36 25.42 58.23 45.92 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 96 ASP.? -4.92 O1P AMP A 901s 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 289 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 26.86 59.76 46.36 25.42 58.23 45.92 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 9 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 20 ASP.? 5.75 O3P AMP B 902 204 GLU A 18 GLU.? 10.44 O3' AMP B 902 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 4.34 62.44 32.05 4.22 64.48 32.53 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 69 ASP.? 5.85 O1P AMP B 902 204 GLU A 18 GLU.? 10.44 O3' AMP B 902 289 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 69 ASP.? 5.85 O1P AMP B 902 227 GLU B 75 GLU^? -4.88 C2 AMP B 902s 289 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 69 ASP.? 5.85 O1P AMP B 902 227 GLU B 75 GLU^? -4.88 C2 AMP B 902s 289 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 96 ASP.? 4.70 O3P AMP B 902 227 GLU B 75 GLU^? -4.88 C2 AMP B 902s 289 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 69 ASP.? 6.10 O2P AMP B 903 227 GLU C 75 GLU^? -5.53 C2 AMP B 903s 289 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo -0.62 65.95 29.97 0.31 67.47 31.05 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 96 ASP.? -3.09 O1P AMP B 903s 227 GLU B 23 GLU.? 19.12 O2P AMP B 903 289 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 3.96 55.76 41.24 4.83 57.69 41.17 23.11 -9.89 1.58 22.67 -8.31 0.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 96 ASP.? -3.09 O1P AMP B 903s 227 GLU C 75 GLU^? -5.53 C2 AMP B 903s 289 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 69 ASP.? 6.83 O3' AMP A 901 227 GLU A 75 GLU^? -5.62 C2 AMP A 901s 289 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo -0.62 65.95 29.97 0.31 67.47 31.05 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 96 ASP.? -4.92 O1P AMP A 901s 227 GLU A 75 GLU^? -5.62 C2 AMP A 901s 289 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 96 ASP.? -4.92 O1P AMP A 901s 227 GLU A 75 GLU^? -5.62 C2 AMP A 901s 289 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 9 hits 1amy_c06 naa= 3 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 A 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 A 42 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 15.53 3.67 5.89 15.40 6.73 5.59 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 20.65 4.50 6.93 19.74 4.89 5.08 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 19.78 9.98 8.03 21.51 8.73 8.26 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 A 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 A 42 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 15.53 3.67 5.89 15.40 6.73 5.59 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 20.65 4.50 6.93 19.74 4.89 5.08 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 19.78 9.98 8.03 21.51 8.73 8.26 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 A 38 ARG B 79 ARG^? 12.83 N6 AMP B 902 A 42 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 71 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo 15.53 3.67 5.89 15.40 6.73 5.59 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo 20.65 4.50 6.93 19.74 4.89 5.08 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 19.78 9.98 8.03 21.51 8.73 8.26 14.70 -19.35 -29.72 16.77 -19.30 -29.18 1apx_c00 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c00 naa= 3 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 B 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 B 42 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 B 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 B 42 HIS A 81 HIS~? 14.35 N6 AMP A 901 B 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 B 38 ARG B 79 ARG^? 12.83 N6 AMP B 902 B 42 HIS B 6 HIS^? 11.24 N6 AMP B 902 B 71 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 14.70 -19.35 -29.72 16.77 -19.30 -29.18 1apx_c01 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c01 naa= 3 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 C 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 C 42 HIS A 6 HIS.? 9.49 N6 AMP A 901 C 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 30.92 18.62 52.11 32.84 21.02 52.26 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 34.83 15.89 54.93 35.12 16.59 52.97 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 37.12 20.79 56.54 37.65 18.79 57.02 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 C 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 C 42 HIS A 81 HIS~? 14.35 N6 AMP A 901 C 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 30.92 18.62 52.11 32.84 21.02 52.26 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 34.83 15.89 54.93 35.12 16.59 52.97 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 37.12 20.79 56.54 37.65 18.79 57.02 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 C 38 ARG B 79 ARG^? 12.83 N6 AMP B 902 C 42 HIS B 6 HIS^? 11.24 N6 AMP B 902 C 71 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo 30.92 18.62 52.11 32.84 21.02 52.26 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo 34.83 15.89 54.93 35.12 16.59 52.97 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 37.12 20.79 56.54 37.65 18.79 57.02 14.70 -19.35 -29.72 16.77 -19.30 -29.18 1apx_c02 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c02 naa= 3 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 D 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 D 42 HIS A 6 HIS.? 9.49 N6 AMP A 901 D 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo -6.22 19.15 57.90 -8.28 20.35 55.95 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo -9.68 15.08 58.37 -9.88 17.07 58.99 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -12.42 16.33 53.67 -12.99 14.86 55.12 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 D 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 D 42 HIS A 81 HIS~? 14.35 N6 AMP A 901 D 71 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo -6.22 19.15 57.90 -8.28 20.35 55.95 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo -9.68 15.08 58.37 -9.88 17.07 58.99 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo -12.42 16.33 53.67 -12.99 14.86 55.12 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 D 38 ARG B 79 ARG^? 12.83 N6 AMP B 902 D 42 HIS B 6 HIS^? 11.24 N6 AMP B 902 D 71 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo -6.22 19.15 57.90 -8.28 20.35 55.95 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo -9.68 15.08 58.37 -9.88 17.07 58.99 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -12.42 16.33 53.67 -12.99 14.86 55.12 14.70 -19.35 -29.72 16.77 -19.30 -29.18 1apx_c03 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c03 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 52 PHE^? -6.76 O2' AMP B 902s A 223 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 265 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 39.74 52.86 65.74 41.15 55.14 66.52 5.94 -15.30 -10.78 8.37 -14.50 -11.95 coo 30.70 47.50 67.53 29.83 49.47 67.39 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 19.99 54.53 64.11 20.55 58.78 68.33 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 52 PHE^? -7.00 C5 AMP B 903s A 223 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 265 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 39.74 52.86 65.74 41.15 55.14 66.52 23.92 -36.74 -3.46 25.01 -38.36 -5.48 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 A 223 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 39.74 52.86 65.74 41.15 55.14 66.52 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 30.70 47.50 67.53 29.83 49.47 67.39 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 19.99 54.53 64.11 20.55 58.78 68.33 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 A 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 39.74 52.86 65.74 41.15 55.14 66.52 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 30.70 47.50 67.53 29.83 49.47 67.39 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 19.99 54.53 64.11 20.55 58.78 68.33 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 A 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 265 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 39.74 52.86 65.74 41.15 55.14 66.52 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 30.70 47.50 67.53 29.83 49.47 67.39 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ax4_c04 source 1ax4 TRYPTOPHANASE : 5 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 52 PHE^? -6.76 O2' AMP B 902s B 223 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 265 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 7.48 54.94 99.62 7.67 52.27 100.42 5.94 -15.30 -10.78 8.37 -14.50 -11.95 coo 10.43 61.66 91.81 9.80 60.04 90.61 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 5.43 58.06 80.08 8.57 53.00 79.37 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 52 PHE^? -7.00 C5 AMP B 903s B 223 ASP B 96 ASP.? -3.09 O1P AMP B 903s B 265 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 7.48 54.94 99.62 7.67 52.27 100.42 23.92 -36.74 -3.46 25.01 -38.36 -5.48 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 B 223 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 7.48 54.94 99.62 7.67 52.27 100.42 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 10.43 61.66 91.81 9.80 60.04 90.61 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 5.43 58.06 80.08 8.57 53.00 79.37 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 B 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 7.48 54.94 99.62 7.67 52.27 100.42 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 10.43 61.66 91.81 9.80 60.04 90.61 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 5.43 58.06 80.08 8.57 53.00 79.37 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 B 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 265 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 7.48 54.94 99.62 7.67 52.27 100.42 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 10.43 61.66 91.81 9.80 60.04 90.61 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ax4_c05 source 1ax4 TRYPTOPHANASE : 5 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 52 PHE^? -6.76 O2' AMP B 902s C 223 ASP A 69 ASP.? 5.85 O1P AMP B 902 C 265 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -6.55 73.45 23.60 -6.77 71.48 21.66 5.94 -15.30 -10.78 8.37 -14.50 -11.95 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 52 PHE^? -7.00 C5 AMP B 903s C 223 ASP B 96 ASP.? -3.09 O1P AMP B 903s C 265 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo -6.55 73.45 23.60 -6.77 71.48 21.66 23.92 -36.74 -3.46 25.01 -38.36 -5.48 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 C 223 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -9.52 75.74 33.62 -8.85 73.74 33.93 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -4.44 67.20 42.32 -7.50 62.41 40.49 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 C 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s C 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -9.52 75.74 33.62 -8.85 73.74 33.93 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -4.44 67.20 42.32 -7.50 62.41 40.49 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 C 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s C 265 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -9.52 75.74 33.62 -8.85 73.74 33.93 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ax4_c06 source 1ax4 TRYPTOPHANASE : 5 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 52 PHE^? -6.76 O2' AMP B 902s D 223 ASP A 69 ASP.? 5.85 O1P AMP B 902 D 265 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -38.60 55.38 52.70 -40.06 57.72 53.04 5.94 -15.30 -10.78 8.37 -14.50 -11.95 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 52 PHE^? -7.00 C5 AMP B 903s D 223 ASP B 96 ASP.? -3.09 O1P AMP B 903s D 265 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo -38.60 55.38 52.70 -40.06 57.72 53.04 23.92 -36.74 -3.46 25.01 -38.36 -5.48 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 D 223 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -29.46 51.67 48.51 -28.63 53.31 49.56 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -18.87 56.53 54.79 -19.47 62.22 53.03 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 D 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s D 265 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -29.46 51.67 48.51 -28.63 53.31 49.56 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -18.87 56.53 54.79 -19.47 62.22 53.03 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE C 52 PHE^? 7.10 C5 AMP A 901 D 223 ASP C 96 ASP.? -4.92 O1P AMP A 901s D 265 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo -29.46 51.67 48.51 -28.63 53.31 49.56 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ax4_c07 source 1ax4 TRYPTOPHANASE : 5 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 22 TRP^? 15.49 O3P AMP B 902 A 222 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 258 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 89.83 15.40 0.01 90.61 18.86 1.71 -13.78 -29.18 -17.67 -13.35 -26.19 -20.20 coo 82.92 20.43 2.47 84.82 20.45 1.55 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP B 22 TRP^? 14.95 O2P AMP B 903 A 222 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 258 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 89.83 15.40 0.01 90.61 18.86 1.71 21.53 -11.97 -1.43 25.21 -12.76 -2.62 coo 82.92 20.43 2.47 84.82 20.45 1.55 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP C 22 TRP^? 16.70 O5' AMP A 901 A 222 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 258 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 89.83 15.40 0.01 90.61 18.86 1.71 17.49 -53.71 -3.88 16.62 -55.87 -7.05 coo 82.92 20.43 2.47 84.82 20.45 1.55 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 3 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 22 TRP^? 15.49 O3P AMP B 902 B 222 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 258 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 103.45 44.39 16.20 102.66 41.02 14.32 -13.78 -29.18 -17.67 -13.35 -26.19 -20.20 coo 110.10 38.66 15.58 108.40 39.41 14.53 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 107.51 45.54 4.76 105.41 44.51 10.25 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP B 22 TRP^? 14.95 O2P AMP B 903 B 222 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 258 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 103.45 44.39 16.20 102.66 41.02 14.32 21.53 -11.97 -1.43 25.21 -12.76 -2.62 coo 110.10 38.66 15.58 108.40 39.41 14.53 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 107.51 45.54 4.76 105.41 44.51 10.25 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP C 22 TRP^? 16.70 O5' AMP A 901 B 222 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 258 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 103.45 44.39 16.20 102.66 41.02 14.32 17.49 -53.71 -3.88 16.62 -55.87 -7.05 coo 110.10 38.66 15.58 108.40 39.41 14.53 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 107.51 45.54 4.76 105.41 44.51 10.25 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 3 hits 1ay4_c03 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 230 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 273 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 9.23 21.44 106.88 10.18 19.34 105.31 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 1.45 22.80 104.16 2.58 21.02 104.01 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 2.97 11.64 107.87 6.59 15.13 107.03 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 230 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 273 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 9.23 21.44 106.88 10.18 19.34 105.31 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 1.45 22.80 104.16 2.58 21.02 104.01 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 2.97 11.64 107.87 6.59 15.13 107.03 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 230 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 273 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 11.81 13.41 73.03 10.00 13.03 75.12 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 19.17 11.01 76.14 17.26 10.42 76.77 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 11.10 2.31 76.60 10.24 7.24 75.62 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR C 50 TYR^? 7.65 O3' AMP A 901 B 230 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 273 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 11.81 13.41 73.03 10.00 13.03 75.12 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 19.17 11.01 76.14 17.26 10.42 76.77 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 11.10 2.31 76.60 10.24 7.24 75.62 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE B 52 PHE^? -7.00 C5 AMP B 903s A 159 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 188 LYS C 34 LYS~? 17.13 N6 AMP B 903 coo 13.91 34.58 14.67 12.95 36.00 12.47 23.92 -36.74 -3.46 25.01 -38.36 -5.48 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 22.55 41.65 15.60 18.92 37.20 14.63 24.06 -46.65 -4.78 27.74 -49.81 -6.72 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE C 52 PHE^? 7.10 C5 AMP A 901 A 159 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 188 LYS A 34 LYS~? 19.00 N1 AMP A 901 coo 13.91 34.58 14.67 12.95 36.00 12.47 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 20.97 28.40 16.26 20.19 30.15 15.34 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 22.55 41.65 15.60 18.92 37.20 14.63 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 20 ASP.? 5.75 O3P AMP B 902 435 GLU A 18 GLU.? 10.44 O3' AMP B 902 510 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 88.62 69.90 41.16 89.05 70.67 43.04 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 89.52 76.11 40.17 89.01 75.16 41.97 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 84.89 77.60 46.67 85.63 75.79 46.03 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 69 ASP.? 5.85 O1P AMP B 902 435 GLU A 18 GLU.? 10.44 O3' AMP B 902 510 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 88.62 69.90 41.16 89.05 70.67 43.04 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 84.89 77.60 46.67 85.63 75.79 46.03 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP C 20 ASP.? 6.67 O5' AMP A 901 435 GLU C 18 GLU.? 10.63 O3' AMP A 901 510 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 88.62 69.90 41.16 89.05 70.67 43.04 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 89.52 76.11 40.17 89.01 75.16 41.97 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP C 69 ASP.? 6.83 O3' AMP A 901 435 GLU C 18 GLU.? 10.63 O3' AMP A 901 510 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 88.62 69.90 41.16 89.05 70.67 43.04 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 89.52 76.11 40.17 89.01 75.16 41.97 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 84.89 77.60 46.67 85.63 75.79 46.03 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1bf2_c00 source 1bf2 ISOAMYLASE : 4 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU B 84 GLU~? 17.85 N6 AMP B 902 70 HIS B 81 HIS~? 16.34 N6 AMP B 902 281 HIS A 6 HIS.? 9.49 N6 AMP A 901 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.05 -14.25 -21.41 23.75 -13.21 -23.10 coo 69.05 50.55 157.03 68.00 52.29 156.51 18.97 -11.27 -24.77 20.54 -9.89 -24.72 coo 100.93 36.73 156.02 100.47 38.42 157.18 9.04 -45.79 -27.38 7.44 -47.11 -27.07 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU B 84 GLU~? 17.85 N6 AMP B 902 70 HIS B 81 HIS~? 16.34 N6 AMP B 902 281 HIS A 81 HIS~? 14.35 N6 AMP A 901 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.05 -14.25 -21.41 23.75 -13.21 -23.10 coo 69.05 50.55 157.03 68.00 52.29 156.51 18.97 -11.27 -24.77 20.54 -9.89 -24.72 coo 100.93 36.73 156.02 100.47 38.42 157.18 3.17 -39.49 -33.40 5.11 -39.25 -34.17 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU C 5 GLU.? 7.68 N6 AMP B 903 70 HIS C 6 HIS.? 9.51 N6 AMP B 903 281 HIS A 81 HIS~? 14.35 N6 AMP A 901 coo 66.09 46.17 155.81 66.77 48.19 155.70 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 69.05 50.55 157.03 68.00 52.29 156.51 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 100.93 36.73 156.02 100.47 38.42 157.18 3.17 -39.49 -33.40 5.11 -39.25 -34.17 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU C 84 GLU~? 17.40 N6 AMP B 903 70 HIS C 81 HIS~? 16.81 N6 AMP B 903 281 HIS B 6 HIS^? 11.24 N6 AMP B 902 coo 66.09 46.17 155.81 66.77 48.19 155.70 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 69.05 50.55 157.03 68.00 52.29 156.51 31.31 -43.94 -20.10 31.86 -45.68 -21.13 coo 100.93 36.73 156.02 100.47 38.42 157.18 8.85 -17.18 -28.64 8.26 -15.17 -28.64 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU C 84 GLU~? 17.40 N6 AMP B 903 70 HIS C 81 HIS~? 16.81 N6 AMP B 903 281 HIS B 81 HIS~? 16.34 N6 AMP B 902 coo 66.09 46.17 155.81 66.77 48.19 155.70 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 69.05 50.55 157.03 68.00 52.29 156.51 31.31 -43.94 -20.10 31.86 -45.68 -21.13 coo 100.93 36.73 156.02 100.47 38.42 157.18 18.97 -11.27 -24.77 20.54 -9.89 -24.72 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 5 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 79.04 80.20 80.81 79.58 81.40 83.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 79.04 80.20 80.81 79.58 81.40 83.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 79.04 80.20 80.81 79.58 81.40 83.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 10 3 # 10 A 382 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 11 3 # 11 A 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 12 3 # 12 A 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 79.04 80.20 80.81 79.58 81.40 83.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 13 3 # 13 A 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 79.04 80.20 80.81 79.58 81.40 83.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 14 3 # 14 A 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 79.04 80.20 80.81 79.58 81.40 83.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.05 -34.46 -21.85 15.11 -35.34 -20.19 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 14 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 82.21 41.07 119.14 83.95 40.66 116.59 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 540 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 86.52 35.28 112.74 87.08 36.38 110.99 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 451 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 9 3 # 9 B 382 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 451 GLU B 37 GLU~? 18.27 N6 AMP B 902 B 540 GLU B 33 GLU~? 17.08 O2' AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 86.52 35.28 112.74 87.08 36.38 110.99 13.62 -6.84 -9.34 14.57 -5.84 -7.75 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.91 -10.56 -3.68 12.98 -9.62 -2.13 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 10 3 # 10 B 382 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 540 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 82.21 41.07 119.14 83.95 40.66 116.59 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 86.52 35.28 112.74 87.08 36.38 110.99 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 11 3 # 11 B 382 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 82.21 41.07 119.14 83.95 40.66 116.59 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 86.52 35.28 112.74 87.08 36.38 110.99 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 12 3 # 12 B 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 451 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 82.21 41.07 119.14 83.95 40.66 116.59 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 86.52 35.28 112.74 87.08 36.38 110.99 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 13 3 # 13 B 382 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 451 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 540 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 82.21 41.07 119.14 83.95 40.66 116.59 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 86.52 35.28 112.74 87.08 36.38 110.99 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 13 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 47 ARG^? 13.44 O3' AMP B 902 183 LYS A 29 LYS~? 17.35 O2' AMP A 901 317 ARG C 65 ARG.? -3.67 O5' AMP A 901s coo 76.57 109.19 73.41 73.86 110.26 72.16 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 82.09 117.51 66.37 80.60 114.32 71.44 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.91 -49.00 -8.95 5.74 -49.26 -9.91 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 25 ARG^? 17.34 O2' AMP B 902 183 LYS B 34 LYS~? 18.46 N1 AMP B 902 317 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 76.57 109.19 73.41 73.86 110.26 72.16 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 82.09 117.51 66.37 80.60 114.32 71.44 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 65.21 120.62 58.76 63.62 123.14 59.66 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG C 36 ARG~? 10.59 O3P AMP B 903 183 LYS B 55 LYS.? 9.89 O1P AMP B 903 317 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG C 36 ARG~? 10.59 O3P AMP B 903 183 LYS B 55 LYS.? 9.89 O1P AMP B 903 317 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG C 36 ARG~? 10.59 O3P AMP B 903 183 LYS B 55 LYS.? 9.89 O1P AMP B 903 317 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 65.21 120.62 58.76 63.62 123.14 59.66 13.26 -36.00 -15.82 10.89 -34.30 -14.90 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 5 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 128 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 225 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 40.16 23.71 17.01 38.52 24.96 17.40 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 128 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 225 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 38.56 19.11 14.83 37.12 21.00 16.76 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 128 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 225 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 40.16 23.71 17.01 38.52 24.96 17.40 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 128 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 225 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 40.16 23.71 17.01 38.52 24.96 17.40 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 128 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 225 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 40.16 23.71 17.01 38.52 24.96 17.40 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 128 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 225 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bqc_c01 BETA-MANNANASE user 7 3 # 7 A 50 ARG B 36 ARG~? 10.26 O2P AMP B 902 A 128 GLU B 37 GLU~? 18.27 N6 AMP B 902 A 225 GLU B 33 GLU~? 17.08 O2' AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 36.48 24.43 22.02 36.86 26.34 21.13 13.62 -6.84 -9.34 14.57 -5.84 -7.75 coo 40.16 23.71 17.01 38.52 24.96 17.40 11.91 -10.56 -3.68 12.98 -9.62 -2.13 ULMN 3 1bqc_c01 BETA-MANNANASE user 8 3 # 8 A 50 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 128 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 225 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 38.56 19.11 14.83 37.12 21.00 16.76 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 36.48 24.43 22.02 36.86 26.34 21.13 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1bqc_c01 BETA-MANNANASE user 9 3 # 9 A 50 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 128 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 225 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 38.56 19.11 14.83 37.12 21.00 16.76 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 36.48 24.43 22.02 36.86 26.34 21.13 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bqc_c01 BETA-MANNANASE user 10 3 # 10 A 50 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 128 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 225 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 38.56 19.11 14.83 37.12 21.00 16.76 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 36.48 24.43 22.02 36.86 26.34 21.13 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1bqc_c01 BETA-MANNANASE user 11 3 # 11 A 50 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 128 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 225 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 38.56 19.11 14.83 37.12 21.00 16.76 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 36.48 24.43 22.02 36.86 26.34 21.13 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 40.16 23.71 17.01 38.52 24.96 17.40 16.05 -34.46 -21.85 15.11 -35.34 -20.19 1bqc_c01 source 1bqc BETA-MANNANASE : 11 hits 1bqc_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 13 ARG^? 9.68 C2 AMP B 902 127 ARG B 11 ARG^? 7.52 N1 AMP B 902 270 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -0.83 25.63 1.57 0.97 28.05 0.90 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG B 13 ARG^? 10.00 C2 AMP B 903 127 ARG C 11 ARG^? 7.32 C2 AMP B 903 270 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -0.83 25.63 1.57 0.97 28.05 0.90 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG C 13 ARG^? 8.59 C2 AMP A 901 127 ARG A 11 ARG^? 7.89 C2 AMP A 901 270 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -0.83 25.63 1.57 0.97 28.05 0.90 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 11.33 -24.73 -14.66 10.03 -26.36 -14.95 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 3 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 69 ASP.? 6.10 O2P AMP B 903 264 GLU B 23 GLU.? 19.12 O2P AMP B 903 328 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 45.62 80.42 43.69 45.65 82.01 45.07 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 23.11 -9.89 1.58 22.67 -8.31 0.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP C 20 ASP.? 6.67 O5' AMP A 901 264 GLU A 114 GLU.? 19.10 O1P AMP A 901 328 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 45.62 80.42 43.69 45.65 82.01 45.07 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 59.69 92.71 39.85 58.53 92.03 41.47 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.52 -51.71 -13.41 4.60 -53.19 -14.62 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY B 51 GLY^? -3.29 O2' AMP B 903s A 228 SER B 67 SER.? 5.89 O3' AMP B 903 A 549 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 19.07 -34.44 -2.79 19.33 -34.63 -2.01 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 20.15 -34.17 4.60 19.43 -33.36 2.42 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY C 51 GLY^? 3.80 O2' AMP A 901 A 228 SER C 67 SER.? 9.87 O3P AMP A 901 A 549 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 0.59 -40.66 -11.26 -0.01 -41.05 -10.86 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY B 51 GLY^? -3.29 O2' AMP B 903s B1228 SER B 67 SER.? 5.89 O3' AMP B 903 B1549 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 126.34 72.75 125.66 125.95 73.27 126.11 19.07 -34.44 -2.79 19.33 -34.63 -2.01 coo 131.65 74.68 129.41 130.31 72.73 128.82 20.15 -34.17 4.60 19.43 -33.36 2.42 coo 134.72 69.43 130.42 133.03 70.65 130.08 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY C 51 GLY^? 3.80 O2' AMP A 901 B1228 SER C 67 SER.? 9.87 O3P AMP A 901 B1549 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 126.34 72.75 125.66 125.95 73.27 126.11 0.59 -40.66 -11.26 -0.01 -41.05 -10.86 coo 131.65 74.68 129.41 130.31 72.73 128.82 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo 134.72 69.43 130.42 133.03 70.65 130.08 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 84 GLU~? 14.99 N1 AMP A 901 447 HIS A 81 HIS~? 14.35 N6 AMP A 901 485 ASN A 82 ASN~? 9.92 N6 AMP A 901 coo -7.99 19.51 30.67 -8.74 17.98 29.42 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo -15.81 17.12 25.99 -13.91 16.92 26.88 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -0.19 -40.04 -27.66 -0.71 -42.03 -28.29 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 1 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 48 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 24.35 4.55 25.11 25.94 3.23 25.53 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 48 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 24.35 4.55 25.11 25.94 3.23 25.53 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 50 TYR^? 6.90 O2' AMP B 902 A 173 ASP A 69 ASP.? 5.85 O1P AMP B 902 C 48 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 C 48 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 24.35 4.55 25.11 25.94 3.23 25.53 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 C 48 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 24.35 4.55 25.11 25.94 3.23 25.53 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 10.31 -28.72 0.63 8.60 -26.56 1.94 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 25 ARG^? 19.99 O3P AMP A 901 C 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 32.27 5.62 48.15 31.93 6.48 51.06 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 47 ARG^? 13.44 O3' AMP B 902 C 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 32.27 5.62 48.15 31.93 6.48 51.06 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 25 ARG^? 17.34 O2' AMP B 902 C 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 32.27 5.62 48.15 31.93 6.48 51.06 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 29.64 3.64 57.39 31.22 5.14 55.65 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 36 ARG~? 10.26 O2P AMP B 902 C 101 TYR A 50 TYR^? 6.90 O2' AMP B 902 C 173 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 32.27 5.62 48.15 31.93 6.48 51.06 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 29.64 3.64 57.39 31.22 5.14 55.65 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG B 47 ARG^? 13.42 O3' AMP B 903 C 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 32.27 5.62 48.15 31.93 6.48 51.06 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 29.64 3.64 57.39 31.22 5.14 55.65 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 21.25 -21.87 0.09 22.11 -23.74 -0.35 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 25 ARG^? 19.99 O3P AMP A 901 D 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 69.08 8.58 32.60 69.70 10.81 30.58 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 71.77 11.86 24.26 70.23 12.22 26.56 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 71.60 6.14 19.25 70.26 6.87 20.69 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 47 ARG^? 13.44 O3' AMP B 902 D 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 69.08 8.58 32.60 69.70 10.81 30.58 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 71.77 11.86 24.26 70.23 12.22 26.56 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 71.60 6.14 19.25 70.26 6.87 20.69 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 25 ARG^? 17.34 O2' AMP B 902 D 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 69.08 8.58 32.60 69.70 10.81 30.58 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 71.77 11.86 24.26 70.23 12.22 26.56 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 71.60 6.14 19.25 70.26 6.87 20.69 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 36 ARG~? 10.26 O2P AMP B 902 D 101 TYR A 50 TYR^? 6.90 O2' AMP B 902 D 173 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 69.08 8.58 32.60 69.70 10.81 30.58 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 71.77 11.86 24.26 70.23 12.22 26.56 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 47 ARG^? 13.42 O3' AMP B 903 D 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 69.08 8.58 32.60 69.70 10.81 30.58 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 71.77 11.86 24.26 70.23 12.22 26.56 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 71.60 6.14 19.25 70.26 6.87 20.69 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 25 ARG^? 18.57 O2' AMP B 903 D 101 TYR C 28 TYR~? 12.81 O2' AMP B 903 D 173 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 69.08 8.58 32.60 69.70 10.81 30.58 17.53 -50.28 2.99 20.10 -49.22 1.88 coo 71.77 11.86 24.26 70.23 12.22 26.56 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG C 47 ARG^? 14.09 O3' AMP A 901 D 101 TYR C 28 TYR~? 12.81 O2' AMP B 903 D 173 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 69.08 8.58 32.60 69.70 10.81 30.58 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 71.77 11.86 24.26 70.23 12.22 26.56 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 D 48 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 173 ASP A 20 ASP.? 5.75 O3P AMP B 902 D 48 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 50 TYR^? 6.90 O2' AMP B 902 B 173 ASP A 69 ASP.? 5.85 O1P AMP B 902 D 48 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 D 48 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 173 ASP B 20 ASP.? 4.50 O2P AMP B 903 D 48 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 10.31 -28.72 0.63 8.60 -26.56 1.94 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c03 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 340 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 395 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1cwy_c00 source 1cwy AMYLOMALTASE : 1 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 56 ILE A 14 ILE^? 9.73 O4' AMP B 902 A 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -0.20 -29.60 -18.56 -1.23 -30.17 -19.18 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 56 ILE A 73 ILE^? 7.17 O4' AMP B 902 A 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 3.81 -29.37 -13.29 4.22 -28.67 -13.09 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 56 ILE A 99 ILE^? 10.51 O4' AMP B 902 A 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.01 -26.39 -23.09 0.00 -27.36 -23.54 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 56 ILE A 16 ILE^? 6.79 C5' AMP B 902 A 82 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -3.01 -25.80 -14.54 -3.58 -27.04 -15.03 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 56 ILE A 49 ILE.? 10.34 O2' AMP B 902 A 82 TYR A 50 TYR^? 6.90 O2' AMP B 902 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 6.84 -24.77 -2.53 8.19 -25.11 -2.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 6.03 -18.98 -5.10 5.67 -16.40 -6.13 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 56 ILE A 14 ILE^? 9.73 O4' AMP B 902 A 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -0.20 -29.60 -18.56 -1.23 -30.17 -19.18 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 56 ILE A 99 ILE^? 10.51 O4' AMP B 902 A 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.01 -26.39 -23.09 0.00 -27.36 -23.54 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 56 ILE B 14 ILE^? 9.58 O4' AMP B 903 A 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 18.12 -22.11 -10.13 18.20 -20.80 -10.18 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 56 ILE B 73 ILE^? 7.25 O2' AMP B 903 A 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.27 -27.32 -8.49 14.61 -28.09 -8.28 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 56 ILE B 99 ILE^? 10.43 O4' AMP B 903 A 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 22.85 -22.92 -13.27 22.67 -21.47 -13.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 56 ILE B 49 ILE.? 10.20 O2' AMP B 903 A 82 TYR B 50 TYR^? 7.37 O3' AMP B 903 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 11.36 -35.82 -0.53 10.49 -36.76 -1.15 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 17.59 -37.29 -0.29 20.29 -37.88 0.15 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 56 ILE B 14 ILE^? 9.58 O4' AMP B 903 A 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 18.12 -22.11 -10.13 18.20 -20.80 -10.18 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 56 ILE B 99 ILE^? 10.43 O4' AMP B 903 A 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 22.85 -22.92 -13.27 22.67 -21.47 -13.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 56 ILE C 14 ILE^? 9.74 O4' AMP A 901 A 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.68 -43.12 -11.94 15.71 -43.78 -11.58 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 15 3 # 15 A 37 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 56 ILE C 73 ILE^? 7.30 O2' AMP A 901 A 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 10.73 -38.02 -10.27 9.93 -37.87 -10.58 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 16 3 # 16 A 37 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 56 ILE C 99 ILE^? 10.32 O4' AMP A 901 A 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.75 -45.16 -16.96 15.89 -45.73 -16.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 17 3 # 17 A 37 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 56 ILE C 16 ILE^? 7.22 O4' AMP A 901 A 82 TYR C 28 TYR~? 12.81 O2' AMP B 903 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 10.11 -46.00 -8.75 11.60 -45.98 -8.53 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 12.98 -43.06 -2.71 12.25 -41.79 -0.32 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 18 3 # 18 A 37 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 56 ILE C 49 ILE.? 10.74 O2' AMP A 901 A 82 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.14 -34.59 -5.67 -0.05 -33.18 -5.94 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 19 3 # 19 A 37 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 56 ILE C 14 ILE^? 9.74 O4' AMP A 901 A 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.68 -43.12 -11.94 15.71 -43.78 -11.58 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 20 3 # 20 A 37 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 56 ILE C 99 ILE^? 10.32 O4' AMP A 901 A 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.75 -45.16 -16.96 15.89 -45.73 -16.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.15 -41.30 -13.86 9.45 -38.89 -15.22 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 20 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 56 ILE A 14 ILE^? 9.73 O4' AMP B 902 B 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -0.20 -29.60 -18.56 -1.23 -30.17 -19.18 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 56 ILE A 73 ILE^? 7.17 O4' AMP B 902 B 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 3.81 -29.37 -13.29 4.22 -28.67 -13.09 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 56 ILE A 99 ILE^? 10.51 O4' AMP B 902 B 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.01 -26.39 -23.09 0.00 -27.36 -23.54 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 56 ILE A 16 ILE^? 6.79 C5' AMP B 902 B 82 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -3.01 -25.80 -14.54 -3.58 -27.04 -15.03 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 56 ILE A 49 ILE.? 10.34 O2' AMP B 902 B 82 TYR A 50 TYR^? 6.90 O2' AMP B 902 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 6.84 -24.77 -2.53 8.19 -25.11 -2.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 6.03 -18.98 -5.10 5.67 -16.40 -6.13 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP A 96 ASP.? 4.70 O3P AMP B 902 B 56 ILE A 14 ILE^? 9.73 O4' AMP B 902 B 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -0.20 -29.60 -18.56 -1.23 -30.17 -19.18 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP A 96 ASP.? 4.70 O3P AMP B 902 B 56 ILE A 99 ILE^? 10.51 O4' AMP B 902 B 82 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.01 -26.39 -23.09 0.00 -27.36 -23.54 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 56 ILE B 14 ILE^? 9.58 O4' AMP B 903 B 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 18.12 -22.11 -10.13 18.20 -20.80 -10.18 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 56 ILE B 73 ILE^? 7.25 O2' AMP B 903 B 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.27 -27.32 -8.49 14.61 -28.09 -8.28 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 56 ILE B 49 ILE.? 10.20 O2' AMP B 903 B 82 TYR B 50 TYR^? 7.37 O3' AMP B 903 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 11.36 -35.82 -0.53 10.49 -36.76 -1.15 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 17.59 -37.29 -0.29 20.29 -37.88 0.15 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 56 ILE B 72 ILE^? 9.15 O3' AMP B 903 B 82 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.51 -24.92 -3.28 13.04 -24.19 -3.06 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 13.87 -20.58 -2.07 11.87 -21.01 -0.16 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP B 96 ASP.? -3.09 O1P AMP B 903s B 56 ILE B 14 ILE^? 9.58 O4' AMP B 903 B 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 18.12 -22.11 -10.13 18.20 -20.80 -10.18 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP B 96 ASP.? -3.09 O1P AMP B 903s B 56 ILE B 99 ILE^? 10.43 O4' AMP B 903 B 82 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 22.85 -22.92 -13.27 22.67 -21.47 -13.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.04 -28.23 -9.37 17.78 -29.61 -11.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 14 3 # 14 B 37 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 56 ILE C 14 ILE^? 9.74 O4' AMP A 901 B 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.68 -43.12 -11.94 15.71 -43.78 -11.58 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 15 3 # 15 B 37 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 56 ILE C 73 ILE^? 7.30 O2' AMP A 901 B 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 10.73 -38.02 -10.27 9.93 -37.87 -10.58 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 16 3 # 16 B 37 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 56 ILE C 16 ILE^? 7.22 O4' AMP A 901 B 82 TYR C 28 TYR~? 12.81 O2' AMP B 903 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 10.11 -46.00 -8.75 11.60 -45.98 -8.53 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 12.98 -43.06 -2.71 12.25 -41.79 -0.32 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 17 3 # 17 B 37 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 56 ILE C 49 ILE.? 10.74 O2' AMP A 901 B 82 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.14 -34.59 -5.67 -0.05 -33.18 -5.94 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 18 3 # 18 B 37 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 56 ILE C 72 ILE^? 8.83 O2' AMP A 901 B 82 TYR C 28 TYR~? 12.81 O2' AMP B 903 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 9.52 -41.65 -5.82 10.00 -40.83 -4.68 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 12.98 -43.06 -2.71 12.25 -41.79 -0.32 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 19 3 # 19 B 37 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 56 ILE C 14 ILE^? 9.74 O4' AMP A 901 B 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.68 -43.12 -11.94 15.71 -43.78 -11.58 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 20 3 # 20 B 37 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 56 ILE C 99 ILE^? 10.32 O4' AMP A 901 B 82 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.75 -45.16 -16.96 15.89 -45.73 -16.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.15 -41.30 -13.86 9.45 -38.89 -15.22 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 20 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 22 TRP^? 15.49 O3P AMP B 902 A 243 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 272 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 18.21 54.75 18.05 19.91 55.17 21.59 -13.78 -29.18 -17.67 -13.35 -26.19 -20.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 22 TRP^? 15.49 O3P AMP B 902 A 243 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 272 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 18.21 54.75 18.05 19.91 55.17 21.59 -13.78 -29.18 -17.67 -13.35 -26.19 -20.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP B 22 TRP^? 14.95 O2P AMP B 903 A 243 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 272 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 18.21 54.75 18.05 19.91 55.17 21.59 21.53 -11.97 -1.43 25.21 -12.76 -2.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP B 22 TRP^? 14.95 O2P AMP B 903 A 243 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 272 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 18.21 54.75 18.05 19.91 55.17 21.59 21.53 -11.97 -1.43 25.21 -12.76 -2.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP C 22 TRP^? 16.70 O5' AMP A 901 A 243 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 272 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 18.21 54.75 18.05 19.91 55.17 21.59 17.49 -53.71 -3.88 16.62 -55.87 -7.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP C 22 TRP^? 16.70 O5' AMP A 901 A 243 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 272 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 18.21 54.75 18.05 19.91 55.17 21.59 17.49 -53.71 -3.88 16.62 -55.87 -7.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 17.40 -51.44 -14.48 19.12 -51.90 -20.49 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 6 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 243 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 272 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 16.93 55.67 9.65 17.16 54.23 11.19 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 243 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 272 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 2.03 68.31 21.46 0.66 68.36 23.90 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 16.93 55.67 9.65 17.16 54.23 11.19 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 46 TYR^? 8.25 O2' AMP A 901 A 243 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 272 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 46 TYR^? 8.25 O2' AMP A 901 A 243 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 272 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 46 TYR^? 8.25 O2' AMP A 901 A 243 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 272 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR A 46 TYR^? 8.25 O2' AMP A 901 A 243 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 272 LYS C 85 LYS~? 15.28 N6 AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.67 -46.79 -15.77 32.41 -44.78 -16.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR A 50 TYR^? 6.90 O2' AMP B 902 A 243 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 272 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 243 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 272 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 2.03 68.31 21.46 0.66 68.36 23.90 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 243 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 272 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 2.03 68.31 21.46 0.66 68.36 23.90 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 46 TYR^? 7.73 N3 AMP B 902 A 243 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 272 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.40 -27.99 -8.79 8.40 -27.73 -11.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR B 46 TYR^? 7.73 N3 AMP B 902 A 243 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 272 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.40 -27.99 -8.79 8.40 -27.73 -11.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 17.40 -51.44 -14.48 19.12 -51.90 -20.49 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR B 46 TYR^? 7.73 N3 AMP B 902 A 243 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 272 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.40 -27.99 -8.79 8.40 -27.73 -11.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 17.40 -51.44 -14.48 19.12 -51.90 -20.49 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 243 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 272 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 243 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 272 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR C 46 TYR^? 7.86 O2' AMP B 903 A 243 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 272 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 2.03 68.31 21.46 0.66 68.36 23.90 11.40 -33.98 -8.06 13.29 -32.33 -9.27 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR C 46 TYR^? 7.86 O2' AMP B 903 A 243 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 272 LYS B 85 LYS~? 13.55 N6 AMP B 902 coo 2.03 68.31 21.46 0.66 68.36 23.90 11.40 -33.98 -8.06 13.29 -32.33 -9.27 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.32 -12.07 -18.16 16.10 -8.70 -17.98 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 16 hits 1d7r_c02 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo 17.92 60.45 -3.51 16.63 61.88 -2.68 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 11.37 50.89 2.29 11.05 51.63 2.25 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1ddj_c12 source 1ddj PLASMINOGEN : 1 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1ddj_c13 source 1ddj PLASMINOGEN : 1 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 C 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 C 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo 15.33 59.81 59.60 13.98 60.99 60.69 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 16.06 55.72 54.73 15.97 56.49 56.70 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 9.38 49.29 65.28 9.01 50.03 65.31 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1ddj_c14 source 1ddj PLASMINOGEN : 1 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 D 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 D 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo -30.51 33.83 43.05 -30.50 33.12 45.03 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -25.73 33.05 39.28 -27.50 34.05 39.88 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -27.66 47.32 40.66 -27.81 47.01 41.41 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1ddj_c15 source 1ddj PLASMINOGEN : 1 hits 1ddj_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 138 ARG A 47 ARG^? 13.44 O3' AMP B 902 A 161 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 29.03 88.95 86.80 28.09 90.57 84.75 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 23.31 93.18 82.88 23.00 93.71 79.86 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 33.83 91.15 88.62 31.07 91.06 83.02 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 138 ARG B 47 ARG^? 13.42 O3' AMP B 903 A 161 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 29.03 88.95 86.80 28.09 90.57 84.75 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 23.31 93.18 82.88 23.00 93.71 79.86 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 33.83 91.15 88.62 31.07 91.06 83.02 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 138 ARG C 47 ARG^? 14.09 O3' AMP A 901 A 161 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 29.03 88.95 86.80 28.09 90.57 84.75 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 23.31 93.18 82.88 23.00 93.71 79.86 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 33.83 91.15 88.62 31.07 91.06 83.02 16.56 -44.53 -0.92 13.96 -43.62 4.72 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 138 ARG A 47 ARG^? 13.44 O3' AMP B 902 B 161 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 4.62 122.69 99.88 5.46 122.82 97.24 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 10.44 122.27 94.08 11.02 123.87 91.53 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo -0.17 119.75 99.65 2.51 123.83 95.70 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 138 ARG B 47 ARG^? 13.42 O3' AMP B 903 B 161 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 4.62 122.69 99.88 5.46 122.82 97.24 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 10.44 122.27 94.08 11.02 123.87 91.53 10.31 -28.72 0.63 8.60 -26.56 1.94 coo -0.17 119.75 99.65 2.51 123.83 95.70 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR C 28 TYR~? 12.81 O2' AMP B 903 B 138 ARG C 47 ARG^? 14.09 O3' AMP A 901 B 161 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 4.62 122.69 99.88 5.46 122.82 97.24 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 10.44 122.27 94.08 11.02 123.87 91.53 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo -0.17 119.75 99.65 2.51 123.83 95.70 16.56 -44.53 -0.92 13.96 -43.62 4.72 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c01 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 183 LYS B 21 LYS^? 13.50 O2P AMP B 903 A 278 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 19.43 18.53 42.32 17.66 18.80 40.15 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 21.92 15.80 36.19 17.64 19.44 36.35 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 15.46 19.03 31.40 15.01 18.25 33.31 26.76 -24.76 -2.38 27.99 -26.49 -2.17 1do8_c00 source 1do8 MALIC ENZYME : 1 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 183 LYS B 21 LYS^? 13.50 O2P AMP B 903 B 278 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 58.62 15.99 58.34 60.98 14.60 58.93 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 60.11 10.60 53.63 62.59 10.74 58.67 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.76 -24.76 -2.38 27.99 -26.49 -2.17 1do8_c01 source 1do8 MALIC ENZYME : 1 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 183 LYS B 21 LYS^? 13.50 O2P AMP B 903 C 278 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 26.76 -24.76 -2.38 27.99 -26.49 -2.17 1do8_c02 source 1do8 MALIC ENZYME : 1 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 183 LYS B 21 LYS^? 13.50 O2P AMP B 903 D 278 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 26.76 -24.76 -2.38 27.99 -26.49 -2.17 1do8_c03 source 1do8 MALIC ENZYME : 1 hits 1do8_c03 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 277 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 13.04 31.88 60.72 10.57 35.34 57.49 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 215 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 277 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 13.06 30.79 51.73 11.40 35.76 53.48 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 13.04 31.88 60.72 10.57 35.34 57.49 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 215 LYS A 21 LYS^? 15.53 O3P AMP B 902 A 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 215 LYS A 21 LYS^? 15.53 O3P AMP B 902 A 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 13.06 30.79 51.73 11.40 35.76 53.48 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 215 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 215 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 277 LYS A 34 LYS~? 19.00 N1 AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 13.06 30.79 51.73 11.40 35.76 53.48 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 13.04 31.88 60.72 10.57 35.34 57.49 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 277 LYS B 85 LYS~? 13.55 N6 AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 20.32 -12.07 -18.16 16.10 -8.70 -17.98 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 215 LYS B 21 LYS^? 13.50 O2P AMP B 903 A 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 13.06 30.79 51.73 11.40 35.76 53.48 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 13.04 31.88 60.72 10.57 35.34 57.49 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 54 LYS.? 8.42 N6 AMP B 903 A 215 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 277 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 54 LYS.? 8.42 N6 AMP B 903 A 215 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 277 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 13.04 31.88 60.72 10.57 35.34 57.49 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 215 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 277 LYS B 34 LYS~? 18.46 N1 AMP B 902 coo 0.50 24.09 51.68 1.51 29.34 52.35 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 13.04 31.88 60.72 10.57 35.34 57.49 14.79 -10.69 -8.44 19.07 -7.28 -9.56 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 277 LYS C 85 LYS~? 15.28 N6 AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 13.06 30.79 51.73 11.40 35.76 53.48 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 26.67 -46.79 -15.77 32.41 -44.78 -16.80 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 13.06 30.79 51.73 11.40 35.76 53.48 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 215 LYS C 21 LYS^? 15.49 O2P AMP A 901 A 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 13.06 30.79 51.73 11.40 35.76 53.48 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 13.04 31.88 60.72 10.57 35.34 57.49 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 13.06 30.79 51.73 11.40 35.76 53.48 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS C 54 LYS.? 9.50 O1P AMP A 901 A 215 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 0.50 24.09 51.68 1.51 29.34 52.35 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 215 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 277 LYS C 34 LYS~? 17.13 N6 AMP B 903 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 13.06 30.79 51.73 11.40 35.76 53.48 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 13.04 31.88 60.72 10.57 35.34 57.49 24.06 -46.65 -4.78 27.74 -49.81 -6.72 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 21 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 277 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 17.88 38.77 19.81 16.38 34.23 17.24 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 20.33 37.78 11.20 16.77 34.53 13.47 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 17.88 38.77 19.81 16.38 34.23 17.24 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 215 LYS A 21 LYS^? 15.53 O3P AMP B 902 B 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 215 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 277 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 215 LYS A 21 LYS^? 15.53 O3P AMP B 902 B 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 17.88 38.77 19.81 16.38 34.23 17.24 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 215 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 17.88 38.77 19.81 16.38 34.23 17.24 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 277 LYS B 85 LYS~? 13.55 N6 AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 20.32 -12.07 -18.16 16.10 -8.70 -17.98 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 215 LYS B 21 LYS^? 13.50 O2P AMP B 903 B 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 17.88 38.77 19.81 16.38 34.23 17.24 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 20.33 37.78 11.20 16.77 34.53 13.47 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 215 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 277 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS B 54 LYS.? 8.42 N6 AMP B 903 B 215 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 277 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 17.88 38.77 19.81 16.38 34.23 17.24 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 215 LYS B 21 LYS^? 13.50 O2P AMP B 903 B 277 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 20.33 37.78 11.20 16.77 34.53 13.47 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 215 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 277 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 6.78 45.91 16.15 7.82 40.81 15.84 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 20.33 37.78 11.20 16.77 34.53 13.47 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 277 LYS C 85 LYS~? 15.28 N6 AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 26.67 -46.79 -15.77 32.41 -44.78 -16.80 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 215 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 277 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 20.33 37.78 11.20 16.77 34.53 13.47 17.40 -51.44 -14.48 19.12 -51.90 -20.49 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 215 LYS C 21 LYS^? 15.49 O2P AMP A 901 B 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 215 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 277 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS C 54 LYS.? 9.50 O1P AMP A 901 B 215 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 277 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 6.78 45.91 16.15 7.82 40.81 15.84 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 17.88 38.77 19.81 16.38 34.23 17.24 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 215 LYS C 21 LYS^? 15.49 O2P AMP A 901 B 277 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 17.88 38.77 19.81 16.38 34.23 17.24 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 B 131 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 215 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 277 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 17.88 38.77 19.81 16.38 34.23 17.24 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 B 131 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 215 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 277 LYS C 34 LYS~? 17.13 N6 AMP B 903 coo 6.78 45.91 16.15 7.82 40.81 15.84 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 17.88 38.77 19.81 16.38 34.23 17.24 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 24.06 -46.65 -4.78 27.74 -49.81 -6.72 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 22 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 40 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 103 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 40 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 103 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 40 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 103 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 3 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 40 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 103 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 40 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 103 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 28 TYR~? 12.81 O2' AMP B 903 B 40 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 103 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 3 hits 1e3v_c03 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 177 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 203 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 8.74 45.76 47.19 9.33 46.93 45.56 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 11.68 42.31 52.96 12.05 43.92 51.65 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 18.07 52.81 49.62 14.17 49.99 48.07 0.63 -48.72 -18.32 2.49 -53.34 -22.30 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 177 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 203 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 8.74 45.76 47.19 9.33 46.93 45.56 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 11.68 42.31 52.96 12.05 43.92 51.65 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 18.07 52.81 49.62 14.17 49.99 48.07 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1ecx_c02 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 177 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 203 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 14.87 88.04 21.51 13.64 87.90 19.81 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 15.87 92.46 27.37 14.46 91.76 25.94 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 3.60 91.42 23.52 8.20 89.55 22.63 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1ecx_c03 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 197 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 223 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 1 hits 1elq_c02 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 193 GLU A 84 GLU~? 14.99 N1 AMP A 901 A 217 VAL A 87 VAL~? 14.64 N1 AMP A 901 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo -5.33 11.71 69.72 -4.62 11.92 67.73 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -2.69 -30.89 -26.75 -0.88 -29.92 -27.50 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 193 GLU B 84 GLU~? 17.85 N6 AMP B 902 A 217 VAL B 87 VAL~? 14.26 N1 AMP B 902 coo 2.10 10.68 61.44 -2.14 13.16 60.61 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 23.05 -14.25 -21.41 23.75 -13.21 -23.10 coo 0.07 12.29 66.53 -0.24 11.95 64.38 22.08 -16.43 -15.16 22.70 -18.11 -16.38 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 193 GLU C 84 GLU~? 17.40 N6 AMP B 903 A 217 VAL C 87 VAL~? 14.17 N1 AMP B 903 coo 2.10 10.68 61.44 -2.14 13.16 60.61 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 0.07 12.29 66.53 -0.24 11.95 64.38 21.13 -47.06 -15.83 20.11 -46.32 -17.60 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 193 GLU A 5 GLU.? 10.94 N7 AMP A 901 A 217 VAL A 109 VAL.? 7.19 N7 AMP A 901 coo 2.10 10.68 61.44 -2.14 13.16 60.61 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 0.07 12.29 66.53 -0.24 11.95 64.38 9.85 -49.56 -18.32 7.86 -49.55 -19.24 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 44 THR^? -3.23 O2' AMP A 901s A 159 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 193 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo -2.58 16.31 54.79 -4.02 14.93 55.64 2.92 -37.69 -13.31 4.88 -38.43 -12.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 44 THR^? -3.23 O2' AMP A 901s A 159 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 193 GLU A 37 GLU~? 17.03 O3P AMP A 901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 2.92 -37.69 -13.31 4.88 -38.43 -12.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -11.27 -41.71 -19.38 -13.11 -40.80 -18.93 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 44 THR^? -3.44 O2' AMP B 902s A 159 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 193 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo -2.58 16.31 54.79 -4.02 14.93 55.64 7.91 -22.45 -10.71 6.46 -23.83 -11.55 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 44 THR^? -3.44 O2' AMP B 902s A 159 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 193 GLU B 37 GLU~? 18.27 N6 AMP B 902 coo -2.58 16.31 54.79 -4.02 14.93 55.64 7.91 -22.45 -10.71 6.46 -23.83 -11.55 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 13.62 -6.84 -9.34 14.57 -5.84 -7.75 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 100 THR^? 7.69 N1 AMP B 903 A 159 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 193 GLU C 3 GLU.? 18.12 O1P AMP B 903 coo -2.58 16.31 54.79 -4.02 14.93 55.64 21.14 -26.34 -16.07 20.32 -28.16 -15.18 coo 2.10 10.68 61.44 -2.14 13.16 60.61 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 33.90 -21.03 -18.59 35.21 -20.12 -17.24 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR C 44 THR^? -3.07 O2' AMP B 903s A 159 LYS B 54 LYS.? 8.42 N6 AMP B 903 A 193 GLU C 5 GLU.? 7.68 N6 AMP B 903 coo -2.58 16.31 54.79 -4.02 14.93 55.64 17.37 -34.76 -6.61 17.02 -32.65 -7.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo -5.33 11.71 69.72 -4.62 11.92 67.73 30.74 -27.65 -13.81 29.58 -28.42 -12.20 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR C 44 THR^? -3.07 O2' AMP B 903s A 159 LYS B 54 LYS.? 8.42 N6 AMP B 903 A 193 GLU C 37 GLU~? 17.52 N1 AMP B 903 coo -2.58 16.31 54.79 -4.02 14.93 55.64 17.37 -34.76 -6.61 17.02 -32.65 -7.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.63 -46.66 -1.86 26.53 -48.46 -1.73 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR C 44 THR^? -3.07 O2' AMP B 903s A 159 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 193 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 17.37 -34.76 -6.61 17.02 -32.65 -7.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR C 44 THR^? -3.07 O2' AMP B 903s A 159 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 193 GLU C 37 GLU~? 17.52 N1 AMP B 903 coo -2.58 16.31 54.79 -4.02 14.93 55.64 17.37 -34.76 -6.61 17.02 -32.65 -7.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.63 -46.66 -1.86 26.53 -48.46 -1.73 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR C 100 THR^? 7.96 N1 AMP A 901 A 159 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 193 GLU A 3 GLU.? 19.16 N7 AMP A 901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.11 -41.21 -19.38 12.34 -40.02 -18.95 coo 2.10 10.68 61.44 -2.14 13.16 60.61 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo -5.33 11.71 69.72 -4.62 11.92 67.73 17.96 -53.90 -26.14 17.70 -55.67 -24.99 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 10 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 78 ASP^? 5.94 N6 AMP A 901 260 GLU A 75 GLU^? -5.62 C2 AMP A 901s 370 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 9.15 -41.30 -13.86 9.45 -38.89 -15.22 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 78 ASP^? 6.36 N6 AMP B 902 260 GLU B 75 GLU^? -4.88 C2 AMP B 902s 370 TYR A 15 TYR^? -4.88 N3 AMP B 902s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 3.91 -25.44 -16.29 6.51 -26.42 -16.58 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 78 ASP^? 6.25 N6 AMP B 903 260 GLU C 75 GLU^? -5.53 C2 AMP B 903s 370 TYR B 15 TYR^? -4.78 N3 AMP B 903s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 19.04 -28.23 -9.37 17.78 -29.61 -11.45 1euu_c00 source 1euu SIALIDASE : 3 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 5 GLU.? 10.94 N7 AMP A 901 A 260 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 270 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 50.99 29.43 12.86 52.11 29.45 14.65 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 39.80 27.50 22.98 42.20 26.56 21.34 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 48.83 21.70 19.50 47.44 24.99 15.25 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 1 hits 1euy_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE C 52 PHE^? 7.10 C5 AMP A 901 A 210 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 244 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 9.23 46.77 25.11 11.48 48.39 24.76 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.63 -52.84 -12.18 10.14 -58.60 -9.63 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE C 52 PHE^? 7.10 C5 AMP A 901 B 210 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 244 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 8.76 47.85 34.91 11.08 46.36 35.41 -2.10 -43.09 -15.14 -2.65 -42.08 -17.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -2.38 51.82 41.62 2.07 49.19 40.42 9.63 -52.84 -12.18 10.14 -58.60 -9.63 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 210 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 244 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 11.28 44.53 18.60 9.91 46.00 19.20 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -1.20 42.34 17.67 3.19 45.13 19.06 0.63 -48.72 -18.32 2.49 -53.34 -22.30 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 210 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 244 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 11.28 44.53 18.60 9.91 46.00 19.20 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 210 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 244 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 10.08 50.18 41.78 8.91 48.61 41.04 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 9.06 56.85 40.30 7.71 55.27 39.90 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -2.38 51.82 41.62 2.07 49.19 40.42 0.63 -48.72 -18.32 2.49 -53.34 -22.30 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 210 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 244 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 10.08 50.18 41.78 8.91 48.61 41.04 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 142 LEU A 70 LEU.? 8.23 O3' AMP B 902 A 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -0.21 -24.85 -4.94 0.93 -24.78 -3.03 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 A 165 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 14.43 -30.09 1.51 13.16 -31.69 2.32 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 142 LEU C 70 LEU.? 8.49 O3' AMP A 901 A 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 2.79 -40.45 -3.85 1.18 -39.29 -2.99 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 16.56 -44.53 -0.92 13.96 -43.62 4.72 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 142 LEU A 70 LEU.? 8.23 O3' AMP B 902 B 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -0.21 -24.85 -4.94 0.93 -24.78 -3.03 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 B 165 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 14.43 -30.09 1.51 13.16 -31.69 2.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 B 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 14.43 -30.09 1.51 13.16 -31.69 2.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR C 28 TYR~? 12.81 O2' AMP B 903 B 142 LEU C 70 LEU.? 8.49 O3' AMP A 901 B 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 2.79 -40.45 -3.85 1.18 -39.29 -2.99 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 142 LEU A 70 LEU.? 8.23 O3' AMP B 902 C 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -0.21 -24.85 -4.94 0.93 -24.78 -3.03 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 C 165 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 14.43 -30.09 1.51 13.16 -31.69 2.32 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 50 TYR^? 7.37 O3' AMP B 903 C 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 C 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 14.43 -30.09 1.51 13.16 -31.69 2.32 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR C 28 TYR~? 12.81 O2' AMP B 903 C 142 LEU C 70 LEU.? 8.49 O3' AMP A 901 C 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 2.79 -40.45 -3.85 1.18 -39.29 -2.99 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR C 50 TYR^? 7.65 O3' AMP A 901 C 142 LEU C 70 LEU.? 8.49 O3' AMP A 901 C 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 2.79 -40.45 -3.85 1.18 -39.29 -2.99 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 142 LEU A 70 LEU.? 8.23 O3' AMP B 902 D 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -0.21 -24.85 -4.94 0.93 -24.78 -3.03 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 D 165 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 14.43 -30.09 1.51 13.16 -31.69 2.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 50 TYR^? 7.37 O3' AMP B 903 D 142 LEU B 70 LEU.? 8.11 O3' AMP B 903 D 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 14.43 -30.09 1.51 13.16 -31.69 2.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR C 28 TYR~? 12.81 O2' AMP B 903 D 142 LEU C 70 LEU.? 8.49 O3' AMP A 901 D 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 2.79 -40.45 -3.85 1.18 -39.29 -2.99 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER B 67 SER.? 5.89 O3' AMP B 903 A 48 THR B 68 THR.? 11.11 O3' AMP B 903 A 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 20.15 -34.17 4.60 19.43 -33.36 2.42 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 18.59 -31.45 6.76 19.44 -30.07 8.19 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER C 67 SER.? 9.87 O3P AMP A 901 A 48 THR C 68 THR.? 11.49 O3' AMP A 901 A 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -2.63 -43.74 -3.41 -4.09 -44.60 -2.09 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER B 67 SER.? 5.89 O3' AMP B 903 B 48 THR B 68 THR.? 11.11 O3' AMP B 903 B 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 20.15 -34.17 4.60 19.43 -33.36 2.42 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 18.59 -31.45 6.76 19.44 -30.07 8.19 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER C 67 SER.? 9.87 O3P AMP A 901 B 48 THR C 68 THR.? 11.49 O3' AMP A 901 B 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -2.63 -43.74 -3.41 -4.09 -44.60 -2.09 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER B 67 SER.? 5.89 O3' AMP B 903 C 48 THR B 68 THR.? 11.11 O3' AMP B 903 C 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 20.15 -34.17 4.60 19.43 -33.36 2.42 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 18.59 -31.45 6.76 19.44 -30.07 8.19 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER C 67 SER.? 9.87 O3P AMP A 901 C 48 THR C 68 THR.? 11.49 O3' AMP A 901 C 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -2.63 -43.74 -3.41 -4.09 -44.60 -2.09 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER B 67 SER.? 5.89 O3' AMP B 903 D 48 THR B 68 THR.? 11.11 O3' AMP B 903 D 165 LYS C 29 LYS~? 16.03 O2' AMP B 903 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 20.15 -34.17 4.60 19.43 -33.36 2.42 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 18.59 -31.45 6.76 19.44 -30.07 8.19 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 16.56 -44.53 -0.92 13.96 -43.62 4.72 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER C 67 SER.? 9.87 O3P AMP A 901 D 48 THR C 68 THR.? 11.49 O3' AMP A 901 D 165 LYS A 29 LYS~? 17.35 O2' AMP A 901 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -2.63 -43.74 -3.41 -4.09 -44.60 -2.09 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.99 34.33 109.92 10.08 34.19 110.77 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.48 30.30 107.06 11.75 30.99 109.44 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.99 34.33 109.92 10.08 34.19 110.77 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 136 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 11.99 34.33 109.92 10.08 34.19 110.77 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 136 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 11.99 34.33 109.92 10.08 34.19 110.77 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 136 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 246 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG B 36 ARG~? 10.26 O2P AMP B 902 A 136 GLU B 37 GLU~? 18.27 N6 AMP B 902 A 246 GLU B 33 GLU~? 17.08 O2' AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 9.46 32.37 115.82 8.50 34.20 115.47 13.62 -6.84 -9.34 14.57 -5.84 -7.75 coo 11.99 34.33 109.92 10.08 34.19 110.77 11.91 -10.56 -3.68 12.98 -9.62 -2.13 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 13.48 30.30 107.06 11.75 30.99 109.44 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 9.46 32.37 115.82 8.50 34.20 115.47 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.48 30.30 107.06 11.75 30.99 109.44 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 9.46 32.37 115.82 8.50 34.20 115.47 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 10 3 # 10 A 45 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.48 30.30 107.06 11.75 30.99 109.44 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 9.46 32.37 115.82 8.50 34.20 115.47 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 11 3 # 11 A 45 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.48 30.30 107.06 11.75 30.99 109.44 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 9.46 32.37 115.82 8.50 34.20 115.47 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.99 34.33 109.92 10.08 34.19 110.77 16.05 -34.46 -21.85 15.11 -35.34 -20.19 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 11 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.94 29.84 106.80 11.67 30.40 108.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 9.52 31.97 115.23 8.45 33.74 114.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.92 33.82 109.35 10.10 33.50 110.39 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.94 29.84 106.80 11.67 30.40 108.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 9.52 31.97 115.23 8.45 33.74 114.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 136 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 246 GLU A 102 GLU^? 11.43 N1 AMP B 902 coo 13.94 29.84 106.80 11.67 30.40 108.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 9.52 31.97 115.23 8.45 33.74 114.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 11.92 33.82 109.35 10.10 33.50 110.39 11.95 -31.02 -23.64 10.59 -30.59 -22.08 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 136 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 246 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 13.94 29.84 106.80 11.67 30.40 108.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 9.52 31.97 115.23 8.45 33.74 114.72 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 36 ARG~? 10.26 O2P AMP B 902 A 136 GLU B 37 GLU~? 18.27 N6 AMP B 902 A 246 GLU B 33 GLU~? 17.08 O2' AMP B 902 coo 13.94 29.84 106.80 11.67 30.40 108.79 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 9.52 31.97 115.23 8.45 33.74 114.72 13.62 -6.84 -9.34 14.57 -5.84 -7.75 coo 11.92 33.82 109.35 10.10 33.50 110.39 11.91 -10.56 -3.68 12.98 -9.62 -2.13 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU B 102 GLU^? 11.34 N1 AMP B 902 coo 13.94 29.84 106.80 11.67 30.40 108.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 9.52 31.97 115.23 8.45 33.74 114.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.67 -28.95 -21.61 16.44 -28.51 -19.56 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.94 29.84 106.80 11.67 30.40 108.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 9.52 31.97 115.23 8.45 33.74 114.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 136 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.94 29.84 106.80 11.67 30.40 108.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 9.52 31.97 115.23 8.45 33.74 114.72 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.05 -34.46 -21.85 15.11 -35.34 -20.19 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 136 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 246 GLU C 102 GLU^? 11.80 C2 AMP B 903 coo 13.94 29.84 106.80 11.67 30.40 108.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 9.52 31.97 115.23 8.45 33.74 114.72 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 11.92 33.82 109.35 10.10 33.50 110.39 16.05 -34.46 -21.85 15.11 -35.34 -20.19 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 9 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 289 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 54.86 40.00 47.23 55.57 38.60 48.67 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 52.08 40.18 50.14 50.83 38.93 47.73 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 57.82 31.70 50.73 57.94 34.00 49.17 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 289 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 54.86 40.00 47.23 55.57 38.60 48.67 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 52.08 40.18 50.14 50.83 38.93 47.73 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 57.82 31.70 50.73 57.94 34.00 49.17 9.15 -41.30 -13.86 9.45 -38.89 -15.22 1foh_c00 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 289 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 90.56 80.24 98.04 90.36 81.53 96.34 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 86.62 80.67 97.51 87.37 82.00 100.10 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 91.83 88.28 92.88 92.60 85.93 94.14 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 289 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 90.56 80.24 98.04 90.36 81.53 96.34 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 86.62 80.67 97.51 87.37 82.00 100.10 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 91.83 88.28 92.88 92.60 85.93 94.14 9.15 -41.30 -13.86 9.45 -38.89 -15.22 1foh_c01 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s C 289 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 42.34 76.83 49.10 43.06 78.59 50.01 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 46.12 77.15 48.13 44.44 77.61 45.70 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 42.69 86.18 51.69 41.59 83.63 51.54 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP C 96 ASP.? -4.92 O1P AMP A 901s C 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s C 289 TYR C 15 TYR^? 4.73 N3 AMP A 901 coo 42.34 76.83 49.10 43.06 78.59 50.01 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 46.12 77.15 48.13 44.44 77.61 45.70 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 42.69 86.18 51.69 41.59 83.63 51.54 9.15 -41.30 -13.86 9.45 -38.89 -15.22 1foh_c02 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 281 ARG C 65 ARG.? -3.67 O5' AMP A 901s D 289 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 75.05 45.80 106.18 74.73 43.88 105.51 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 78.52 44.93 104.78 78.72 44.49 107.76 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 72.35 36.51 104.82 72.00 39.20 105.46 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 1foh_c03 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c03 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU B 18 GLU.? 10.73 O3' AMP B 903 A 47 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 161 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 37.12 18.35 73.76 37.09 16.69 72.44 14.19 -24.84 2.24 12.77 -26.14 3.06 coo 29.81 8.06 73.13 30.21 10.11 72.95 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 37.29 15.56 67.90 37.37 13.79 70.08 13.87 -20.58 -2.07 11.87 -21.01 -0.16 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU B 18 GLU.? 10.73 O3' AMP B 903 B 47 ASP B 96 ASP.? -3.09 O1P AMP B 903s B 161 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 53.87 35.49 53.22 55.44 35.72 54.61 14.19 -24.84 2.24 12.77 -26.14 3.06 coo 63.47 43.65 53.95 61.45 43.07 54.06 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 56.38 35.81 59.19 58.25 35.77 57.10 13.87 -20.58 -2.07 11.87 -21.01 -0.16 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 29 LYS~? 17.35 O2' AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 34 LYS~? 19.00 N1 AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 85 LYS~? 14.18 N6 AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 85 LYS~? 14.18 N6 AMP A 901 210 ARG A 13 ARG^? 9.68 C2 AMP B 902 225 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 27.81 15.44 77.10 25.66 16.50 75.19 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 91 LYS~? 16.71 N7 AMP B 902 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS A 91 LYS~? 16.71 N7 AMP B 902 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS A 91 LYS~? 16.71 N7 AMP B 902 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS B 29 LYS~? 16.31 O2' AMP B 902 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS B 34 LYS~? 18.46 N1 AMP B 902 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS B 54 LYS.? 8.42 N6 AMP B 903 210 ARG B 13 ARG^? 10.00 C2 AMP B 903 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS B 54 LYS.? 8.42 N6 AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS B 54 LYS.? 8.42 N6 AMP B 903 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS B 54 LYS.? 8.42 N6 AMP B 903 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS B 55 LYS.? 9.89 O1P AMP B 903 210 ARG B 13 ARG^? 10.00 C2 AMP B 903 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 15 3 # 15 160 LYS B 55 LYS.? 9.89 O1P AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 16 3 # 16 160 LYS B 55 LYS.? 9.89 O1P AMP B 903 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 17 3 # 17 160 LYS B 55 LYS.? 9.89 O1P AMP B 903 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 18 3 # 18 160 LYS B 85 LYS~? 13.55 N6 AMP B 902 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 20.32 -12.07 -18.16 16.10 -8.70 -17.98 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 19 3 # 19 160 LYS B 85 LYS~? 13.55 N6 AMP B 902 210 ARG B 13 ARG^? 10.00 C2 AMP B 903 225 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 20.32 -12.07 -18.16 16.10 -8.70 -17.98 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 20 3 # 20 160 LYS B 91 LYS~? 15.95 O1P AMP B 903 210 ARG B 11 ARG^? 7.52 N1 AMP B 902 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 21 3 # 21 160 LYS B 91 LYS~? 15.95 O1P AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 17.51 28.50 73.42 17.24 23.02 75.86 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 22 3 # 22 160 LYS B 91 LYS~? 15.95 O1P AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 23 3 # 23 160 LYS C 29 LYS~? 16.03 O2' AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 24 3 # 24 160 LYS C 34 LYS~? 17.13 N6 AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 25 3 # 25 160 LYS C 54 LYS.? 9.50 O1P AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 26 3 # 26 160 LYS C 54 LYS.? 9.50 O1P AMP A 901 210 ARG A 13 ARG^? 9.68 C2 AMP B 902 225 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 24.74 11.56 73.05 25.29 14.32 71.80 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 27.81 15.44 77.10 25.66 16.50 75.19 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 27 3 # 27 160 LYS C 54 LYS.? 9.50 O1P AMP A 901 210 ARG A 13 ARG^? 9.68 C2 AMP B 902 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 24.74 11.56 73.05 25.29 14.32 71.80 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 28 3 # 28 160 LYS C 54 LYS.? 9.50 O1P AMP A 901 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.63 -48.72 -18.32 2.49 -53.34 -22.30 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 29 3 # 29 160 LYS C 85 LYS~? 15.28 N6 AMP B 903 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 26.67 -46.79 -15.77 32.41 -44.78 -16.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 30 3 # 30 160 LYS C 85 LYS~? 15.28 N6 AMP B 903 210 ARG C 13 ARG^? 8.59 C2 AMP A 901 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 26.67 -46.79 -15.77 32.41 -44.78 -16.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 31 3 # 31 160 LYS C 91 LYS~? 16.75 C8 AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 32 3 # 32 160 LYS C 91 LYS~? 16.75 C8 AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 33 3 # 33 160 LYS C 91 LYS~? 16.75 C8 AMP A 901 210 ARG C 11 ARG^? 7.32 C2 AMP B 903 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 24.74 11.56 73.05 25.29 14.32 71.80 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 34 3 # 34 160 LYS C 95 LYS.? 12.30 O2P AMP A 901 210 ARG A 11 ARG^? 7.89 C2 AMP A 901 225 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 17.51 28.50 73.42 17.24 23.02 75.86 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 24.74 11.56 73.05 25.29 14.32 71.80 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 27.81 15.44 77.10 25.66 16.50 75.19 13.26 -36.00 -15.82 10.89 -34.30 -14.90 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 34 hits 1gsa_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 475 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 477 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.27 46.15 59.96 13.96 44.19 59.76 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 9.69 44.01 59.12 10.58 42.11 58.89 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 13.49 45.17 55.56 13.84 42.22 54.75 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 2 3 # 2 A 311 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 475 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 477 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.27 46.15 59.96 13.96 44.19 59.76 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 9.69 44.01 59.12 10.58 42.11 58.89 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.49 45.17 55.56 13.84 42.22 54.75 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 3 3 # 3 A 311 GLU C 33 GLU~? 17.24 O2' AMP B 903 A 475 GLU C 37 GLU~? 17.52 N1 AMP B 903 A 477 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 13.27 46.15 59.96 13.96 44.19 59.76 23.08 -46.28 0.12 22.30 -47.65 1.53 coo 9.69 44.01 59.12 10.58 42.11 58.89 27.63 -46.66 -1.86 26.53 -48.46 -1.73 coo 13.49 45.17 55.56 13.84 42.22 54.75 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 4 3 # 4 A 311 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 475 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 477 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.27 46.15 59.96 13.96 44.19 59.76 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 9.69 44.01 59.12 10.58 42.11 58.89 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 13.49 45.17 55.56 13.84 42.22 54.75 16.60 -33.12 -16.39 17.81 -30.41 -15.70 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 4 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 475 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 477 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 42.69 29.93 84.57 42.00 28.96 82.83 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 46.14 28.45 82.89 45.10 27.86 81.15 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 42.47 25.53 85.29 42.25 23.66 82.85 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 2 3 # 2 B 311 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 475 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 477 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 42.69 29.93 84.57 42.00 28.96 82.83 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 46.14 28.45 82.89 45.10 27.86 81.15 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 42.47 25.53 85.29 42.25 23.66 82.85 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 3 3 # 3 B 311 GLU C 33 GLU~? 17.24 O2' AMP B 903 B 475 GLU C 37 GLU~? 17.52 N1 AMP B 903 B 477 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 42.69 29.93 84.57 42.00 28.96 82.83 23.08 -46.28 0.12 22.30 -47.65 1.53 coo 46.14 28.45 82.89 45.10 27.86 81.15 27.63 -46.66 -1.86 26.53 -48.46 -1.73 coo 42.47 25.53 85.29 42.25 23.66 82.85 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 4 3 # 4 B 311 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 475 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 477 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 42.69 29.93 84.57 42.00 28.96 82.83 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 46.14 28.45 82.89 45.10 27.86 81.15 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 42.47 25.53 85.29 42.25 23.66 82.85 16.60 -33.12 -16.39 17.81 -30.41 -15.70 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 4 hits 1i19_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 200 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 23.24 46.58 4.39 24.43 46.59 2.66 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 1i29_c01 source 1i29 CSDB : 1 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 45 VAL^? 8.09 O2' AMP A 901 A 200 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 226 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.51 -34.68 -11.44 -0.61 -34.12 -11.40 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 45 VAL^? 8.09 O2' AMP A 901 A 200 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 226 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.51 -34.68 -11.44 -0.61 -34.12 -11.40 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.63 -52.84 -12.18 10.14 -58.60 -9.63 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 106 VAL^? 7.88 N6 AMP A 901 A 200 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 226 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.47 -43.56 -22.85 10.35 -43.87 -22.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 10.86 -51.86 -2.39 9.09 -50.05 2.40 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 109 VAL.? 7.19 N7 AMP A 901 A 200 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 226 LYS A 34 LYS~? 19.00 N1 AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 9.85 -49.56 -18.32 7.86 -49.55 -19.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 34.47 51.09 7.19 28.58 51.18 7.53 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 30 VAL~? 16.23 O2P AMP B 903 A 200 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 15.74 -13.64 -3.06 17.55 -12.72 -2.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 32 VAL~? 9.91 O2' AMP B 902 A 200 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 45 VAL^? 7.51 O2' AMP B 902 A 200 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 226 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo 19.13 38.05 1.41 19.72 38.80 -0.53 9.61 -23.48 -7.47 10.43 -22.01 -6.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 45 VAL^? 7.51 O2' AMP B 902 A 200 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 226 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo 19.13 38.05 1.41 19.72 38.80 -0.53 9.61 -23.48 -7.47 10.43 -22.01 -6.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 45 VAL^? 7.51 O2' AMP B 902 A 200 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 9.61 -23.48 -7.47 10.43 -22.01 -6.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 109 VAL.? 8.19 N7 AMP B 902 A 200 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 226 LYS B 34 LYS~? 18.46 N1 AMP B 902 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -0.10 -19.04 -22.61 1.06 -17.73 -23.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.79 -10.69 -8.44 19.07 -7.28 -9.56 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL C 45 VAL^? 7.43 O2' AMP B 903 A 200 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 226 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo 19.13 38.05 1.41 19.72 38.80 -0.53 14.29 -36.68 -5.52 14.47 -38.62 -4.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL C 45 VAL^? 7.43 O2' AMP B 903 A 200 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 226 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 14.29 -36.68 -5.52 14.47 -38.62 -4.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL C 45 VAL^? 7.43 O2' AMP B 903 A 200 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 226 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 14.29 -36.68 -5.52 14.47 -38.62 -4.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 34.47 51.09 7.19 28.58 51.18 7.53 0.63 -48.72 -18.32 2.49 -53.34 -22.30 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL C 74 VAL^? 8.37 C2 AMP B 903 A 200 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 226 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 14.93 -39.55 -8.92 16.00 -41.17 -7.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 34.47 51.09 7.19 28.58 51.18 7.53 0.63 -48.72 -18.32 2.49 -53.34 -22.30 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL C 87 VAL~? 14.17 N1 AMP B 903 A 200 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 21.13 -47.06 -15.83 20.11 -46.32 -17.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL C 89 VAL~? 16.55 N1 AMP B 903 A 200 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 22.93 -50.74 -12.30 24.38 -50.13 -10.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL C 101 VAL^? 12.51 N1 AMP B 903 A 200 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 226 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 17.13 -39.29 -20.54 18.95 -40.22 -21.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL C 106 VAL^? 7.95 N6 AMP B 903 A 200 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 226 LYS C 34 LYS~? 17.13 N6 AMP B 903 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.07 -27.38 -16.90 26.07 -28.98 -15.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.06 -46.65 -4.78 27.74 -49.81 -6.72 1i29_c03 source 1i29 CSDB : 18 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 74 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 74 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 11 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 74 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 74 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 B 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 9 hits 1idt_c01 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 47 ARG^? 13.44 O3' AMP B 902 A 581 ARG B 47 ARG^? 13.42 O3' AMP B 903 A 713 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.08 -38.28 -1.54 7.50 -37.49 1.03 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 47 ARG^? 13.44 O3' AMP B 902 A 581 ARG C 47 ARG^? 14.09 O3' AMP A 901 A 713 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG B 47 ARG^? 13.42 O3' AMP B 903 A 581 ARG A 47 ARG^? 13.44 O3' AMP B 902 A 713 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.08 -38.28 -1.54 7.50 -37.49 1.03 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 47 ARG^? 13.42 O3' AMP B 903 A 581 ARG C 47 ARG^? 14.09 O3' AMP A 901 A 713 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG C 47 ARG^? 14.09 O3' AMP A 901 A 581 ARG A 47 ARG^? 13.44 O3' AMP B 902 A 713 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG C 47 ARG^? 14.09 O3' AMP A 901 A 581 ARG B 47 ARG^? 13.42 O3' AMP B 903 A 713 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 6 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 58 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 424 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 112.10 61.46 19.99 111.82 60.65 18.07 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 117.85 63.62 21.08 115.96 63.25 20.18 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 118.47 57.23 15.57 119.32 58.77 16.73 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 58 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 424 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 112.10 61.46 19.99 111.82 60.65 18.07 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 117.85 63.62 21.08 115.96 63.25 20.18 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 118.47 57.23 15.57 119.32 58.77 16.73 14.19 -24.84 2.24 12.77 -26.14 3.06 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU C 5 GLU.? 7.68 N6 AMP B 903 A 56 LYS B 55 LYS.? 9.89 O1P AMP B 903 A 258 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo 42.33 1.56 26.99 42.38 2.91 28.66 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 38.45 -0.44 19.89 37.36 0.90 25.90 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU C 5 GLU.? 7.68 N6 AMP B 903 B 56 LYS B 55 LYS.? 9.89 O1P AMP B 903 B 258 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU C 5 GLU.? 7.68 N6 AMP B 903 C 56 LYS B 55 LYS.? 9.89 O1P AMP B 903 C 258 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU C 5 GLU.? 7.68 N6 AMP B 903 D 56 LYS B 55 LYS.? 9.89 O1P AMP B 903 D 258 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 163 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 222 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 48.06 78.22 50.94 48.51 78.27 53.98 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 54.85 84.16 52.60 54.26 81.23 53.34 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 163 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 222 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 48.06 78.22 50.94 48.51 78.27 53.98 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 163 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 222 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 163 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 222 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 51.27 81.34 48.31 51.67 80.79 50.28 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 48.06 78.22 50.94 48.51 78.27 53.98 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 54.85 84.16 52.60 54.26 81.23 53.34 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 163 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 222 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 163 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 222 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 48.06 78.22 50.94 48.51 78.27 53.98 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 163 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 222 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 48.06 78.22 50.94 48.51 78.27 53.98 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 54.85 84.16 52.60 54.26 81.23 53.34 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 163 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 222 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 48.06 78.22 50.94 48.51 78.27 53.98 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 54.85 84.16 52.60 54.26 81.23 53.34 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 163 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 222 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 54.85 84.16 52.60 54.26 81.23 53.34 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 163 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 222 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 51.27 81.34 48.31 51.67 80.79 50.28 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 54.85 84.16 52.60 54.26 81.23 53.34 9.83 -34.01 -19.55 11.45 -36.64 -19.39 1kim_c00 source 1kim THYMIDINE KINASE : 10 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 74 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 74 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 24.97 5.82 58.78 26.79 1.97 55.46 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 24.97 5.82 58.78 26.79 1.97 55.46 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 24.97 5.82 58.78 26.79 1.97 55.46 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 24.97 5.82 58.78 26.79 1.97 55.46 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 19.46 3.44 61.93 23.95 1.12 60.13 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 24.97 5.82 58.78 26.79 1.97 55.46 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 24.97 5.82 58.78 26.79 1.97 55.46 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 19.46 3.44 61.93 23.95 1.12 60.13 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 10 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 B 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 4.84 5.09 23.75 3.30 1.39 27.48 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 4.84 5.09 23.75 3.30 1.39 27.48 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 4.84 5.09 23.75 3.30 1.39 27.48 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 B 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 4.84 5.09 23.75 3.30 1.39 27.48 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 10.43 2.88 20.75 5.72 0.41 23.95 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 B 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 4.84 5.09 23.75 3.30 1.39 27.48 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 10.43 2.88 20.75 5.72 0.41 23.95 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 4.84 5.09 23.75 3.30 1.39 27.48 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 4.84 5.09 23.75 3.30 1.39 27.48 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 10.43 2.88 20.75 5.72 0.41 23.95 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 C 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 C 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 17.59 37.25 25.80 19.64 34.15 21.60 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 12.06 27.10 15.56 13.23 27.02 13.80 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 C 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 C 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 17.59 37.25 25.80 19.64 34.15 21.60 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 12.29 34.52 28.11 16.84 32.47 25.43 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 12.06 27.10 15.56 13.23 27.02 13.80 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 C 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 C 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 17.59 37.25 25.80 19.64 34.15 21.60 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 12.29 34.52 28.11 16.84 32.47 25.43 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 12.06 27.10 15.56 13.23 27.02 13.80 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 C 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 C 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 C 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 C 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 12.29 34.52 28.11 16.84 32.47 25.43 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 5 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 29 LYS~? 17.35 O2' AMP A 901 D 74 LYS A 34 LYS~? 19.00 N1 AMP A 901 D 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 34 LYS~? 19.00 N1 AMP A 901 D 74 LYS A 29 LYS~? 17.35 O2' AMP A 901 D 165 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 D 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 D 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 D 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 D 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 D 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 D 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 D 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 D 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 D 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 D 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 D 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 D 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 D 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 D 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 D 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 D 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 D 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 D 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 11 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 197 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 446 ARG B 79 ARG^? 12.83 N6 AMP B 902 coo 3.26 62.02 109.14 4.83 57.73 107.38 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 9.48 43.28 113.60 10.05 44.21 111.80 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 12.14 46.28 115.16 13.57 43.60 115.68 11.40 -13.41 -25.51 10.95 -12.93 -28.51 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 197 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 446 ARG B 79 ARG^? 12.83 N6 AMP B 902 coo 3.26 62.02 109.14 4.83 57.73 107.38 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 9.48 43.28 113.60 10.05 44.21 111.80 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 12.14 46.28 115.16 13.57 43.60 115.68 11.40 -13.41 -25.51 10.95 -12.93 -28.51 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 3 3 # 3 A 94 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 197 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 446 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo 3.26 62.02 109.14 4.83 57.73 107.38 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 9.48 43.28 113.60 10.05 44.21 111.80 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 12.14 46.28 115.16 13.57 43.60 115.68 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 3 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 20 ASP.? 5.75 O3P AMP B 902 262 LYS A 95 LYS.? 10.91 O3P AMP B 902 336 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 61.88 50.78 12.96 63.84 50.60 13.71 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 63.59 44.40 18.32 63.20 49.74 17.95 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 72.60 57.42 15.86 71.61 56.68 18.70 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 78 ASP^? 5.94 N6 AMP A 901 262 LYS A 85 LYS~? 14.18 N6 AMP A 901 336 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 61.88 50.78 12.96 63.84 50.60 13.71 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 63.59 44.40 18.32 63.20 49.74 17.95 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 coo 72.60 57.42 15.86 71.61 56.68 18.70 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP A 78 ASP^? 5.94 N6 AMP A 901 262 LYS A 85 LYS~? 14.18 N6 AMP A 901 336 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo 61.88 50.78 12.96 63.84 50.60 13.71 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 63.59 44.40 18.32 63.20 49.74 17.95 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 coo 72.60 57.42 15.86 71.61 56.68 18.70 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 20 ASP.? 4.50 O2P AMP B 903 262 LYS B 95 LYS.? 10.50 O1P AMP B 903 336 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 61.88 50.78 12.96 63.84 50.60 13.71 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 63.59 44.40 18.32 63.20 49.74 17.95 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP B 78 ASP^? 6.36 N6 AMP B 902 262 LYS B 85 LYS~? 13.55 N6 AMP B 902 336 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 61.88 50.78 12.96 63.84 50.60 13.71 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 63.59 44.40 18.32 63.20 49.74 17.95 20.32 -12.07 -18.16 16.10 -8.70 -17.98 coo 72.60 57.42 15.86 71.61 56.68 18.70 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP B 78 ASP^? 6.36 N6 AMP B 902 262 LYS B 85 LYS~? 13.55 N6 AMP B 902 336 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 61.88 50.78 12.96 63.84 50.60 13.71 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 63.59 44.40 18.32 63.20 49.74 17.95 20.32 -12.07 -18.16 16.10 -8.70 -17.98 coo 72.60 57.42 15.86 71.61 56.68 18.70 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP C 20 ASP.? 6.67 O5' AMP A 901 262 LYS C 95 LYS.? 12.30 O2P AMP A 901 336 ARG C 25 ARG^? 18.57 O2' AMP B 903 coo 61.88 50.78 12.96 63.84 50.60 13.71 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 63.59 44.40 18.32 63.20 49.74 17.95 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.53 -50.28 2.99 20.10 -49.22 1.88 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP C 78 ASP^? 6.25 N6 AMP B 903 262 LYS B 54 LYS.? 8.42 N6 AMP B 903 336 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 61.88 50.78 12.96 63.84 50.60 13.71 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 29.14 -34.12 -5.07 32.41 -32.79 -9.64 coo 72.60 57.42 15.86 71.61 56.68 18.70 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP C 78 ASP^? 6.25 N6 AMP B 903 262 LYS C 85 LYS~? 15.28 N6 AMP B 903 336 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 61.88 50.78 12.96 63.84 50.60 13.71 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 26.67 -46.79 -15.77 32.41 -44.78 -16.80 coo 72.60 57.42 15.86 71.61 56.68 18.70 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 10 3 # 10 255 ASP C 78 ASP^? 6.25 N6 AMP B 903 262 LYS C 85 LYS~? 15.28 N6 AMP B 903 336 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 61.88 50.78 12.96 63.84 50.60 13.71 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 26.67 -46.79 -15.77 32.41 -44.78 -16.80 coo 72.60 57.42 15.86 71.61 56.68 18.70 25.67 -40.51 -0.27 25.52 -39.03 2.41 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 10 hits 1lam_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 295 GLU A 18 GLU.? 10.44 O3' AMP B 902 A 369 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 16.11 33.72 80.99 14.10 33.54 81.63 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 295 GLU A 18 GLU.? 10.44 O3' AMP B 902 A 369 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 16.11 33.72 80.99 14.10 33.54 81.63 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 295 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 16.11 33.72 80.99 14.10 33.54 81.63 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 295 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 369 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 16.11 33.72 80.99 14.10 33.54 81.63 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 265 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 369 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 265 GLU B 23 GLU.? 19.12 O2P AMP B 903 A 369 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 11.74 38.14 80.19 10.63 36.40 80.65 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 23.11 -9.89 1.58 22.67 -8.31 0.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 265 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 369 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 11.74 38.14 80.19 10.63 36.40 80.65 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 265 GLU B 23 GLU.? 19.12 O2P AMP B 903 A 369 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 17.36 23.57 72.04 18.68 21.92 71.98 23.11 -9.89 1.58 22.67 -8.31 0.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 265 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 369 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.74 38.14 80.19 10.63 36.40 80.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 265 GLU C 23 GLU.? 21.28 O2P AMP A 901 A 369 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 17.32 -56.91 -1.57 19.42 -57.00 -1.46 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 265 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 265 GLU C 23 GLU.? 21.28 O2P AMP A 901 A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 17.36 23.57 72.04 18.68 21.92 71.98 17.32 -56.91 -1.57 19.42 -57.00 -1.46 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 18 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 279 GLU A 37 GLU~? 17.03 O3P AMP A 901 A 369 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 -11.27 -41.71 -19.38 -13.11 -40.80 -18.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 279 GLU B 18 GLU.? 10.73 O3' AMP B 903 A 369 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 14.19 -24.84 2.24 12.77 -26.14 3.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 96 ASP.? 4.70 O3P AMP B 902 A 279 GLU A 84 GLU~? 14.99 N1 AMP A 901 A 369 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 12.19 31.08 87.29 11.13 32.66 86.38 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 279 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 369 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 11.74 38.14 80.19 10.63 36.40 80.65 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 279 GLU C 3 GLU.? 18.12 O1P AMP B 903 A 369 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 33.90 -21.03 -18.59 35.21 -20.12 -17.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 279 GLU C 37 GLU~? 17.52 N1 AMP B 903 A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 16.54 46.37 63.94 14.77 45.79 62.95 27.63 -46.66 -1.86 26.53 -48.46 -1.73 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 279 GLU A 18 GLU.? 10.44 O3' AMP B 902 A 369 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.74 38.14 80.19 10.63 36.40 80.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 16.54 46.37 63.94 14.77 45.79 62.95 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 279 GLU A 3 GLU.? 19.16 N7 AMP A 901 A 369 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 16.54 46.37 63.94 14.77 45.79 62.95 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c06 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 132 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.61 22.83 17.30 14.06 21.71 15.78 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.37 24.94 11.48 12.48 24.45 13.28 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 16.14 18.17 13.37 15.92 19.81 14.71 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.61 22.83 17.30 14.06 21.71 15.78 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.37 24.94 11.48 12.48 24.45 13.28 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 16.14 18.17 13.37 15.92 19.81 14.71 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.61 22.83 17.30 14.06 21.71 15.78 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.37 24.94 11.48 12.48 24.45 13.28 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 16.14 18.17 13.37 15.92 19.81 14.71 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 132 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.61 3.43 18.38 9.11 4.29 16.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.74 0.51 12.98 10.75 1.32 14.67 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 6.93 7.52 14.08 7.18 6.08 15.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.61 3.43 18.38 9.11 4.29 16.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.74 0.51 12.98 10.75 1.32 14.67 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 6.93 7.52 14.08 7.18 6.08 15.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.61 3.43 18.38 9.11 4.29 16.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.74 0.51 12.98 10.75 1.32 14.67 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 6.93 7.52 14.08 7.18 6.08 15.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 132 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.50 22.77 17.24 14.00 21.62 15.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.19 25.00 11.76 12.16 24.45 13.59 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 16.04 18.11 13.43 15.88 19.70 14.83 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.50 22.77 17.24 14.00 21.62 15.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.19 25.00 11.76 12.16 24.45 13.59 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 16.04 18.11 13.43 15.88 19.70 14.83 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 101 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.50 22.77 17.24 14.00 21.62 15.86 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.19 25.00 11.76 12.16 24.45 13.59 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 16.04 18.11 13.43 15.88 19.70 14.83 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 132 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 11.48 3.09 18.25 9.01 4.07 16.77 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.83 0.33 13.01 10.88 1.04 14.81 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 6.85 7.33 14.07 7.10 5.88 15.60 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.48 3.09 18.25 9.01 4.07 16.77 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.83 0.33 13.01 10.88 1.04 14.81 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 6.85 7.33 14.07 7.10 5.88 15.60 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 101 ASP C 96 ASP.? -4.92 O1P AMP A 901s B 132 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 11.48 3.09 18.25 9.01 4.07 16.77 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.83 0.33 13.01 10.88 1.04 14.81 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 6.85 7.33 14.07 7.10 5.88 15.60 8.87 -49.22 -5.46 7.44 -48.97 -6.99 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nww_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 1.87 119.38 16.45 1.41 122.11 16.84 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -3.50 124.89 25.05 -2.25 124.77 23.26 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 1.87 119.38 16.45 1.41 122.11 16.84 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -2.59 124.07 12.67 -0.91 126.17 18.42 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -3.50 124.89 25.05 -2.25 124.77 23.26 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 1.87 119.38 16.45 1.41 122.11 16.84 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -2.59 124.07 12.67 -0.91 126.17 18.42 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -7.43 109.06 51.23 -5.84 110.54 50.86 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 0.22 114.56 44.62 -0.76 115.18 47.18 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -4.18 120.17 46.85 -4.02 115.31 51.00 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 B 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -7.43 109.06 51.23 -5.84 110.54 50.86 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 0.22 114.56 44.62 -0.76 115.18 47.18 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -4.18 120.17 46.85 -4.02 115.31 51.00 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 C 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 C 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -13.49 79.65 43.90 -12.13 80.29 45.45 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -5.65 86.78 48.49 -7.16 84.72 49.65 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -11.22 87.18 53.49 -10.94 81.64 50.31 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 C 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -13.49 79.65 43.90 -12.13 80.29 45.45 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -5.65 86.78 48.49 -7.16 84.72 49.65 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -11.22 87.18 53.49 -10.94 81.64 50.31 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 D 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 D 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -13.44 77.36 13.12 -12.53 75.97 14.48 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -7.85 74.44 22.75 -9.22 72.86 20.89 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -14.24 70.61 23.48 -12.55 71.73 17.42 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 D 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -13.44 77.36 13.12 -12.53 75.97 14.48 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -7.85 74.44 22.75 -9.22 72.86 20.89 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -14.24 70.61 23.48 -12.55 71.73 17.42 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 E 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 E 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 E 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 E 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -7.12 105.25 1.43 -6.30 103.34 0.77 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -3.11 94.55 3.01 -3.83 95.92 0.66 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 E 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 E 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -7.12 105.25 1.43 -6.30 103.34 0.77 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -3.11 94.55 3.01 -3.83 95.92 0.66 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 F 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 F 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 F 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 F 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -44.75 128.15 10.28 -45.68 129.67 11.55 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -50.43 131.90 19.60 -49.04 133.31 17.60 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -44.10 135.86 19.99 -45.67 134.21 14.07 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 F 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 F 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -44.75 128.15 10.28 -45.68 129.67 11.55 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -50.43 131.90 19.60 -49.04 133.31 17.60 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -44.10 135.86 19.99 -45.67 134.21 14.07 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 G 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 G 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 G 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 G 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -44.97 128.78 41.20 -46.32 128.26 42.83 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -52.83 122.13 46.42 -51.31 124.30 47.39 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -47.30 122.24 51.49 -47.46 127.44 47.81 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 G 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 G 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -44.97 128.78 41.20 -46.32 128.26 42.83 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -52.83 122.13 46.42 -51.31 124.30 47.39 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -47.30 122.24 51.49 -47.46 127.44 47.81 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 H 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 H 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 H 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 H 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -51.11 100.30 51.41 -52.67 98.82 51.12 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -58.70 94.17 45.32 -57.76 93.82 47.92 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -54.32 88.79 48.13 -54.61 94.04 51.74 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 H 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 H 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -51.11 100.30 51.41 -52.67 98.82 51.12 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -58.70 94.17 45.32 -57.76 93.82 47.92 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -54.32 88.79 48.13 -54.61 94.04 51.74 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 I 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 I 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 I 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 I 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -54.65 81.97 26.87 -55.88 81.89 25.07 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -59.92 86.62 17.74 -59.42 83.94 18.40 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -55.38 81.61 14.50 -57.11 80.05 20.41 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 I 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 I 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -54.65 81.97 26.87 -55.88 81.89 25.07 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -59.92 86.62 17.74 -59.42 83.94 18.40 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -55.38 81.61 14.50 -57.11 80.05 20.41 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 69 ASP.? 5.85 O1P AMP B 902 J 146 TYR A 28 TYR~? 12.65 O3' AMP B 902 J 177 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 69 ASP.? 6.10 O2P AMP B 903 J 146 TYR B 28 TYR~? 12.70 O3' AMP B 903 J 177 LYS B 21 LYS^? 13.50 O2P AMP B 903 coo -50.64 99.08 1.52 -51.52 100.83 0.67 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 21.11 -17.93 2.45 18.52 -19.86 7.94 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP C 69 ASP.? 6.83 O3' AMP A 901 J 146 TYR C 28 TYR~? 12.81 O2' AMP B 903 J 177 LYS C 21 LYS^? 15.49 O2P AMP A 901 coo -50.64 99.08 1.52 -51.52 100.83 0.67 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 10.86 -51.86 -2.39 9.09 -50.05 2.40 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c09 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 247 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 342 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 44.36 35.68 9.71 43.29 36.20 11.51 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 41.40 28.81 12.91 40.82 30.90 12.97 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 40.37 33.11 18.06 39.99 34.93 17.06 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 247 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 342 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 44.36 35.68 9.71 43.29 36.20 11.51 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 41.40 28.81 12.91 40.82 30.90 12.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 40.37 33.11 18.06 39.99 34.93 17.06 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 247 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 342 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 44.36 35.68 9.71 43.29 36.20 11.51 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 41.40 28.81 12.91 40.82 30.90 12.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 40.37 33.11 18.06 39.99 34.93 17.06 6.18 -43.03 -1.28 4.85 -41.58 -0.59 1oyg_c00 source 1oyg LEVANSUCRASE : 3 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP B 96 ASP.? -3.09 O1P AMP B 903s A 167 LYS B 55 LYS.? 9.89 O1P AMP B 903 A 201 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 26.53 8.31 20.37 28.45 8.41 19.40 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 24.92 6.08 13.38 27.75 4.33 18.83 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 29.08 5.53 11.69 30.46 5.61 17.93 29.14 -34.12 -5.07 32.41 -32.79 -9.64 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP B 96 ASP.? -3.09 O1P AMP B 903s B1167 LYS B 55 LYS.? 9.89 O1P AMP B 903 B1201 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 26.10 12.11 49.61 24.19 12.48 50.51 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 27.70 11.69 56.92 24.82 8.55 52.12 29.71 -30.40 -5.65 34.42 -26.97 -8.24 coo 23.50 11.64 58.67 22.19 10.19 52.59 29.14 -34.12 -5.07 32.41 -32.79 -9.64 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c01 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 55.48 26.51 40.65 55.39 23.99 39.43 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 47.58 17.35 41.83 51.40 20.85 40.83 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 55.48 26.51 40.65 55.39 23.99 39.43 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 47.58 17.35 41.83 51.40 20.85 40.83 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 B 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 C 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 C 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 39.51 34.34 13.63 37.63 32.61 14.79 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 37.54 22.37 12.10 37.83 27.55 13.24 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 C 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 39.51 34.34 13.63 37.63 32.61 14.79 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 37.54 22.37 12.10 37.83 27.55 13.24 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 D 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 D 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 D 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 E 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 E 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 E 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 E 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 F 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 F 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 F 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 F 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 G 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 G 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 G 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 G 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 H 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 H 261 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 H 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 H 261 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 0.63 -48.72 -18.32 2.49 -53.34 -22.30 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 C 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 39.01 29.77 22.02 37.48 31.30 19.84 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 C 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 C 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 39.01 29.77 22.02 37.48 31.30 19.84 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 39.51 34.34 13.63 37.63 32.61 14.79 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 C 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 C 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 39.01 29.77 22.02 37.48 31.30 19.84 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 C 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 39.01 29.77 22.02 37.48 31.30 19.84 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 39.51 34.34 13.63 37.63 32.61 14.79 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 45.78 31.11 9.51 44.25 30.06 10.53 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 C 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 C 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 39.01 29.77 22.02 37.48 31.30 19.84 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 39.51 34.34 13.63 37.63 32.61 14.79 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 C 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 C 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 39.01 29.77 22.02 37.48 31.30 19.84 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 39.51 34.34 13.63 37.63 32.61 14.79 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 45.78 31.11 9.51 44.25 30.06 10.53 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 C 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 C 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 39.01 29.77 22.02 37.48 31.30 19.84 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 39.51 34.34 13.63 37.63 32.61 14.79 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 20.07 -28.61 3.38 19.95 -26.81 2.29 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 D 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 D 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 D 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 D 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 D 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 D 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 D 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 D 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 D 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 D 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 D 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 D 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 20.07 -28.61 3.38 19.95 -26.81 2.29 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 52.39 23.42 32.10 54.51 23.27 34.29 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 A 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 52.39 23.42 32.10 54.51 23.27 34.29 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 A 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 C 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 55.48 26.51 40.65 55.39 23.99 39.43 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 52.39 23.42 32.10 54.51 23.27 34.29 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 C 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 55.48 26.51 40.65 55.39 23.99 39.43 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 48.87 29.19 44.63 49.10 27.34 43.63 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 C 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 55.48 26.51 40.65 55.39 23.99 39.43 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 48.87 29.19 44.63 49.10 27.34 43.63 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 C 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 55.48 26.51 40.65 55.39 23.99 39.43 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 52.39 23.42 32.10 54.51 23.27 34.29 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 C 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo 55.48 26.51 40.65 55.39 23.99 39.43 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 52.39 23.42 32.10 54.51 23.27 34.29 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 D 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 B 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 D 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 B 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 D 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 D 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 D 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 D 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 B 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 D 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 G 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 G 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 G 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 G 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 G 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 G 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 G 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 G 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 G 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 G 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 G 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 G 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 G 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 G 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 20.07 -28.61 3.38 19.95 -26.81 2.29 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 H 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 H 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 H 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 H 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 H 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 H 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 H 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 H 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 H 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 H 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 H 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 H 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 21.25 -21.87 0.09 22.11 -23.74 -0.35 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 H 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 H 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 20.07 -28.61 3.38 19.95 -26.81 2.29 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 E 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 G 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 E 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 G 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 E 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 G 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 E 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 G 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 E 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 G 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 E 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 G 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 E 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 G 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 F 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 H 110 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 28 TYR~? 12.65 O3' AMP B 902 F 236 ASP A 20 ASP.? 5.75 O3P AMP B 902 H 110 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 50 TYR^? 6.90 O2' AMP B 902 F 236 ASP A 69 ASP.? 5.85 O1P AMP B 902 H 110 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 F 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 H 110 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 28 TYR~? 12.70 O3' AMP B 903 F 236 ASP B 20 ASP.? 4.50 O2P AMP B 903 H 110 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 50 TYR^? 7.37 O3' AMP B 903 F 236 ASP B 69 ASP.? 6.10 O2P AMP B 903 H 110 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 50 TYR^? 7.65 O3' AMP A 901 F 236 ASP C 69 ASP.? 6.83 O3' AMP A 901 H 110 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 261 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 329 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 28.46 69.88 26.74 30.40 70.70 26.53 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 34.02 79.89 42.60 34.73 78.01 41.86 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.52 -51.71 -13.41 4.60 -53.19 -14.62 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 739 GLY A 110 GLY.? 9.55 O1P AMP A 901 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -18.83 7.68 26.86 -20.89 7.78 26.56 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 10.72 -52.80 -16.55 10.06 -52.72 -17.00 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 739 GLY A 97 GLY.? 3.90 C5' AMP B 902 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.29 -21.19 -17.82 -1.26 -20.84 -18.62 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 739 GLY B 110 GLY.? 7.19 O3P AMP B 902 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -3.02 -16.90 -21.50 -2.63 -16.50 -22.07 1qrz_c20 source 1qrz PLASMINOGEN : 3 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 739 GLY A 110 GLY.? 9.55 O1P AMP A 901 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 10.72 -52.80 -16.55 10.06 -52.72 -17.00 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 739 GLY C 97 GLY.? 4.38 O4' AMP A 901 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 8.33 -47.69 -13.78 8.41 -48.09 -14.57 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 B 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 B 739 GLY A 97 GLY.? 3.90 C5' AMP B 902 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.29 -21.19 -17.82 -1.26 -20.84 -18.62 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 B 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 B 739 GLY B 110 GLY.? 7.19 O3P AMP B 902 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -3.02 -16.90 -21.50 -2.63 -16.50 -22.07 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1qrz_c21 source 1qrz PLASMINOGEN : 5 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 C 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 C 739 GLY A 110 GLY.? 9.55 O1P AMP A 901 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 7.82 1.25 3.03 7.30 1.31 3.65 10.72 -52.80 -16.55 10.06 -52.72 -17.00 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 C 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 C 739 GLY C 97 GLY.? 4.38 O4' AMP A 901 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 7.82 1.25 3.03 7.30 1.31 3.65 8.33 -47.69 -13.78 8.41 -48.09 -14.57 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 C 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 C 739 GLY A 97 GLY.? 3.90 C5' AMP B 902 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.29 -21.19 -17.82 -1.26 -20.84 -18.62 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 C 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 C 739 GLY B 110 GLY.? 7.19 O3P AMP B 902 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -3.02 -16.90 -21.50 -2.63 -16.50 -22.07 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 C 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 C 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 7.82 1.25 3.03 7.30 1.31 3.65 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1qrz_c22 source 1qrz PLASMINOGEN : 5 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 D 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 D 739 GLY A 110 GLY.? 9.55 O1P AMP A 901 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -45.82 1.31 41.67 -46.38 1.39 42.31 10.72 -52.80 -16.55 10.06 -52.72 -17.00 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 6 HIS.? 9.49 N6 AMP A 901 D 646 ASP A 78 ASP^? 5.94 N6 AMP A 901 D 739 GLY C 97 GLY.? 4.38 O4' AMP A 901 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -45.82 1.31 41.67 -46.38 1.39 42.31 8.33 -47.69 -13.78 8.41 -48.09 -14.57 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS B 6 HIS^? 11.24 N6 AMP B 902 D 646 ASP B 78 ASP^? 6.36 N6 AMP B 902 D 739 GLY B 110 GLY.? 7.19 O3P AMP B 902 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -3.02 -16.90 -21.50 -2.63 -16.50 -22.07 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS C 6 HIS.? 9.51 N6 AMP B 903 D 646 ASP C 78 ASP^? 6.25 N6 AMP B 903 D 739 GLY B 97 GLY.? -3.32 O1P AMP B 903s coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -45.82 1.31 41.67 -46.38 1.39 42.31 24.07 -25.86 -6.22 24.84 -25.72 -6.62 1qrz_c23 source 1qrz PLASMINOGEN : 4 hits 1qrz_c23 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 3 GLU.? 19.16 N7 AMP A 901 A 288 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 329 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 29.27 18.78 14.99 27.16 18.62 14.76 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 3 GLU.? 19.16 N7 AMP A 901 B 288 HIS A 81 HIS~? 14.35 N6 AMP A 901 B 329 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 80 GLU A 5 GLU.? 10.94 N7 AMP A 901 B 223 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 6 HIS.? 9.49 N6 AMP A 901 B 80 GLU A 5 GLU.? 10.94 N7 AMP A 901 B 223 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 6 HIS^? 11.24 N6 AMP B 902 B 80 GLU B 5 GLU.? 11.45 N6 AMP B 902 B 223 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 3.19 -19.09 -26.75 1.87 -17.61 -27.49 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 6 HIS^? 11.24 N6 AMP B 902 B 80 GLU B 5 GLU.? 11.45 N6 AMP B 902 B 223 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 3.19 -19.09 -26.75 1.87 -17.61 -27.49 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 31.94 -36.24 -18.49 34.43 -34.81 -19.58 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 81 HIS~? 16.34 N6 AMP B 902 B 80 GLU B 84 GLU~? 17.85 N6 AMP B 902 B 223 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 18.97 -11.27 -24.77 20.54 -9.89 -24.72 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 23.05 -14.25 -21.41 23.75 -13.21 -23.10 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 80 GLU C 5 GLU.? 7.68 N6 AMP B 903 B 223 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS C 6 HIS.? 9.51 N6 AMP B 903 B 80 GLU C 5 GLU.? 7.68 N6 AMP B 903 B 223 ARG C 25 ARG^? 18.57 O2' AMP B 903 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 17.53 -50.28 2.99 20.10 -49.22 1.88 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS C 81 HIS~? 16.81 N6 AMP B 903 B 80 GLU C 84 GLU~? 17.40 N6 AMP B 903 B 223 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 31.31 -43.94 -20.10 31.86 -45.68 -21.13 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 10.31 -28.72 0.63 8.60 -26.56 1.94 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 8 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 110 GLY.? 9.55 O1P AMP A 901 B 17 GLN A 112 GLN.? 15.37 O1P AMP A 901 B 140 GLU A 113 GLU.? 15.54 O2P AMP A 901 coo 61.49 19.86 5.96 61.52 19.46 5.16 10.72 -52.80 -16.55 10.06 -52.72 -17.00 coo 63.76 11.90 7.93 65.18 13.07 6.77 9.41 -59.16 -20.04 9.51 -59.78 -22.07 coo 66.44 19.00 7.38 67.69 17.67 8.37 14.09 -57.67 -13.98 15.22 -57.96 -12.25 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 69 ASP.? 6.10 O2P AMP B 903 218 GLU C 84 GLU~? 17.40 N6 AMP B 903 329 ASP B 96 ASP.? -3.09 O1P AMP B 903s coo 49.16 35.16 15.19 51.08 34.43 15.65 20.07 -28.61 3.38 19.95 -26.81 2.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.76 -24.76 -2.38 27.99 -26.49 -2.17 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 96 ASP.? -3.09 O1P AMP B 903s 218 GLU C 23 GLU.? 21.28 O2P AMP A 901 329 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 70.09 11.71 8.46 70.56 12.89 6.77 17.32 -56.91 -1.57 19.42 -57.00 -1.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 20 ASP.? 6.67 O5' AMP A 901 218 GLU A 84 GLU~? 14.99 N1 AMP A 901 329 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 49.16 35.16 15.19 51.08 34.43 15.65 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 69 ASP.? 6.83 O3' AMP A 901 218 GLU A 84 GLU~? 14.99 N1 AMP A 901 329 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 49.16 35.16 15.19 51.08 34.43 15.65 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.52 -51.71 -13.41 4.60 -53.19 -14.62 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 96 ASP.? -4.92 O1P AMP A 901s 218 GLU A 23 GLU.? 20.44 O3P AMP B 902 329 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 69 ASP.? 5.85 O1P AMP B 902 242 GLU B 18 GLU.? 10.73 O3' AMP B 903 329 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo 49.16 35.16 15.19 51.08 34.43 15.65 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 14.19 -24.84 2.24 12.77 -26.14 3.06 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 96 ASP.? -3.09 O1P AMP B 903s 242 GLU B 84 GLU~? 17.85 N6 AMP B 902 329 ASP B 69 ASP.? 6.10 O2P AMP B 903 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.76 -24.76 -2.38 27.99 -26.49 -2.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 23.05 -14.25 -21.41 23.75 -13.21 -23.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.07 -28.61 3.38 19.95 -26.81 2.29 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 96 ASP.? -4.92 O1P AMP A 901s 242 GLU C 84 GLU~? 17.40 N6 AMP B 903 329 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo 30.42 34.74 5.00 29.09 35.09 3.38 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.23 -46.27 -4.81 3.28 -46.78 -4.78 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 10 3 # 10 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 11 3 # 11 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 12 3 # 12 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 13 3 # 13 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 14 3 # 14 A 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 15 3 # 15 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 16 3 # 16 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 17 3 # 17 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 18 3 # 18 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 19 3 # 19 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 20 3 # 20 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 66.09 40.54 34.70 66.92 37.69 35.49 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 21 3 # 21 A 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 22 3 # 22 A 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 A 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 70.89 37.31 29.70 69.54 36.29 32.39 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 23 3 # 23 A 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 A 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 70.89 37.31 29.70 69.54 36.29 32.39 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 24 3 # 24 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 66.09 40.54 34.70 66.92 37.69 35.49 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 25 3 # 25 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 26 3 # 26 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 66.09 40.54 34.70 66.92 37.69 35.49 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 27 3 # 27 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 28 3 # 28 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 29 3 # 29 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 30 3 # 30 A 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 31 3 # 31 A 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 32 3 # 32 A 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 33 3 # 33 A 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 34 3 # 34 A 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 A 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 34 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 10 3 # 10 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 11 3 # 11 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 12 3 # 12 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 13 3 # 13 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 14 3 # 14 B 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 15 3 # 15 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 16 3 # 16 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 17 3 # 17 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 18 3 # 18 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 19 3 # 19 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 20 3 # 20 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 31.43 57.38 61.97 31.90 55.58 64.41 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 21 3 # 21 B 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s B 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 22 3 # 22 B 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 34.24 60.89 68.08 33.31 57.93 67.63 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 23 3 # 23 B 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 34.24 60.89 68.08 33.31 57.93 67.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 24 3 # 24 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 31.43 57.38 61.97 31.90 55.58 64.41 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 25 3 # 25 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 26 3 # 26 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 31.43 57.38 61.97 31.90 55.58 64.41 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 27 3 # 27 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 28 3 # 28 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 29 3 # 29 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 30 3 # 30 B 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 31 3 # 31 B 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 32 3 # 32 B 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 33 3 # 33 B 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 34 3 # 34 B 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 34 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 11 3 # 11 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 12 3 # 12 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 13 3 # 13 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 14 3 # 14 C 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 15 3 # 15 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 16 3 # 16 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 17 3 # 17 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 18 3 # 18 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 19 3 # 19 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 20 3 # 20 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 21 3 # 21 C 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 22 3 # 22 C 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 13.44 32.78 22.07 15.56 30.91 23.37 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 23 3 # 23 C 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 24 3 # 24 C 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 25 3 # 25 C 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 13.44 32.78 22.07 15.56 30.91 23.37 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 26 3 # 26 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 27 3 # 27 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 28 3 # 28 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 C 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 21.00 33.35 22.82 19.83 30.82 24.09 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 29 3 # 29 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 30 3 # 30 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 C 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 31 3 # 31 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 32 3 # 32 C 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 33 3 # 33 C 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 34 3 # 34 C 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 35 3 # 35 C 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 36 3 # 36 C 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 C 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 36 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 10 3 # 10 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 11 3 # 11 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 12 3 # 12 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 13 3 # 13 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 14 3 # 14 D 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 15 3 # 15 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 16 3 # 16 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 17 3 # 17 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 18 3 # 18 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 19 3 # 19 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 20 3 # 20 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 D 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 21 3 # 21 D 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s D 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 22 3 # 22 D 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 D 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 D 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 23 3 # 23 D 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 D 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 24 3 # 24 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 D 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 25 3 # 25 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 26 3 # 26 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 D 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 27 3 # 27 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 28 3 # 28 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 D 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 29 3 # 29 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 30 3 # 30 D 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 31 3 # 31 D 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 D 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 32 3 # 32 D 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 D 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 33 3 # 33 D 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 34 3 # 34 D 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 D 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 D 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 34 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 12 3 # 12 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 13 3 # 13 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 14 3 # 14 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 15 3 # 15 E 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 16 3 # 16 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 17 3 # 17 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 18 3 # 18 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 19 3 # 19 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 20 3 # 20 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 21 3 # 21 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 22 3 # 22 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 E 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 23 3 # 23 E 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s E 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 24 3 # 24 E 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 25 3 # 25 E 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 26 3 # 26 E 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 E 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 E 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 27 3 # 27 E 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 28 3 # 28 E 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 29 3 # 29 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 30 3 # 30 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 31 3 # 31 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 32 3 # 32 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 33 3 # 33 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 34 3 # 34 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 35 3 # 35 E 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 36 3 # 36 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 37 3 # 37 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 38 3 # 38 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 39 3 # 39 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 40 3 # 40 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 41 3 # 41 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 42 3 # 42 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 43 3 # 43 E 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 E 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 E 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 43 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s F 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU A 75 GLU^? -5.62 C2 AMP A 901s F 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 10 3 # 10 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG A 13 ARG^? 9.68 C2 AMP B 902 F 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 11 3 # 11 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 12 3 # 12 F 581 GLU A 102 GLU^? 11.43 N1 AMP B 902 F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 13 3 # 13 F 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 14 3 # 14 F 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG C 11 ARG^? 7.32 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.60 -33.12 -16.39 17.81 -30.41 -15.70 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 15 3 # 15 F 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 16 3 # 16 F 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s F 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 17 3 # 17 F 581 GLU B 75 GLU^? -4.88 C2 AMP B 902s F 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 F 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 18 3 # 18 F 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 19 3 # 19 F 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 F 596 ARG B 11 ARG^? 7.52 N1 AMP B 902 F 647 ARG C 13 ARG^? 8.59 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 13.26 -36.00 -15.82 10.89 -34.30 -14.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 20 3 # 20 F 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 21 3 # 21 F 581 GLU B 102 GLU^? 11.34 N1 AMP B 902 F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 22 3 # 22 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 23 3 # 23 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG B 13 ARG^? 10.00 C2 AMP B 903 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 24 3 # 24 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG A 11 ARG^? 7.89 C2 AMP A 901 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.83 -34.01 -19.55 11.45 -36.64 -19.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 25 3 # 25 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 26 3 # 26 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 27 3 # 27 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 28 3 # 28 F 581 GLU C 75 GLU^? -5.53 C2 AMP B 903s F 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 29 3 # 29 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 30 3 # 30 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG A 11 ARG^? 7.89 C2 AMP A 901 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 31 3 # 31 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 32 3 # 32 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG C 11 ARG^? 7.32 C2 AMP B 903 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 33 3 # 33 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 F 647 ARG A 13 ARG^? 9.68 C2 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.88 -30.42 -17.75 10.91 -30.56 -18.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 34 3 # 34 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 F 647 ARG B 11 ARG^? 7.52 N1 AMP B 902 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.47 -27.35 -18.27 9.78 -27.52 -19.74 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 35 3 # 35 F 581 GLU C 102 GLU^? 11.80 C2 AMP B 903 F 596 ARG C 13 ARG^? 8.59 C2 AMP A 901 F 647 ARG B 13 ARG^? 10.00 C2 AMP B 903 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 14.87 -28.28 -14.27 14.20 -30.13 -16.64 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 35 hits 1v0e_c05 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 15 TYR^? -4.88 N3 AMP B 902s A 317 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 365 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 1.77 6.56 57.05 3.05 7.44 59.37 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 3.06 2.85 52.79 4.83 3.89 53.24 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 3.82 17.09 49.56 4.09 14.32 50.84 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 15 TYR^? -4.78 N3 AMP B 903s A 317 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 365 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 1.77 6.56 57.05 3.05 7.44 59.37 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 3.06 2.85 52.79 4.83 3.89 53.24 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 3.82 17.09 49.56 4.09 14.32 50.84 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR C 15 TYR^? 4.73 N3 AMP A 901 A 317 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 365 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 1.77 6.56 57.05 3.05 7.44 59.37 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo 3.06 2.85 52.79 4.83 3.89 53.24 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 6.08 -38.28 -1.54 7.50 -37.49 1.03 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 317 GLU C 18 GLU.? 10.63 O3' AMP A 901 A 365 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 1.77 6.56 57.05 3.05 7.44 59.37 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 3.06 2.85 52.79 4.83 3.89 53.24 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 3.82 17.09 49.56 4.09 14.32 50.84 10.31 -28.72 0.63 8.60 -26.56 1.94 1vzx_c02 source 1vzx 2.04.01.0087 : 4 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 15 TYR^? -4.88 N3 AMP B 902s B1317 GLU B 75 GLU^? -4.88 C2 AMP B 902s B1365 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 15 TYR^? -4.78 N3 AMP B 903s B1317 GLU C 75 GLU^? -5.53 C2 AMP B 903s B1365 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR C 15 TYR^? 4.73 N3 AMP A 901 B1317 GLU A 75 GLU^? -5.62 C2 AMP A 901s B1365 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 6.08 -38.28 -1.54 7.50 -37.49 1.03 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR C 15 TYR^? 4.73 N3 AMP A 901 B1317 GLU A 75 GLU^? -5.62 C2 AMP A 901s B1365 ARG C 65 ARG.? -3.67 O5' AMP A 901s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 2.91 -49.00 -8.95 5.74 -49.26 -9.91 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 28 TYR~? 12.81 O2' AMP B 903 B1317 GLU C 18 GLU.? 10.63 O3' AMP A 901 B1365 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 10.31 -28.72 0.63 8.60 -26.56 1.94 1vzx_c03 source 1vzx 2.04.01.0087 : 5 hits 1vzx_c03 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 53 GLY.? -3.03 O2P AMP B 902s B 419 GLY B 42 GLY.? 4.07 C5 AMP B 902 B 420 ALA B 41 ALA.? 4.03 N6 AMP B 902 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 3.10 -16.67 -14.45 2.80 -16.03 -14.03 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 7.37 -16.61 -14.90 8.15 -16.78 -15.17 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 7.96 -14.54 -18.03 8.19 -15.62 -19.09 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 53 GLY.? -3.03 O2P AMP B 902s B 419 GLY B 42 GLY.? 4.07 C5 AMP B 902 B 420 ALA B 43 ALA^? -4.85 C2 AMP B 902s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 3.10 -16.67 -14.45 2.80 -16.03 -14.03 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 7.37 -16.61 -14.90 8.15 -16.78 -15.17 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 8.76 -19.29 -12.60 9.80 -18.56 -11.76 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY B 53 GLY^? 3.90 C8 AMP B 903 B 419 GLY C 42 GLY^? -3.50 C6 AMP B 903s B 420 ALA C 41 ALA.? 3.94 N6 AMP B 903 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 25.54 -32.88 -5.01 25.85 -33.19 -4.25 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 24.43 -35.52 -7.75 24.29 -36.09 -8.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 27.72 -35.97 -9.59 27.60 -35.28 -10.95 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY B 53 GLY^? 3.90 C8 AMP B 903 B 419 GLY C 42 GLY^? -3.50 C6 AMP B 903s B 420 ALA C 43 ALA^? -4.76 C2 AMP B 903s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 25.54 -32.88 -5.01 25.85 -33.19 -4.25 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 24.43 -35.52 -7.75 24.29 -36.09 -8.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 20.72 -36.32 -7.58 20.68 -37.80 -7.20 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY C 53 GLY.? -3.70 O1P AMP A 901s B 419 GLY A 42 GLY.? -3.55 C6 AMP A 901s B 420 ALA A 41 ALA.? -3.40 N6 AMP A 901s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 1.50 -45.86 -15.96 0.71 -46.04 -15.90 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 0.97 -42.40 -18.34 1.06 -41.78 -18.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.12 -43.96 -21.79 2.53 -43.59 -22.29 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY C 53 GLY.? -3.70 O1P AMP A 901s B 419 GLY A 42 GLY.? -3.55 C6 AMP A 901s B 420 ALA A 43 ALA^? -4.91 C2 AMP A 901s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 1.50 -45.86 -15.96 0.71 -46.04 -15.90 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 0.97 -42.40 -18.34 1.06 -41.78 -18.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 6 hits 1xny_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 43 ALA^? -4.91 C2 AMP A 901s B 126 ARG A 36 ARG~? 10.98 O3P AMP A 901 B 138 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 2.11 4.00 19.31 3.14 4.86 19.99 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 coo 2.45 5.53 11.28 3.59 7.56 13.29 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 6.10 2.00 25.24 6.12 1.84 23.13 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 43 ALA^? -4.85 C2 AMP B 902s B 126 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 138 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 2.11 4.00 19.31 3.14 4.86 19.99 8.76 -19.29 -12.60 9.80 -18.56 -11.76 coo 2.45 5.53 11.28 3.59 7.56 13.29 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 6.10 2.00 25.24 6.12 1.84 23.13 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA C 43 ALA^? -4.76 C2 AMP B 903s B 126 ARG C 36 ARG~? 10.59 O3P AMP B 903 B 138 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 2.11 4.00 19.31 3.14 4.86 19.99 20.72 -36.32 -7.58 20.68 -37.80 -7.20 coo 2.45 5.53 11.28 3.59 7.56 13.29 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 6.10 2.00 25.24 6.12 1.84 23.13 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 43 ALA^? -4.91 C2 AMP A 901s C 126 ARG A 36 ARG~? 10.98 O3P AMP A 901 C 138 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 43 ALA^? -4.85 C2 AMP B 902s C 126 ARG B 36 ARG~? 10.26 O2P AMP B 902 C 138 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 8.76 -19.29 -12.60 9.80 -18.56 -11.76 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA C 43 ALA^? -4.76 C2 AMP B 903s C 126 ARG C 36 ARG~? 10.59 O3P AMP B 903 C 138 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 20.72 -36.32 -7.58 20.68 -37.80 -7.20 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 43 ALA^? -4.91 C2 AMP A 901s D 126 ARG A 36 ARG~? 10.98 O3P AMP A 901 D 138 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 6.23 0.50 57.10 5.93 0.72 59.19 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 43 ALA^? -4.85 C2 AMP B 902s D 126 ARG B 36 ARG~? 10.26 O2P AMP B 902 D 138 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 8.76 -19.29 -12.60 9.80 -18.56 -11.76 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 6.23 0.50 57.10 5.93 0.72 59.19 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA C 43 ALA^? -4.76 C2 AMP B 903s D 126 ARG C 36 ARG~? 10.59 O3P AMP B 903 D 138 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 20.72 -36.32 -7.58 20.68 -37.80 -7.20 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 6.23 0.50 57.10 5.93 0.72 59.19 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 43 ALA^? -4.91 C2 AMP A 901s E 126 ARG A 36 ARG~? 10.98 O3P AMP A 901 E 138 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -4.56 10.03 62.36 -4.38 11.31 61.55 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -8.67 12.22 56.54 -8.68 12.09 58.65 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 43 ALA^? -4.85 C2 AMP B 902s E 126 ARG B 36 ARG~? 10.26 O2P AMP B 902 E 138 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -4.56 10.03 62.36 -4.38 11.31 61.55 8.76 -19.29 -12.60 9.80 -18.56 -11.76 coo -3.02 12.00 70.07 -1.94 13.84 67.82 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo -8.67 12.22 56.54 -8.68 12.09 58.65 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA C 43 ALA^? -4.76 C2 AMP B 903s E 126 ARG C 36 ARG~? 10.59 O3P AMP B 903 E 138 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -4.56 10.03 62.36 -4.38 11.31 61.55 20.72 -36.32 -7.58 20.68 -37.80 -7.20 coo -3.02 12.00 70.07 -1.94 13.84 67.82 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo -8.67 12.22 56.54 -8.68 12.09 58.65 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 43 ALA^? -4.91 C2 AMP A 901s F 126 ARG A 36 ARG~? 10.98 O3P AMP A 901 F 138 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 1.22 -39.18 -16.38 -0.13 -38.50 -16.48 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 43 ALA^? -4.85 C2 AMP B 902s F 126 ARG B 36 ARG~? 10.26 O2P AMP B 902 F 138 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 8.76 -19.29 -12.60 9.80 -18.56 -11.76 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA C 43 ALA^? -4.76 C2 AMP B 903s F 126 ARG C 36 ARG~? 10.59 O3P AMP B 903 F 138 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 20.72 -36.32 -7.58 20.68 -37.80 -7.20 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 16.76 -34.80 -12.34 15.78 -32.94 -12.53 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 42 GLY.? -3.55 C6 AMP A 901s B 175 ARG A 36 ARG~? 10.98 O3P AMP A 901 B 242 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 99.45 58.28 3.33 99.57 58.61 4.10 0.97 -42.40 -18.34 1.06 -41.78 -18.91 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 100.93 69.04 4.38 99.52 68.48 2.09 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 48 GLY.? 7.43 O2' AMP B 902 B 175 ARG B 47 ARG^? 13.42 O3' AMP B 903 B 242 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 99.45 58.28 3.33 99.57 58.61 4.10 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 100.93 69.04 4.38 99.52 68.48 2.09 13.87 -20.58 -2.07 11.87 -21.01 -0.16 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 48 GLY.? 7.43 O2' AMP B 902 B 175 ARG B 47 ARG^? 13.42 O3' AMP B 903 B 242 TYR C 46 TYR^? 7.86 O2' AMP B 903 coo 99.45 58.28 3.33 99.57 58.61 4.10 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 10.31 -28.72 0.63 8.60 -26.56 1.94 coo 100.93 69.04 4.38 99.52 68.48 2.09 11.40 -33.98 -8.06 13.29 -32.33 -9.27 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 53 GLY.? -3.03 O2P AMP B 902s B 175 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 242 TYR A 50 TYR^? 6.90 O2' AMP B 902 coo 99.45 58.28 3.33 99.57 58.61 4.10 3.10 -16.67 -14.45 2.80 -16.03 -14.03 coo 106.37 63.53 0.89 108.02 63.40 -1.62 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 6.03 -18.98 -5.10 5.67 -16.40 -6.13 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 42 GLY.? 4.07 C5 AMP B 902 B 175 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 242 TYR A 50 TYR^? 6.90 O2' AMP B 902 coo 99.45 58.28 3.33 99.57 58.61 4.10 7.37 -16.61 -14.90 8.15 -16.78 -15.17 coo 106.37 63.53 0.89 108.02 63.40 -1.62 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 6.03 -18.98 -5.10 5.67 -16.40 -6.13 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 48 GLY.? 6.82 O2' AMP B 903 B 175 ARG C 47 ARG^? 14.09 O3' AMP A 901 B 242 TYR C 28 TYR~? 12.81 O2' AMP B 903 coo 99.45 58.28 3.33 99.57 58.61 4.10 12.57 -32.06 -3.34 12.38 -31.65 -2.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 100.93 69.04 4.38 99.52 68.48 2.09 12.98 -43.06 -2.71 12.25 -41.79 -0.32 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY B 53 GLY^? 3.90 C8 AMP B 903 B 175 ARG C 36 ARG~? 10.59 O3P AMP B 903 B 242 TYR B 50 TYR^? 7.37 O3' AMP B 903 coo 99.45 58.28 3.33 99.57 58.61 4.10 25.54 -32.88 -5.01 25.85 -33.19 -4.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 17.59 -37.29 -0.29 20.29 -37.88 0.15 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY C 42 GLY^? -3.50 C6 AMP B 903s B 175 ARG C 36 ARG~? 10.59 O3P AMP B 903 B 242 TYR B 50 TYR^? 7.37 O3' AMP B 903 coo 99.45 58.28 3.33 99.57 58.61 4.10 24.43 -35.52 -7.75 24.29 -36.09 -8.36 coo 106.37 63.53 0.89 108.02 63.40 -1.62 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 17.59 -37.29 -0.29 20.29 -37.88 0.15 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY C 48 GLY.? 7.32 O2' AMP A 901 B 175 ARG A 47 ARG^? 13.44 O3' AMP B 902 B 242 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo 99.45 58.28 3.33 99.57 58.61 4.10 4.45 -36.24 -7.07 4.39 -36.62 -6.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 100.93 69.04 4.38 99.52 68.48 2.09 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY C 48 GLY.? 7.32 O2' AMP A 901 B 175 ARG A 47 ARG^? 13.44 O3' AMP B 902 B 242 TYR B 46 TYR^? 7.73 N3 AMP B 902 coo 99.45 58.28 3.33 99.57 58.61 4.10 4.45 -36.24 -7.07 4.39 -36.62 -6.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 coo 100.93 69.04 4.38 99.52 68.48 2.09 9.40 -27.99 -8.79 8.40 -27.73 -11.39 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY C 53 GLY.? -3.70 O1P AMP A 901s B 175 ARG A 36 ARG~? 10.98 O3P AMP A 901 B 242 TYR C 50 TYR^? 7.65 O3' AMP A 901 coo 99.45 58.28 3.33 99.57 58.61 4.10 1.50 -45.86 -15.96 0.71 -46.04 -15.90 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 100.93 69.04 4.38 99.52 68.48 2.09 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 11 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 A 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 A 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 18.28 7.83 36.39 22.82 8.75 39.52 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 22.22 16.06 48.76 23.94 15.33 49.78 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 74 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 18.28 7.83 36.39 22.82 8.75 39.52 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 74 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 165 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 18.28 7.83 36.39 22.82 8.75 39.52 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 18.28 7.83 36.39 22.82 8.75 39.52 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 14.16 13.09 37.03 20.00 12.44 37.49 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 22.22 16.06 48.76 23.94 15.33 49.78 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 A 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 A 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 18.28 7.83 36.39 22.82 8.75 39.52 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 14.16 13.09 37.03 20.00 12.44 37.49 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 22.22 16.06 48.76 23.94 15.33 49.78 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 74 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 18.28 7.83 36.39 22.82 8.75 39.52 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 14.16 13.09 37.03 20.00 12.44 37.49 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 74 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 165 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 18.28 7.83 36.39 22.82 8.75 39.52 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 14.16 13.09 37.03 20.00 12.44 37.49 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 A 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 A 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 14.16 13.09 37.03 20.00 12.44 37.49 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 91 LYS~? 16.71 N7 AMP B 902 B 74 LYS A 95 LYS.? 10.91 O3P AMP B 902 B 165 GLU A 23 GLU.? 20.44 O3P AMP B 902 coo 13.51 0.92 76.10 12.98 6.13 74.68 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 coo 21.39 11.56 68.52 20.24 13.13 67.73 -17.66 -28.33 -17.35 -18.28 -30.03 -18.45 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 74 LYS B 95 LYS.? 10.50 O1P AMP B 903 B 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 13.51 0.92 76.10 12.98 6.13 74.68 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 19.89 -0.55 76.51 17.10 4.32 77.43 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 21.39 11.56 68.52 20.24 13.13 67.73 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 95 LYS.? 10.50 O1P AMP B 903 B 74 LYS B 91 LYS~? 15.95 O1P AMP B 903 B 165 GLU B 23 GLU.? 19.12 O2P AMP B 903 coo 13.51 0.92 76.10 12.98 6.13 74.68 28.16 -20.89 -4.35 31.71 -19.40 -6.33 coo 19.89 -0.55 76.51 17.10 4.32 77.43 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 21.39 11.56 68.52 20.24 13.13 67.73 23.11 -9.89 1.58 22.67 -8.31 0.21 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 74 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.32 -56.91 -1.57 19.42 -57.00 -1.46 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS C 95 LYS.? 12.30 O2P AMP A 901 B 74 LYS C 91 LYS~? 16.75 C8 AMP A 901 B 165 GLU C 23 GLU.? 21.28 O2P AMP A 901 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 -52.84 -12.18 10.14 -58.60 -9.63 coo 19.89 -0.55 76.51 17.10 4.32 77.43 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.32 -56.91 -1.57 19.42 -57.00 -1.46 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 5 hits 1ylu_c01 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 48 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 77 LYS A 85 LYS~? 14.18 N6 AMP A 901 coo 13.04 30.41 72.50 12.95 30.65 70.36 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 12.77 23.50 68.33 13.58 25.42 68.49 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 7.53 29.84 65.06 12.29 29.41 67.79 -3.83 -35.53 -29.64 -4.48 -41.11 -30.81 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 1 hits 2acu_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 20 ASP.? 5.75 O3P AMP B 902 219 GLU A 18 GLU.? 10.44 O3' AMP B 902 294 ASP A 69 ASP.? 5.85 O1P AMP B 902 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 25.84 105.87 9.06 27.86 105.55 8.74 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 69 ASP.? 5.85 O1P AMP B 902 219 GLU A 18 GLU.? 10.44 O3' AMP B 902 294 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 27.89 102.52 14.98 29.35 101.92 13.57 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo 25.84 105.87 9.06 27.86 105.55 8.74 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP C 20 ASP.? 6.67 O5' AMP A 901 219 GLU C 18 GLU.? 10.63 O3' AMP A 901 294 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo 27.89 102.52 14.98 29.35 101.92 13.57 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 25.84 105.87 9.06 27.86 105.55 8.74 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP C 69 ASP.? 6.83 O3' AMP A 901 219 GLU C 18 GLU.? 10.63 O3' AMP A 901 294 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo 27.89 102.52 14.98 29.35 101.92 13.57 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo 25.84 105.87 9.06 27.86 105.55 8.74 6.18 -43.03 -1.28 4.85 -41.58 -0.59 coo 33.16 106.80 7.72 33.34 104.87 6.92 8.87 -49.22 -5.46 7.44 -48.97 -6.99 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 4 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 20 ASP.? 5.75 O3P AMP B 902 231 ASP A 78 ASP^? 5.94 N6 AMP A 901 294 ASP A 96 ASP.? 4.70 O3P AMP B 902 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 96 ASP.? 4.70 O3P AMP B 902 231 ASP A 78 ASP^? 5.94 N6 AMP A 901 294 ASP A 20 ASP.? 5.75 O3P AMP B 902 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.78 -17.95 -17.90 -3.40 -16.36 -18.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP C 20 ASP.? 6.67 O5' AMP A 901 231 ASP C 78 ASP^? 6.25 N6 AMP B 903 294 ASP C 96 ASP.? -4.92 O1P AMP A 901s coo 27.89 102.52 14.98 29.35 101.92 13.57 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.52 -51.71 -13.41 4.60 -53.19 -14.62 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 3 hits 2amg_c06 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 13 ARG^? 9.68 C2 AMP B 902 A 161 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 174 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 13 ARG^? 10.00 C2 AMP B 903 A 161 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 174 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 13.87 -20.58 -2.07 11.87 -21.01 -0.16 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 161 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 174 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 161 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 174 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -14.86 10.19 8.14 -14.82 12.31 8.42 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -21.46 12.70 8.53 -19.04 12.30 7.24 13.87 -20.58 -2.07 11.87 -21.01 -0.16 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 13 ARG^? 9.68 C2 AMP B 902 C 161 ASP A 20 ASP.? 5.75 O3P AMP B 902 C 174 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo 2.84 19.43 40.34 1.59 20.35 37.65 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo 5.94 13.28 27.17 3.53 13.05 28.58 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 13 ARG^? 10.00 C2 AMP B 903 C 161 ASP B 20 ASP.? 4.50 O2P AMP B 903 C 174 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo 2.84 19.43 40.34 1.59 20.35 37.65 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -0.62 11.10 28.05 -0.65 13.15 27.46 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo 5.94 13.28 27.17 3.53 13.05 28.58 13.87 -20.58 -2.07 11.87 -21.01 -0.16 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 13 ARG^? 9.68 C2 AMP B 902 D 161 ASP A 20 ASP.? 5.75 O3P AMP B 902 D 174 TYR A 28 TYR~? 12.65 O3' AMP B 902 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -4.84 -31.26 -10.71 -5.31 -31.73 -7.99 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 13 ARG^? 10.00 C2 AMP B 903 D 161 ASP B 20 ASP.? 4.50 O2P AMP B 903 D 174 TYR B 28 TYR~? 12.70 O3' AMP B 903 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 13.87 -20.58 -2.07 11.87 -21.01 -0.16 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 A 156 GLU A 5 GLU.? 10.94 N7 AMP A 901 A 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 74.14 15.91 8.55 72.08 15.36 8.63 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 67.47 20.07 1.34 65.99 20.06 2.88 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 67.44 25.26 13.91 67.54 23.65 15.28 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 A 156 GLU A 114 GLU.? 19.10 O1P AMP A 901 A 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 74.14 15.91 8.55 72.08 15.36 8.63 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 67.47 20.07 1.34 65.99 20.06 2.88 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 67.44 25.26 13.91 67.54 23.65 15.28 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 114 GLU.? 19.10 O1P AMP A 901 A 156 GLU A 3 GLU.? 19.16 N7 AMP A 901 A 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 74.14 15.91 8.55 72.08 15.36 8.63 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 67.44 25.26 13.91 67.54 23.65 15.28 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 156 GLU C 102 GLU^? 11.80 C2 AMP B 903 A 194 ASN C 82 ASN~? 10.04 N6 AMP B 903 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 67.47 20.07 1.34 65.99 20.06 2.88 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 67.44 25.26 13.91 67.54 23.65 15.28 28.40 -40.74 -15.04 30.38 -40.42 -14.36 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 B 156 GLU A 5 GLU.? 10.94 N7 AMP A 901 B 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 45.64 63.11 17.20 47.48 62.43 16.45 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 54.43 67.89 19.82 55.62 67.90 18.07 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 49.79 70.75 7.78 50.10 68.90 6.86 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 B 156 GLU A 114 GLU.? 19.10 O1P AMP A 901 B 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 45.64 63.11 17.20 47.48 62.43 16.45 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 54.43 67.89 19.82 55.62 67.90 18.07 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 49.79 70.75 7.78 50.10 68.90 6.86 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 114 GLU.? 19.10 O1P AMP A 901 B 156 GLU A 3 GLU.? 19.16 N7 AMP A 901 B 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 45.64 63.11 17.20 47.48 62.43 16.45 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 49.79 70.75 7.78 50.10 68.90 6.86 24.58 -50.38 -16.44 25.19 -52.40 -16.37 2dbt_c01 source 2dbt CHITINASE C : 3 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 C 156 GLU A 5 GLU.? 10.94 N7 AMP A 901 C 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 41.23 29.31 13.28 43.03 29.85 12.29 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 44.75 23.09 5.51 46.77 22.91 6.12 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 49.75 21.00 18.12 50.45 23.02 18.26 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 3 GLU.? 19.16 N7 AMP A 901 C 156 GLU A 114 GLU.? 19.10 O1P AMP A 901 C 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 41.23 29.31 13.28 43.03 29.85 12.29 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 44.75 23.09 5.51 46.77 22.91 6.12 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 49.75 21.00 18.12 50.45 23.02 18.26 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 5 GLU.? 10.94 N7 AMP A 901 C 156 GLU A 3 GLU.? 19.16 N7 AMP A 901 C 194 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 41.23 29.31 13.28 43.03 29.85 12.29 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 44.75 23.09 5.51 46.77 22.91 6.12 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 75 GLU^? -5.62 C2 AMP A 901s C 156 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 194 ASN A 82 ASN~? 9.92 N6 AMP A 901 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo 44.75 23.09 5.51 46.77 22.91 6.12 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 49.75 21.00 18.12 50.45 23.02 18.26 -0.19 -40.04 -27.66 -0.71 -42.03 -28.29 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 114 GLU.? 19.10 O1P AMP A 901 C 156 GLU A 3 GLU.? 19.16 N7 AMP A 901 C 194 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 41.23 29.31 13.28 43.03 29.85 12.29 15.34 -60.76 -19.73 15.15 -60.69 -21.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 17.96 -53.90 -26.14 17.70 -55.67 -24.99 coo 49.75 21.00 18.12 50.45 23.02 18.26 24.58 -50.38 -16.44 25.19 -52.40 -16.37 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU B 75 GLU^? -4.88 C2 AMP B 902s C 156 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 194 ASN B 82 ASN~? 10.16 N6 AMP B 902 coo 41.23 29.31 13.28 43.03 29.85 12.29 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo 44.75 23.09 5.51 46.77 22.91 6.12 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 49.75 21.00 18.12 50.45 23.02 18.26 14.55 -13.43 -20.87 13.40 -11.78 -21.59 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU C 75 GLU^? -5.53 C2 AMP B 903s C 156 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 194 ASN C 82 ASN~? 10.04 N6 AMP B 903 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo 44.75 23.09 5.51 46.77 22.91 6.12 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 49.75 21.00 18.12 50.45 23.02 18.26 28.40 -40.74 -15.04 30.38 -40.42 -14.36 2dbt_c02 source 2dbt CHITINASE C : 7 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS C 34 LYS~? 17.13 N6 AMP B 903 L 184 LYS C 29 LYS~? 16.03 O2' AMP B 903 L 345 ASP C 78 ASP^? 6.25 N6 AMP B 903 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 26.09 -37.43 -14.21 28.04 -37.58 -13.32 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 34 LYS~? 19.00 N1 AMP A 901 M 184 LYS A 29 LYS~? 17.35 O2' AMP A 901 M 345 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS C 34 LYS~? 17.13 N6 AMP B 903 M 184 LYS C 29 LYS~? 16.03 O2' AMP B 903 M 345 ASP C 78 ASP^? 6.25 N6 AMP B 903 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 26.09 -37.43 -14.21 28.04 -37.58 -13.32 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS C 34 LYS~? 17.13 N6 AMP B 903 P 184 LYS C 29 LYS~? 16.03 O2' AMP B 903 P 345 ASP C 78 ASP^? 6.25 N6 AMP B 903 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 26.09 -37.43 -14.21 28.04 -37.58 -13.32 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 245 ASP B 20 ASP.? 4.50 O2P AMP B 903 A 273 LYS B 91 LYS~? 15.95 O1P AMP B 903 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 25.56 -16.77 -10.74 28.77 -17.65 -15.89 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 245 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 273 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 245 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 273 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 245 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 273 LYS C 91 LYS~? 16.75 C8 AMP A 901 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.40 -51.44 -14.48 19.12 -51.90 -20.49 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 245 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 273 LYS C 54 LYS.? 9.50 O1P AMP A 901 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 0.63 -48.72 -18.32 2.49 -53.34 -22.30 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 5 hits 2gsa_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 20 ASP.? 5.75 O3P AMP B 902 166 GLY C 48 GLY.? 7.32 O2' AMP A 901 169 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.45 -36.24 -7.07 4.39 -36.62 -6.29 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 20 ASP.? 5.75 O3P AMP B 902 166 GLY C 51 GLY^? 3.80 O2' AMP A 901 169 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.59 -40.66 -11.26 -0.01 -41.05 -10.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 69 ASP.? 5.85 O1P AMP B 902 166 GLY B 48 GLY.? 6.82 O2' AMP B 903 169 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo 8.28 6.87 1.62 10.08 5.77 1.34 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.57 -32.06 -3.34 12.38 -31.65 -2.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 69 ASP.? 5.85 O1P AMP B 902 166 GLY C 48 GLY.? 7.32 O2' AMP A 901 169 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.45 -36.24 -7.07 4.39 -36.62 -6.29 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 78 ASP^? 5.94 N6 AMP A 901 166 GLY A 110 GLY.? 9.55 O1P AMP A 901 169 GLU A 114 GLU.? 19.10 O1P AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 10.72 -52.80 -16.55 10.06 -52.72 -17.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 15.34 -60.76 -19.73 15.15 -60.69 -21.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 78 ASP^? 5.94 N6 AMP A 901 166 GLY C 48 GLY.? 7.32 O2' AMP A 901 169 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.45 -36.24 -7.07 4.39 -36.62 -6.29 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 20 ASP.? 4.50 O2P AMP B 903 166 GLY A 48 GLY.? 7.43 O2' AMP B 902 169 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 20 ASP.? 4.50 O2P AMP B 903 166 GLY A 51 GLY^? -2.89 O2' AMP B 902s 169 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.82 -20.06 -8.78 4.43 -19.55 -8.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 69 ASP.? 6.10 O2P AMP B 903 166 GLY A 48 GLY.? 7.43 O2' AMP B 902 169 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 8.28 6.87 1.62 10.08 5.77 1.34 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 78 ASP^? 6.36 N6 AMP B 902 166 GLY A 48 GLY.? 7.43 O2' AMP B 902 169 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 20 ASP.? 6.67 O5' AMP A 901 166 GLY B 48 GLY.? 6.82 O2' AMP B 903 169 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 8.28 6.87 1.62 10.08 5.77 1.34 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.57 -32.06 -3.34 12.38 -31.65 -2.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 69 ASP.? 6.83 O3' AMP A 901 166 GLY A 48 GLY.? 7.43 O2' AMP B 902 169 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo 8.28 6.87 1.62 10.08 5.77 1.34 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.24 -26.69 -6.67 4.51 -26.79 -6.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 69 ASP.? 6.83 O3' AMP A 901 166 GLY A 110 GLY.? 9.55 O1P AMP A 901 169 GLU A 114 GLU.? 19.10 O1P AMP A 901 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -8.58 13.22 3.21 -8.90 13.15 4.05 10.72 -52.80 -16.55 10.06 -52.72 -17.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 15.34 -60.76 -19.73 15.15 -60.69 -21.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 69 ASP.? 6.83 O3' AMP A 901 166 GLY B 48 GLY.? 6.82 O2' AMP B 903 169 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.57 -32.06 -3.34 12.38 -31.65 -2.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP C 78 ASP^? 6.25 N6 AMP B 903 166 GLY B 48 GLY.? 6.82 O2' AMP B 903 169 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -8.58 13.22 3.21 -8.90 13.15 4.05 12.57 -32.06 -3.34 12.38 -31.65 -2.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 14.19 -24.84 2.24 12.77 -26.14 3.06 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 15 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 15 TYR^? -4.88 N3 AMP B 902s A 214 ASP A 20 ASP.? 5.75 O3P AMP B 902 A 256 LYS A 34 LYS~? 19.00 N1 AMP A 901 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 50 TYR^? 6.90 O2' AMP B 902 A 214 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 256 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 50 TYR^? 6.90 O2' AMP B 902 A 214 ASP A 69 ASP.? 5.85 O1P AMP B 902 A 256 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 256 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR B 28 TYR~? 12.70 O3' AMP B 903 A 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 256 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 256 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 50 TYR^? 7.37 O3' AMP B 903 A 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 A 256 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 214 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 256 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 9.63 -52.84 -12.18 10.14 -58.60 -9.63 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 8 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 15 TYR^? -4.88 N3 AMP B 902s B 214 ASP A 20 ASP.? 5.75 O3P AMP B 902 B 256 LYS A 34 LYS~? 19.00 N1 AMP A 901 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.07 -24.00 -12.71 -5.66 -22.44 -12.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 50 TYR^? 6.90 O2' AMP B 902 B 214 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 256 LYS A 21 LYS^? 15.53 O3P AMP B 902 coo -32.67 22.74 10.17 -32.85 23.98 7.70 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 50 TYR^? 6.90 O2' AMP B 902 B 214 ASP A 69 ASP.? 5.85 O1P AMP B 902 B 256 LYS A 95 LYS.? 10.91 O3P AMP B 902 coo -32.67 22.74 10.17 -32.85 23.98 7.70 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -2.63 -19.86 -6.95 -3.91 -20.85 -8.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -7.71 -20.47 -20.10 -12.25 -18.56 -17.32 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 15 TYR^? -4.78 N3 AMP B 903s B 214 ASP B 20 ASP.? 4.50 O2P AMP B 903 B 256 LYS B 34 LYS~? 18.46 N1 AMP B 902 coo -32.67 22.74 10.17 -32.85 23.98 7.70 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 21.25 -21.87 0.09 22.11 -23.74 -0.35 coo -16.04 12.06 11.09 -17.97 10.54 5.71 14.79 -10.69 -8.44 19.07 -7.28 -9.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 256 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -26.88 17.61 16.89 -26.08 17.11 15.00 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 29.14 -34.12 -5.07 32.41 -32.79 -9.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR B 28 TYR~? 12.70 O3' AMP B 903 B 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 256 LYS B 55 LYS.? 9.89 O1P AMP B 903 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.87 -20.58 -2.07 11.87 -21.01 -0.16 coo -26.88 17.61 16.89 -26.08 17.11 15.00 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 29.71 -30.40 -5.65 34.42 -26.97 -8.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 256 LYS B 29 LYS~? 16.31 O2' AMP B 902 coo -32.67 22.74 10.17 -32.85 23.98 7.70 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -26.88 17.61 16.89 -26.08 17.11 15.00 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 13.21 -16.35 -2.11 10.27 -17.60 3.37 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR B 50 TYR^? 7.37 O3' AMP B 903 B 214 ASP B 69 ASP.? 6.10 O2P AMP B 903 B 256 LYS B 95 LYS.? 10.50 O1P AMP B 903 coo -32.67 22.74 10.17 -32.85 23.98 7.70 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo -26.88 17.61 16.89 -26.08 17.11 15.00 20.07 -28.61 3.38 19.95 -26.81 2.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 28.16 -20.89 -4.35 31.71 -19.40 -6.33 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR C 15 TYR^? 4.73 N3 AMP A 901 B 214 ASP C 20 ASP.? 6.67 O5' AMP A 901 B 256 LYS C 34 LYS~? 17.13 N6 AMP B 903 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo -26.88 17.61 16.89 -26.08 17.11 15.00 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo -16.04 12.06 11.09 -17.97 10.54 5.71 24.06 -46.65 -4.78 27.74 -49.81 -6.72 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR C 50 TYR^? 7.65 O3' AMP A 901 B 214 ASP C 69 ASP.? 6.83 O3' AMP A 901 B 256 LYS C 95 LYS.? 12.30 O2P AMP A 901 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -16.04 12.06 11.09 -17.97 10.54 5.71 9.63 -52.84 -12.18 10.14 -58.60 -9.63 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 10 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG C 36 ARG~? 10.59 O3P AMP B 903 A 130 SER B 67 SER.? 5.89 O3' AMP B 903 A 159 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 18.35 45.84 20.99 16.20 47.83 21.89 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 15.14 43.67 10.77 15.61 44.43 13.04 20.15 -34.17 4.60 19.43 -33.36 2.42 coo 11.57 48.49 22.18 13.51 49.99 17.21 29.14 -34.12 -5.07 32.41 -32.79 -9.64 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG C 36 ARG~? 10.59 O3P AMP B 903 B 130 SER B 67 SER.? 5.89 O3' AMP B 903 B 159 LYS B 54 LYS.? 8.42 N6 AMP B 903 coo 58.72 31.58 20.45 60.80 29.39 20.94 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 61.66 35.17 10.39 61.29 34.14 12.56 20.15 -34.17 4.60 19.43 -33.36 2.42 coo 65.38 28.77 21.17 63.49 28.03 16.12 29.14 -34.12 -5.07 32.41 -32.79 -9.64 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c01 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 11 ARG^? 7.89 C2 AMP A 901 127 ARG C 13 ARG^? 8.59 C2 AMP A 901 270 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -1.14 25.72 1.64 0.76 28.10 1.50 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 11.33 -24.73 -14.66 10.03 -26.36 -14.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG B 11 ARG^? 7.52 N1 AMP B 902 127 ARG A 13 ARG^? 9.68 C2 AMP B 902 270 GLU C 75 GLU^? -5.53 C2 AMP B 903s coo -1.14 25.72 1.64 0.76 28.10 1.50 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.76 -34.80 -12.34 15.78 -32.94 -12.53 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 13 ARG^? 10.00 C2 AMP B 903 127 ARG C 11 ARG^? 7.32 C2 AMP B 903 270 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -1.14 25.72 1.64 0.76 28.10 1.50 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG C 11 ARG^? 7.32 C2 AMP B 903 127 ARG B 13 ARG^? 10.00 C2 AMP B 903 270 GLU A 75 GLU^? -5.62 C2 AMP A 901s coo -1.14 25.72 1.64 0.76 28.10 1.50 16.60 -33.12 -16.39 17.81 -30.41 -15.70 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.13 -35.02 -17.20 7.93 -35.29 -16.18 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG C 13 ARG^? 8.59 C2 AMP A 901 127 ARG A 11 ARG^? 7.89 C2 AMP A 901 270 GLU B 75 GLU^? -4.88 C2 AMP B 902s coo -1.14 25.72 1.64 0.76 28.10 1.50 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 11.33 -24.73 -14.66 10.03 -26.36 -14.95 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 5 hits 5cpa_c01 naa= 3 ULMN 3 7atj_c00 PEROXIDASE C1A user 1 3 # 1 A 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 A 42 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 70 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 1.39 6.34 11.43 0.09 6.19 8.61 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 5.40 8.25 8.15 4.09 6.62 7.93 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 1.54 10.80 4.23 3.44 10.57 5.15 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 7atj_c00 PEROXIDASE C1A user 2 3 # 2 A 38 ARG A 79 ARG^? 11.76 N6 AMP A 901 A 42 HIS A 81 HIS~? 14.35 N6 AMP A 901 A 70 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 1.39 6.34 11.43 0.09 6.19 8.61 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 5.40 8.25 8.15 4.09 6.62 7.93 3.17 -39.49 -33.40 5.11 -39.25 -34.17 coo 1.54 10.80 4.23 3.44 10.57 5.15 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 3 7atj_c00 PEROXIDASE C1A user 3 3 # 3 A 38 ARG B 79 ARG^? 12.83 N6 AMP B 902 A 42 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 70 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo 1.39 6.34 11.43 0.09 6.19 8.61 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo 5.40 8.25 8.15 4.09 6.62 7.93 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 1.54 10.80 4.23 3.44 10.57 5.15 14.70 -19.35 -29.72 16.77 -19.30 -29.18 7atj_c00 source 7atj PEROXIDASE C1A : 3 hits 7atj_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 8 ASN.? 11.89 N6 AMP A 901 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.90 -41.73 -31.70 8.52 -43.07 -30.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 19 ASN.? 10.11 O1P AMP B 902 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.25 -22.51 -7.08 -6.24 -22.66 -5.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 82 ASN~? 9.92 N6 AMP A 901 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.19 -40.04 -27.66 -0.71 -42.03 -28.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 88 ASN~? 18.60 N6 AMP A 901 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.16 -31.15 -30.13 -4.72 -31.21 -31.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 8 ASN^? 14.36 N6 AMP B 902 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.70 -19.35 -29.72 16.77 -19.30 -29.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 19 ASN.? 10.32 O2P AMP B 903 coo 5.80 63.03 55.85 5.52 65.03 56.45 19.24 -24.20 5.03 17.75 -25.40 5.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 82 ASN~? 10.16 N6 AMP B 902 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.55 -13.43 -20.87 13.40 -11.78 -21.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 88 ASN~? 18.59 N1 AMP B 902 coo 5.80 63.03 55.85 5.52 65.03 56.45 24.42 -12.36 -16.29 25.36 -13.07 -18.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 8 ASN.? 14.04 N6 AMP B 903 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.61 -35.12 -23.42 27.13 -36.51 -24.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 19 ASN.? 10.79 O3' AMP A 901 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.38 -48.28 -1.80 3.20 -46.97 -0.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 82 ASN~? 10.04 N6 AMP B 903 coo 5.80 63.03 55.85 5.52 65.03 56.45 28.40 -40.74 -15.04 30.38 -40.42 -14.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 88 ASN~? 19.61 N1 AMP B 903 coo 5.80 63.03 55.85 5.52 65.03 56.45 24.58 -50.38 -16.44 25.19 -52.40 -16.37 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 12 hits 1kbk_p00 naa= 1 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 6 HIS.? 9.49 N6 AMP A 901 A 76 ASN A 82 ASN~? 9.92 N6 AMP A 901 A 81 ASP A 78 ASP^? 5.94 N6 AMP A 901 coo 4.09 43.69 67.89 2.45 42.40 68.10 9.04 -45.79 -27.38 7.44 -47.11 -27.07 coo 4.75 48.17 75.81 4.99 47.30 77.74 -0.19 -40.04 -27.66 -0.71 -42.03 -28.29 coo 0.57 50.41 73.18 0.46 48.28 73.56 2.95 -40.37 -24.73 1.78 -42.09 -25.10 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 6 HIS^? 11.24 N6 AMP B 902 A 76 ASN B 82 ASN~? 10.16 N6 AMP B 902 A 81 ASP B 78 ASP^? 6.36 N6 AMP B 902 coo 4.09 43.69 67.89 2.45 42.40 68.10 8.85 -17.18 -28.64 8.26 -15.17 -28.64 coo 4.75 48.17 75.81 4.99 47.30 77.74 14.55 -13.43 -20.87 13.40 -11.78 -21.59 coo 0.57 50.41 73.18 0.46 48.28 73.56 12.15 -16.83 -20.34 11.30 -14.93 -20.75 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS C 6 HIS.? 9.51 N6 AMP B 903 A 76 ASN C 82 ASN~? 10.04 N6 AMP B 903 A 81 ASP C 78 ASP^? 6.25 N6 AMP B 903 coo 4.09 43.69 67.89 2.45 42.40 68.10 31.25 -31.71 -16.30 32.78 -32.33 -15.00 coo 4.75 48.17 75.81 4.99 47.30 77.74 28.40 -40.74 -15.04 30.38 -40.42 -14.36 coo 0.57 50.41 73.18 0.46 48.28 73.56 26.09 -37.43 -14.21 28.04 -37.58 -13.32 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 3 hits 2c3x_p00 naa= 3 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP C 20 ASP.? 6.67 O5' AMP A 901 A 184 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 400 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 416 ASP C 69 ASP.? 6.83 O3' AMP A 901 coo -0.32 21.89 76.95 -2.29 21.43 77.55 8.87 -49.22 -5.46 7.44 -48.97 -6.99 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo -2.45 25.99 82.19 -2.93 24.57 79.52 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo -5.39 20.15 83.91 -5.94 21.73 82.59 1.23 -46.27 -4.81 3.28 -46.78 -4.78 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 2 4 # 2 A 87 ASP C 69 ASP.? 6.83 O3' AMP A 901 A 184 TYR C 15 TYR^? 4.73 N3 AMP A 901 A 400 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 416 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo -0.32 21.89 76.95 -2.29 21.43 77.55 1.23 -46.27 -4.81 3.28 -46.78 -4.78 coo -13.84 24.02 81.30 -13.39 23.42 78.61 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo -2.45 25.99 82.19 -2.93 24.57 79.52 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo -5.39 20.15 83.91 -5.94 21.73 82.59 8.87 -49.22 -5.46 7.44 -48.97 -6.99 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 3 4 # 3 A 87 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 184 TYR C 28 TYR~? 12.81 O2' AMP B 903 A 400 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 416 ASP C 20 ASP.? 6.67 O5' AMP A 901 coo -0.32 21.89 76.95 -2.29 21.43 77.55 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -13.84 24.02 81.30 -13.39 23.42 78.61 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo -2.45 25.99 82.19 -2.93 24.57 79.52 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo -5.39 20.15 83.91 -5.94 21.73 82.59 8.87 -49.22 -5.46 7.44 -48.97 -6.99 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 3 hits 2g3n_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG C 65 ARG.? -3.67 O5' AMP A 901s A 188 TYR C 50 TYR^? 7.65 O3' AMP A 901 A 190 SER C 67 SER.? 9.87 O3P AMP A 901 coo 37.69 7.64 13.51 38.82 8.84 16.11 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 47.14 12.10 13.73 48.75 12.33 16.01 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 43.77 6.93 15.46 45.49 7.21 17.11 -3.69 -45.02 -6.82 -6.01 -44.87 -6.10 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 8 ASN.? 11.89 N6 AMP A 901 A 384 ASN C 88 ASN~? 19.61 N1 AMP B 903 A 385 GLU C 84 GLU~? 17.40 N6 AMP B 903 coo 22.28 63.17 110.61 22.47 65.06 111.53 9.90 -41.73 -31.70 8.52 -43.07 -30.79 coo 7.06 50.07 96.17 8.50 48.54 96.31 24.58 -50.38 -16.44 25.19 -52.40 -16.37 coo 11.59 49.83 99.41 10.92 47.97 100.16 26.21 -46.33 -20.81 27.15 -45.80 -22.61 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN B 8 ASN^? 14.36 N6 AMP B 902 A 384 ASN A 88 ASN~? 18.60 N6 AMP A 901 A 385 GLU A 84 GLU~? 14.99 N1 AMP A 901 coo 22.28 63.17 110.61 22.47 65.06 111.53 14.70 -19.35 -29.72 16.77 -19.30 -29.18 coo 7.06 50.07 96.17 8.50 48.54 96.31 -6.16 -31.15 -30.13 -4.72 -31.21 -31.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 0.74 -32.42 -31.70 2.62 -32.20 -30.76 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN C 8 ASN.? 14.04 N6 AMP B 903 A 384 ASN B 88 ASN~? 18.59 N1 AMP B 902 A 385 GLU B 84 GLU~? 17.85 N6 AMP B 902 coo 22.28 63.17 110.61 22.47 65.06 111.53 28.61 -35.12 -23.42 27.13 -36.51 -24.02 coo 7.06 50.07 96.17 8.50 48.54 96.31 24.42 -12.36 -16.29 25.36 -13.07 -18.08 coo 11.59 49.83 99.41 10.92 47.97 100.16 23.05 -14.25 -21.41 23.75 -13.21 -23.10 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 3 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 11 ARG^? 7.89 C2 AMP A 901 B 6 THR B 104 THR^? 8.91 N1 AMP B 902 B 8 THR B 9 THR^? 7.58 N6 AMP B 902 coo 40.52 16.08 100.90 37.97 16.41 102.60 9.83 -34.01 -19.55 11.45 -36.64 -19.39 coo 36.11 13.64 95.03 34.54 14.86 95.91 11.98 -26.45 -24.97 10.79 -26.06 -23.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 6 THR B 104 THR^? 8.91 N1 AMP B 902 B 8 THR B 9 THR^? 7.58 N6 AMP B 902 coo 40.52 16.08 100.90 37.97 16.41 102.60 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 36.11 13.64 95.03 34.54 14.86 95.91 11.98 -26.45 -24.97 10.79 -26.06 -23.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 79 ARG^? 11.76 N6 AMP A 901 B 6 THR A 9 THR^? 8.17 N6 AMP A 901 B 8 THR A 104 THR.? 9.25 N1 AMP A 901 coo 40.52 16.08 100.90 37.97 16.41 102.60 3.12 -44.08 -29.78 5.35 -45.82 -30.86 coo 36.11 13.64 95.03 34.54 14.86 95.91 8.99 -39.81 -27.46 9.32 -41.46 -26.10 coo 32.72 8.05 92.39 31.25 9.11 91.35 13.23 -37.26 -24.51 12.15 -37.84 -22.73 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 6 THR C 104 THR^? 9.22 N1 AMP B 903 B 8 THR C 9 THR^? 8.23 N6 AMP B 903 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.16 -30.50 -20.95 20.80 -30.35 -18.84 coo 32.72 8.05 92.39 31.25 9.11 91.35 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 6 THR C 104 THR^? 9.22 N1 AMP B 903 B 8 THR C 9 THR^? 8.23 N6 AMP B 903 coo 40.52 16.08 100.90 37.97 16.41 102.60 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 36.11 13.64 95.03 34.54 14.86 95.91 21.16 -30.50 -20.95 20.80 -30.35 -18.84 coo 32.72 8.05 92.39 31.25 9.11 91.35 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG B 79 ARG^? 12.83 N6 AMP B 902 B 6 THR B 9 THR^? 7.58 N6 AMP B 902 B 8 THR B 104 THR^? 8.91 N1 AMP B 902 coo 40.52 16.08 100.90 37.97 16.41 102.60 11.40 -13.41 -25.51 10.95 -12.93 -28.51 coo 36.11 13.64 95.03 34.54 14.86 95.91 12.57 -20.91 -25.61 10.56 -20.92 -24.85 coo 32.72 8.05 92.39 31.25 9.11 91.35 11.98 -26.45 -24.97 10.79 -26.06 -23.21 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 6 THR A 104 THR.? 9.25 N1 AMP A 901 B 8 THR A 9 THR^? 8.17 N6 AMP A 901 coo 40.52 16.08 100.90 37.97 16.41 102.60 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 36.11 13.64 95.03 34.54 14.86 95.91 13.23 -37.26 -24.51 12.15 -37.84 -22.73 coo 32.72 8.05 92.39 31.25 9.11 91.35 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG C 79 ARG^? 13.72 N6 AMP B 903 B 6 THR C 9 THR^? 8.23 N6 AMP B 903 B 8 THR C 104 THR^? 9.22 N1 AMP B 903 coo 40.52 16.08 100.90 37.97 16.41 102.60 31.94 -36.24 -18.49 34.43 -34.81 -19.58 coo 36.11 13.64 95.03 34.54 14.86 95.91 25.76 -33.90 -19.68 26.28 -32.22 -18.47 coo 32.72 8.05 92.39 31.25 9.11 91.35 21.16 -30.50 -20.95 20.80 -30.35 -18.84 1b01_d00 source 1b01 GENE REGULATION/DNA : 8 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 15 TYR^? -4.88 N3 AMP B 902s I 306 VAL A 74 VAL^? 8.30 C2 AMP A 901 I 308 VAL A 76 VAL^? 4.53 N1 AMP A 901 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.94 -32.63 -15.17 -1.02 -33.46 -15.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.16 -36.80 -19.86 1.11 -36.98 -20.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 15 TYR^? -4.88 N3 AMP B 902s I 306 VAL B 77 VAL^? -3.71 N6 AMP B 902s I 308 VAL B 106 VAL^? 7.74 N6 AMP B 902 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.91 -25.44 -16.29 6.51 -26.42 -16.58 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.92 -20.93 -19.11 9.73 -22.59 -19.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 6.18 -23.37 -25.50 6.42 -21.65 -24.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 46 TYR^? 8.25 O2' AMP A 901 I 306 VAL A 74 VAL^? 8.30 C2 AMP A 901 I 308 VAL A 32 VAL~? 10.26 C2 AMP A 901 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.94 -32.63 -15.17 -1.02 -33.46 -15.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 46 TYR^? 8.25 O2' AMP A 901 I 306 VAL A 74 VAL^? 8.30 C2 AMP A 901 I 308 VAL A 76 VAL^? 4.53 N1 AMP A 901 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.81 -32.86 -10.56 7.54 -34.57 -11.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.94 -32.63 -15.17 -1.02 -33.46 -15.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.16 -36.80 -19.86 1.11 -36.98 -20.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 50 TYR^? 6.90 O2' AMP B 902 I 306 VAL B 32 VAL~? 9.91 O2' AMP B 902 I 308 VAL B 30 VAL~? 16.23 O2P AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.74 -13.64 -3.06 17.55 -12.72 -2.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 50 TYR^? 6.90 O2' AMP B 902 I 306 VAL B 32 VAL~? 9.91 O2' AMP B 902 I 308 VAL B 74 VAL^? 8.20 C2 AMP B 902 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.65 -22.73 -9.33 13.93 -20.71 -8.55 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 50 TYR^? 6.90 O2' AMP B 902 I 306 VAL B 45 VAL^? 7.51 O2' AMP B 902 I 308 VAL B 76 VAL^? -4.50 N1 AMP B 902s coo 26.18 35.24 6.87 24.33 35.18 8.97 6.03 -18.98 -5.10 5.67 -16.40 -6.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.61 -23.48 -7.47 10.43 -22.01 -6.07 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.10 -20.57 -15.52 13.63 -19.23 -14.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 15 TYR^? -4.78 N3 AMP B 903s I 306 VAL B 74 VAL^? 8.20 C2 AMP B 902 I 308 VAL B 76 VAL^? -4.50 N1 AMP B 902s coo 26.18 35.24 6.87 24.33 35.18 8.97 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.65 -22.73 -9.33 13.93 -20.71 -8.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.10 -20.57 -15.52 13.63 -19.23 -14.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 15 TYR^? -4.78 N3 AMP B 903s I 306 VAL C 77 VAL^? -3.94 N1 AMP B 903s I 308 VAL C 106 VAL^? 7.95 N6 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.04 -28.23 -9.37 17.78 -29.61 -11.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 22.41 -34.88 -14.11 21.80 -32.85 -14.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.07 -27.38 -16.90 26.07 -28.98 -15.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 46 TYR^? 7.73 N3 AMP B 902 I 306 VAL B 74 VAL^? 8.20 C2 AMP B 902 I 308 VAL B 32 VAL~? 9.91 O2' AMP B 902 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.40 -27.99 -8.79 8.40 -27.73 -11.39 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.65 -22.73 -9.33 13.93 -20.71 -8.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.48 -15.49 -7.06 10.85 -16.84 -6.61 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 46 TYR^? 7.73 N3 AMP B 902 I 306 VAL B 74 VAL^? 8.20 C2 AMP B 902 I 308 VAL B 76 VAL^? -4.50 N1 AMP B 902s coo 26.18 35.24 6.87 24.33 35.18 8.97 9.40 -27.99 -8.79 8.40 -27.73 -11.39 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.65 -22.73 -9.33 13.93 -20.71 -8.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.10 -20.57 -15.52 13.63 -19.23 -14.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 50 TYR^? 7.37 O3' AMP B 903 I 306 VAL C 32 VAL~? 10.03 O2' AMP B 903 I 308 VAL C 30 VAL~? 16.93 C2 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.37 -47.66 -2.17 17.90 -49.80 -2.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 50 TYR^? 7.37 O3' AMP B 903 I 306 VAL C 32 VAL~? 10.03 O2' AMP B 903 I 308 VAL C 74 VAL^? 8.37 C2 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.93 -39.55 -8.92 16.00 -41.17 -7.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 50 TYR^? 7.37 O3' AMP B 903 I 306 VAL C 45 VAL^? 7.43 O2' AMP B 903 I 308 VAL C 76 VAL^? 4.41 N1 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 17.59 -37.29 -0.29 20.29 -37.88 0.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.29 -36.68 -5.52 14.47 -38.62 -4.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.39 -37.30 -11.99 21.55 -39.05 -11.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR C 15 TYR^? 4.73 N3 AMP A 901 I 306 VAL C 74 VAL^? 8.37 C2 AMP B 903 I 308 VAL C 76 VAL^? 4.41 N1 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.15 -41.30 -13.86 9.45 -38.89 -15.22 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.93 -39.55 -8.92 16.00 -41.17 -7.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.39 -37.30 -11.99 21.55 -39.05 -11.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR C 28 TYR~? 12.81 O2' AMP B 903 I 306 VAL C 45 VAL^? 7.43 O2' AMP B 903 I 308 VAL C 76 VAL^? 4.41 N1 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.29 -36.68 -5.52 14.47 -38.62 -4.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.39 -37.30 -11.99 21.55 -39.05 -11.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR C 28 TYR~? 12.81 O2' AMP B 903 I 306 VAL C 74 VAL^? 8.37 C2 AMP B 903 I 308 VAL C 76 VAL^? 4.41 N1 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.98 -43.06 -2.71 12.25 -41.79 -0.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.93 -39.55 -8.92 16.00 -41.17 -7.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.39 -37.30 -11.99 21.55 -39.05 -11.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR C 46 TYR^? 7.86 O2' AMP B 903 I 306 VAL C 74 VAL^? 8.37 C2 AMP B 903 I 308 VAL C 32 VAL~? 10.03 O2' AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.40 -33.98 -8.06 13.29 -32.33 -9.27 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.93 -39.55 -8.92 16.00 -41.17 -7.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.10 -42.83 -4.07 19.26 -41.01 -3.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR C 46 TYR^? 7.86 O2' AMP B 903 I 306 VAL C 74 VAL^? 8.37 C2 AMP B 903 I 308 VAL C 76 VAL^? 4.41 N1 AMP B 903 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.40 -33.98 -8.06 13.29 -32.33 -9.27 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.93 -39.55 -8.92 16.00 -41.17 -7.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.39 -37.30 -11.99 21.55 -39.05 -11.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR C 50 TYR^? 7.65 O3' AMP A 901 I 306 VAL A 32 VAL~? 10.26 C2 AMP A 901 I 308 VAL A 30 VAL~? 16.21 C5' AMP B 902 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo 16.43 30.18 9.35 15.05 30.67 11.01 -10.11 -33.45 -15.15 -10.89 -31.76 -16.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR C 50 TYR^? 7.65 O3' AMP A 901 I 306 VAL A 45 VAL^? 8.09 O2' AMP A 901 I 308 VAL A 76 VAL^? 4.53 N1 AMP A 901 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.51 -34.68 -11.44 -0.61 -34.12 -11.40 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.16 -36.80 -19.86 1.11 -36.98 -20.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR C 50 TYR^? 7.65 O3' AMP A 901 I 306 VAL A 74 VAL^? 8.30 C2 AMP A 901 I 308 VAL A 76 VAL^? 4.53 N1 AMP A 901 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.56 -38.72 -9.80 -3.85 -40.54 -11.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.94 -32.63 -15.17 -1.02 -33.46 -15.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.16 -36.80 -19.86 1.11 -36.98 -20.57 1cqt_d00 source 1cqt GENE REGULATION/DNA : 22 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO C 103 PRO^? 13.78 N1 AMP B 903 A 272 LEU C 10 LEU^? 11.24 N6 AMP B 903 A 276 ARG C 79 ARG^? 13.72 N6 AMP B 903 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 20.81 -34.28 -25.29 20.17 -34.12 -23.03 coo 10.97 0.43 16.73 11.31 2.11 18.06 22.50 -37.08 -20.13 23.06 -37.72 -22.12 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 31.94 -36.24 -18.49 34.43 -34.81 -19.58 1emh_d00 source 1emh HYDROLASE/DNA : 1 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 25 ARG^? 19.99 O3P AMP A 901 C 71 LYS A 29 LYS~? 17.35 O2' AMP A 901 C 72 VAL A 30 VAL~? 16.21 C5' AMP B 902 coo 23.89 33.54 29.21 26.59 34.86 28.68 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 25.82 26.89 29.68 23.33 22.98 25.84 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 28.86 29.08 30.37 28.04 31.02 29.93 -10.11 -33.45 -15.15 -10.89 -31.76 -16.33 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG A 36 ARG~? 10.98 O3P AMP A 901 C 71 LYS A 34 LYS~? 19.00 N1 AMP A 901 C 72 VAL A 32 VAL~? 10.26 C2 AMP A 901 coo 23.89 33.54 29.21 26.59 34.86 28.68 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 25.82 26.89 29.68 23.33 22.98 25.84 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 28.86 29.08 30.37 28.04 31.02 29.93 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 25 ARG^? 17.34 O2' AMP B 902 C 71 LYS B 29 LYS~? 16.31 O2' AMP B 902 C 72 VAL B 30 VAL~? 16.23 O2P AMP B 903 coo 23.89 33.54 29.21 26.59 34.86 28.68 15.31 -11.22 2.31 12.71 -12.26 0.95 coo 25.82 26.89 29.68 23.33 22.98 25.84 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 28.86 29.08 30.37 28.04 31.02 29.93 15.74 -13.64 -3.06 17.55 -12.72 -2.24 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG B 36 ARG~? 10.26 O2P AMP B 902 C 71 LYS B 34 LYS~? 18.46 N1 AMP B 902 C 72 VAL B 32 VAL~? 9.91 O2' AMP B 902 coo 23.89 33.54 29.21 26.59 34.86 28.68 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 25.82 26.89 29.68 23.33 22.98 25.84 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 28.86 29.08 30.37 28.04 31.02 29.93 12.48 -15.49 -7.06 10.85 -16.84 -6.61 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 5 3 # 5 C 70 ARG C 25 ARG^? 18.57 O2' AMP B 903 C 71 LYS C 29 LYS~? 16.03 O2' AMP B 903 C 72 VAL C 30 VAL~? 16.93 C2 AMP B 903 coo 23.89 33.54 29.21 26.59 34.86 28.68 17.53 -50.28 2.99 20.10 -49.22 1.88 coo 25.82 26.89 29.68 23.33 22.98 25.84 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 28.86 29.08 30.37 28.04 31.02 29.93 18.37 -47.66 -2.17 17.90 -49.80 -2.09 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 6 3 # 6 C 70 ARG C 36 ARG~? 10.59 O3P AMP B 903 C 71 LYS C 34 LYS~? 17.13 N6 AMP B 903 C 72 VAL C 32 VAL~? 10.03 O2' AMP B 903 coo 23.89 33.54 29.21 26.59 34.86 28.68 25.67 -40.51 -0.27 25.52 -39.03 2.41 coo 25.82 26.89 29.68 23.33 22.98 25.84 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 28.86 29.08 30.37 28.04 31.02 29.93 20.10 -42.83 -4.07 19.26 -41.01 -3.23 1hwt_d00 source 1hwt GENE REGULATION/DNA : 6 hits 1hwt_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 564 VAL A 30 VAL~? 16.21 C5' AMP B 902 A 568 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -10.11 -33.45 -15.15 -10.89 -31.76 -16.33 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS A 29 LYS~? 17.35 O2' AMP A 901 A 564 VAL A 32 VAL~? 10.26 C2 AMP A 901 A 568 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 563 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 564 VAL A 32 VAL~? 10.26 C2 AMP A 901 A 568 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 563 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 564 VAL B 30 VAL~? 16.23 O2P AMP B 903 A 568 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo -6.60 80.79 55.64 -8.55 79.48 61.01 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -9.25 78.14 55.31 -11.11 77.94 56.39 15.74 -13.64 -3.06 17.55 -12.72 -2.24 coo -12.31 74.86 52.32 -13.99 74.91 54.92 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 563 LYS B 29 LYS~? 16.31 O2' AMP B 902 A 564 VAL B 32 VAL~? 9.91 O2' AMP B 902 A 568 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo -6.60 80.79 55.64 -8.55 79.48 61.01 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -9.25 78.14 55.31 -11.11 77.94 56.39 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo -12.31 74.86 52.32 -13.99 74.91 54.92 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 563 LYS B 34 LYS~? 18.46 N1 AMP B 902 A 564 VAL B 32 VAL~? 9.91 O2' AMP B 902 A 568 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo -6.60 80.79 55.64 -8.55 79.48 61.01 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo -9.25 78.14 55.31 -11.11 77.94 56.39 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo -12.31 74.86 52.32 -13.99 74.91 54.92 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 563 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 564 VAL C 30 VAL~? 16.93 C2 AMP B 903 A 568 ARG C 25 ARG^? 18.57 O2' AMP B 903 coo -6.60 80.79 55.64 -8.55 79.48 61.01 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -9.25 78.14 55.31 -11.11 77.94 56.39 18.37 -47.66 -2.17 17.90 -49.80 -2.09 coo -12.31 74.86 52.32 -13.99 74.91 54.92 17.53 -50.28 2.99 20.10 -49.22 1.88 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 563 LYS C 29 LYS~? 16.03 O2' AMP B 903 A 564 VAL C 32 VAL~? 10.03 O2' AMP B 903 A 568 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo -6.60 80.79 55.64 -8.55 79.48 61.01 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -9.25 78.14 55.31 -11.11 77.94 56.39 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo -12.31 74.86 52.32 -13.99 74.91 54.92 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 9 3 # 9 A 563 LYS C 34 LYS~? 17.13 N6 AMP B 903 A 564 VAL C 32 VAL~? 10.03 O2' AMP B 903 A 568 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo -6.60 80.79 55.64 -8.55 79.48 61.01 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo -9.25 78.14 55.31 -11.11 77.94 56.39 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo -12.31 74.86 52.32 -13.99 74.91 54.92 25.67 -40.51 -0.27 25.52 -39.03 2.41 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 9 hits 1r4i_d00 naa= 3 ULMN 4 1r4o_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 461 LYS A 34 LYS~? 19.00 N1 AMP A 901 A 462 VAL A 32 VAL~? 10.26 C2 AMP A 901 A 466 ARG A 36 ARG~? 10.98 O3P AMP A 901 A 511 LYS A 91 LYS~? 16.71 N7 AMP B 902 coo -5.66 13.16 26.70 -4.75 8.81 29.44 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -4.44 10.22 24.56 -5.83 8.69 23.87 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo -1.96 7.90 20.67 -4.06 5.76 20.87 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo -3.55 13.28 40.04 -1.35 8.66 38.23 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 1r4o_d00 source 1r4o TRANSCRIPTION/DNA : 1 hits 1r4o_d00 naa= 4 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 21 LYS^? 15.53 O3P AMP B 902 A1294 ASN A 19 ASN.? 10.11 O1P AMP B 902 A1297 GLU A 18 GLU.? 10.44 O3' AMP B 902 coo 39.24 18.84-161.99 36.62 21.47-165.99 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 33.53 17.37-161.81 34.31 17.81-163.76 -7.25 -22.51 -7.08 -6.24 -22.66 -5.21 coo 29.78 23.31-161.30 31.23 23.66-162.84 -3.87 -26.88 -5.70 -2.84 -26.89 -3.86 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 91 LYS~? 16.71 N7 AMP B 902 A1294 ASN A 88 ASN~? 18.60 N6 AMP A 901 A1297 GLU A 84 GLU~? 14.99 N1 AMP A 901 coo 39.24 18.84-161.99 36.62 21.47-165.99 -5.62 -26.14 -25.28 -2.24 -25.55 -30.45 coo 33.53 17.37-161.81 34.31 17.81-163.76 -6.16 -31.15 -30.13 -4.72 -31.21 -31.71 coo 29.78 23.31-161.30 31.23 23.66-162.84 0.74 -32.42 -31.70 2.62 -32.20 -30.76 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS B 21 LYS^? 13.50 O2P AMP B 903 A1294 ASN B 19 ASN.? 10.32 O2P AMP B 903 A1297 GLU B 18 GLU.? 10.73 O3' AMP B 903 coo 39.24 18.84-161.99 36.62 21.47-165.99 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 33.53 17.37-161.81 34.31 17.81-163.76 19.24 -24.20 5.03 17.75 -25.40 5.89 coo 29.78 23.31-161.30 31.23 23.66-162.84 14.19 -24.84 2.24 12.77 -26.14 3.06 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 91 LYS~? 15.95 O1P AMP B 903 A1294 ASN B 88 ASN~? 18.59 N1 AMP B 902 A1297 GLU B 84 GLU~? 17.85 N6 AMP B 902 coo 39.24 18.84-161.99 36.62 21.47-165.99 25.56 -16.77 -10.74 28.77 -17.65 -15.89 coo 33.53 17.37-161.81 34.31 17.81-163.76 24.42 -12.36 -16.29 25.36 -13.07 -18.08 coo 29.78 23.31-161.30 31.23 23.66-162.84 23.05 -14.25 -21.41 23.75 -13.21 -23.10 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS C 21 LYS^? 15.49 O2P AMP A 901 A1294 ASN C 19 ASN.? 10.79 O3' AMP A 901 A1297 GLU C 18 GLU.? 10.63 O3' AMP A 901 coo 39.24 18.84-161.99 36.62 21.47-165.99 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 33.53 17.37-161.81 34.31 17.81-163.76 4.38 -48.28 -1.80 3.20 -46.97 -0.60 coo 29.78 23.31-161.30 31.23 23.66-162.84 6.18 -43.03 -1.28 4.85 -41.58 -0.59 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS C 91 LYS~? 16.75 C8 AMP A 901 A1294 ASN C 88 ASN~? 19.61 N1 AMP B 903 A1297 GLU C 84 GLU~? 17.40 N6 AMP B 903 coo 39.24 18.84-161.99 36.62 21.47-165.99 17.40 -51.44 -14.48 19.12 -51.90 -20.49 coo 33.53 17.37-161.81 34.31 17.81-163.76 24.58 -50.38 -16.44 25.19 -52.40 -16.37 coo 29.78 23.31-161.30 31.23 23.66-162.84 26.21 -46.33 -20.81 27.15 -45.80 -22.61 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 6 hits 1xpx_d00 naa= 3 ULMN 4 2c7a_d00 RECEPTOR/DNA user 1 4 # 1 B 588 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 589 VAL A 30 VAL~? 16.21 C5' AMP B 902 B 593 ARG A 25 ARG^? 19.99 O3P AMP A 901 B 637 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 15.04 42.21 35.01 15.60 47.38 33.10 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 16.13 44.67 37.72 14.94 46.37 38.42 -10.11 -33.45 -15.15 -10.89 -31.76 -16.33 coo 17.98 46.28 41.95 15.61 48.20 41.79 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 coo 20.10 48.80 24.99 18.70 47.38 22.62 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 4 2c7a_d00 RECEPTOR/DNA user 2 4 # 2 B 588 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 589 VAL A 32 VAL~? 10.26 C2 AMP A 901 B 593 ARG A 36 ARG~? 10.98 O3P AMP A 901 B 637 ARG A 47 ARG^? 13.44 O3' AMP B 902 coo 15.04 42.21 35.01 15.60 47.38 33.10 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo 16.13 44.67 37.72 14.94 46.37 38.42 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo 17.98 46.28 41.95 15.61 48.20 41.79 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 coo 20.10 48.80 24.99 18.70 47.38 22.62 0.36 -29.13 -3.99 -1.78 -31.00 -2.89 ULMN 4 2c7a_d00 RECEPTOR/DNA user 3 4 # 3 B 588 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 589 VAL B 32 VAL~? 9.91 O2' AMP B 902 B 593 ARG B 36 ARG~? 10.26 O2P AMP B 902 B 637 ARG B 47 ARG^? 13.42 O3' AMP B 903 coo 15.04 42.21 35.01 15.60 47.38 33.10 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo 16.13 44.67 37.72 14.94 46.37 38.42 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo 17.98 46.28 41.95 15.61 48.20 41.79 7.38 -11.54 -7.56 4.42 -10.73 -7.41 coo 20.10 48.80 24.99 18.70 47.38 22.62 10.31 -28.72 0.63 8.60 -26.56 1.94 ULMN 4 2c7a_d00 RECEPTOR/DNA user 4 4 # 4 B 588 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 589 VAL C 30 VAL~? 16.93 C2 AMP B 903 B 593 ARG C 25 ARG^? 18.57 O2' AMP B 903 B 637 ARG C 47 ARG^? 14.09 O3' AMP A 901 coo 15.04 42.21 35.01 15.60 47.38 33.10 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo 16.13 44.67 37.72 14.94 46.37 38.42 18.37 -47.66 -2.17 17.90 -49.80 -2.09 coo 17.98 46.28 41.95 15.61 48.20 41.79 17.53 -50.28 2.99 20.10 -49.22 1.88 coo 20.10 48.80 24.99 18.70 47.38 22.62 6.08 -38.28 -1.54 7.50 -37.49 1.03 2c7a_d00 source 2c7a RECEPTOR/DNA : 4 hits 2c7a_d00 naa= 4 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 1 4 # 1 A 13 VAL C 77 VAL^? -3.94 N1 AMP B 903s A 24 THR C 9 THR^? 8.23 N6 AMP B 903 A 26 ARG C 79 ARG^? 13.72 N6 AMP B 903 A 27 ASN C 8 ASN.? 14.04 N6 AMP B 903 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 22.41 -34.88 -14.11 21.80 -32.85 -14.61 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 25.76 -33.90 -19.68 26.28 -32.22 -18.47 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 31.94 -36.24 -18.49 34.43 -34.81 -19.58 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 28.61 -35.12 -23.42 27.13 -36.51 -24.02 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 2 4 # 2 A 13 VAL C 106 VAL^? 7.95 N6 AMP B 903 A 24 THR C 9 THR^? 8.23 N6 AMP B 903 A 26 ARG C 79 ARG^? 13.72 N6 AMP B 903 A 27 ASN C 8 ASN.? 14.04 N6 AMP B 903 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 25.07 -27.38 -16.90 26.07 -28.98 -15.75 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 25.76 -33.90 -19.68 26.28 -32.22 -18.47 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 31.94 -36.24 -18.49 34.43 -34.81 -19.58 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 28.61 -35.12 -23.42 27.13 -36.51 -24.02 2jzw_d00 source 2jzw VIRAL PROTEIN/DNA : 2 hits 2jzw_d00 naa= 4 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 13 ARG^? 9.68 C2 AMP B 902 B 148 LYS A 21 LYS^? 15.53 O3P AMP B 902 B 151 LEU A 27 LEU~? 10.30 O3P AMP B 902 B 154 ILE A 31 ILE~? 12.61 C2 AMP A 901 coo 13.00 32.05 60.31 16.02 31.73 59.80 7.88 -30.42 -17.75 10.91 -30.56 -18.25 coo 11.05 44.13 44.68 12.77 44.45 49.56 -11.41 -25.46 -12.12 -15.13 -23.07 -8.28 coo 11.72 38.91 44.77 13.11 39.67 46.23 -7.90 -27.36 -14.25 -7.61 -26.69 -16.29 coo 7.03 36.97 46.99 7.83 37.90 47.52 -5.87 -32.55 -17.36 -4.93 -31.63 -18.00 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 148 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 151 LEU B 35 LEU~? 9.10 N1 AMP B 902 B 154 ILE B 31 ILE~? 12.78 C2 AMP B 902 coo 13.00 32.05 60.31 16.02 31.73 59.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 11.05 44.13 44.68 12.77 44.45 49.56 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 11.72 38.91 44.77 13.11 39.67 46.23 12.72 -14.09 -11.26 14.08 -15.75 -11.52 coo 7.03 36.97 46.99 7.83 37.90 47.52 16.68 -16.77 -6.66 17.62 -17.70 -7.34 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG B 11 ARG^? 7.52 N1 AMP B 902 B 148 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 151 LEU B 35 LEU~? 9.10 N1 AMP B 902 B 154 ILE B 40 ILE.? 7.73 N6 AMP B 902 coo 13.00 32.05 60.31 16.02 31.73 59.80 12.47 -27.35 -18.27 9.78 -27.52 -19.74 coo 11.05 44.13 44.68 12.77 44.45 49.56 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo 11.72 38.91 44.77 13.11 39.67 46.23 12.72 -14.09 -11.26 14.08 -15.75 -11.52 coo 7.03 36.97 46.99 7.83 37.90 47.52 11.68 -13.41 -15.64 12.48 -13.31 -15.86 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 4 4 # 4 B 122 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 148 LYS B 21 LYS^? 13.50 O2P AMP B 903 B 151 LEU B 27 LEU~? 9.79 O2P AMP B 903 B 154 ILE B 31 ILE~? 12.78 C2 AMP B 902 coo 13.00 32.05 60.31 16.02 31.73 59.80 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 11.05 44.13 44.68 12.77 44.45 49.56 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 11.72 38.91 44.77 13.11 39.67 46.23 19.64 -18.61 -1.49 21.21 -18.29 -2.97 coo 7.03 36.97 46.99 7.83 37.90 47.52 16.68 -16.77 -6.66 17.62 -17.70 -7.34 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 5 4 # 5 B 122 ARG B 13 ARG^? 10.00 C2 AMP B 903 B 148 LYS B 21 LYS^? 13.50 O2P AMP B 903 B 151 LEU B 27 LEU~? 9.79 O2P AMP B 903 B 154 ILE B 94 ILE.? 8.18 O1P AMP B 903 coo 13.00 32.05 60.31 16.02 31.73 59.80 14.87 -28.28 -14.27 14.20 -30.13 -16.64 coo 11.05 44.13 44.68 12.77 44.45 49.56 21.11 -17.93 2.45 18.52 -19.86 7.94 coo 11.72 38.91 44.77 13.11 39.67 46.23 19.64 -18.61 -1.49 21.21 -18.29 -2.97 coo 7.03 36.97 46.99 7.83 37.90 47.52 24.21 -19.99 -6.93 23.07 -20.72 -7.36 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 6 4 # 6 B 122 ARG C 13 ARG^? 8.59 C2 AMP A 901 B 148 LYS C 21 LYS^? 15.49 O2P AMP A 901 B 151 LEU C 27 LEU~? 11.64 O5' AMP A 901 B 154 ILE C 31 ILE~? 12.40 C2 AMP B 903 coo 13.00 32.05 60.31 16.02 31.73 59.80 13.26 -36.00 -15.82 10.89 -34.30 -14.90 coo 11.05 44.13 44.68 12.77 44.45 49.56 10.86 -51.86 -2.39 9.09 -50.05 2.40 coo 11.72 38.91 44.77 13.11 39.67 46.23 12.76 -48.95 -4.65 13.48 -49.56 -6.59 coo 7.03 36.97 46.99 7.83 37.90 47.52 17.74 -45.54 -6.55 17.04 -45.55 -7.81 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 7 4 # 7 B 122 ARG C 47 ARG^? 14.09 O3' AMP A 901 B 148 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 151 LEU C 35 LEU~? 8.74 N1 AMP B 903 B 154 ILE C 31 ILE~? 12.40 C2 AMP B 903 coo 13.00 32.05 60.31 16.02 31.73 59.80 6.08 -38.28 -1.54 7.50 -37.49 1.03 coo 11.05 44.13 44.68 12.77 44.45 49.56 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo 11.72 38.91 44.77 13.11 39.67 46.23 23.26 -42.42 -7.05 21.86 -42.28 -8.70 coo 7.03 36.97 46.99 7.83 37.90 47.52 17.74 -45.54 -6.55 17.04 -45.55 -7.81 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 8 4 # 8 B 122 ARG C 65 ARG.? -3.67 O5' AMP A 901s B 148 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 151 LEU A 35 LEU~? 8.79 N1 AMP A 901 B 154 ILE A 40 ILE.? 7.28 N6 AMP A 901 coo 13.00 32.05 60.31 16.02 31.73 59.80 2.91 -49.00 -8.95 5.74 -49.26 -9.91 coo 11.05 44.13 44.68 12.77 44.45 49.56 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo 11.72 38.91 44.77 13.11 39.67 46.23 -4.27 -38.10 -19.60 -3.11 -36.29 -19.75 coo 7.03 36.97 46.99 7.83 37.90 47.52 -2.03 -40.71 -22.34 -2.30 -40.08 -22.82 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 8 hits 3odc_d00 naa= 4 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 443 VAL A 30 VAL~? 16.21 C5' AMP B 902 B 447 ARG A 25 ARG^? 19.99 O3P AMP A 901 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -10.11 -33.45 -15.15 -10.89 -31.76 -16.33 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -15.02 -33.46 -11.28 -15.31 -36.26 -9.98 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS A 29 LYS~? 17.35 O2' AMP A 901 B 443 VAL A 32 VAL~? 10.26 C2 AMP A 901 B 447 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -8.01 -33.96 -11.99 -9.69 -33.16 -5.92 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 3 3 # 3 B 442 LYS A 34 LYS~? 19.00 N1 AMP A 901 B 443 VAL A 32 VAL~? 10.26 C2 AMP A 901 B 447 ARG A 36 ARG~? 10.98 O3P AMP A 901 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -9.03 -37.36 -19.97 -13.72 -35.16 -20.65 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -5.66 -36.65 -15.90 -4.46 -37.15 -14.15 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -6.19 -43.01 -15.18 -8.12 -41.55 -13.30 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 4 3 # 4 B 442 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 443 VAL B 30 VAL~? 16.23 O2P AMP B 903 B 447 ARG B 25 ARG^? 17.34 O2' AMP B 902 coo -11.49 8.72 29.13 -11.20 3.78 25.16 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -11.96 6.22 31.96 -10.74 4.61 32.81 15.74 -13.64 -3.06 17.55 -12.72 -2.24 coo -14.58 4.58 36.41 -12.11 2.82 36.84 15.31 -11.22 2.31 12.71 -12.26 0.95 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 5 3 # 5 B 442 LYS B 29 LYS~? 16.31 O2' AMP B 902 B 443 VAL B 32 VAL~? 9.91 O2' AMP B 902 B 447 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo -11.49 8.72 29.13 -11.20 3.78 25.16 13.21 -16.35 -2.11 10.27 -17.60 3.37 coo -11.96 6.22 31.96 -10.74 4.61 32.81 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo -14.58 4.58 36.41 -12.11 2.82 36.84 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 6 3 # 6 B 442 LYS B 34 LYS~? 18.46 N1 AMP B 902 B 443 VAL B 32 VAL~? 9.91 O2' AMP B 902 B 447 ARG B 36 ARG~? 10.26 O2P AMP B 902 coo -11.49 8.72 29.13 -11.20 3.78 25.16 14.79 -10.69 -8.44 19.07 -7.28 -9.56 coo -11.96 6.22 31.96 -10.74 4.61 32.81 12.48 -15.49 -7.06 10.85 -16.84 -6.61 coo -14.58 4.58 36.41 -12.11 2.82 36.84 7.38 -11.54 -7.56 4.42 -10.73 -7.41 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 7 3 # 7 B 442 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 443 VAL C 30 VAL~? 16.93 C2 AMP B 903 B 447 ARG C 25 ARG^? 18.57 O2' AMP B 903 coo -11.49 8.72 29.13 -11.20 3.78 25.16 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -11.96 6.22 31.96 -10.74 4.61 32.81 18.37 -47.66 -2.17 17.90 -49.80 -2.09 coo -14.58 4.58 36.41 -12.11 2.82 36.84 17.53 -50.28 2.99 20.10 -49.22 1.88 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 8 3 # 8 B 442 LYS C 29 LYS~? 16.03 O2' AMP B 903 B 443 VAL C 32 VAL~? 10.03 O2' AMP B 903 B 447 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo -11.49 8.72 29.13 -11.20 3.78 25.16 16.56 -44.53 -0.92 13.96 -43.62 4.72 coo -11.96 6.22 31.96 -10.74 4.61 32.81 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo -14.58 4.58 36.41 -12.11 2.82 36.84 25.67 -40.51 -0.27 25.52 -39.03 2.41 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 9 3 # 9 B 442 LYS C 34 LYS~? 17.13 N6 AMP B 903 B 443 VAL C 32 VAL~? 10.03 O2' AMP B 903 B 447 ARG C 36 ARG~? 10.59 O3P AMP B 903 coo -11.49 8.72 29.13 -11.20 3.78 25.16 24.06 -46.65 -4.78 27.74 -49.81 -6.72 coo -11.96 6.22 31.96 -10.74 4.61 32.81 20.10 -42.83 -4.07 19.26 -41.01 -3.23 coo -14.58 4.58 36.41 -12.11 2.82 36.84 25.67 -40.51 -0.27 25.52 -39.03 2.41 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 9 hits 4hn5_d00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 5 GLU.? 10.94 N7 AMP A 901 A 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 5 GLU.? 10.94 N7 AMP A 901 A 44 ASP C 96 ASP.? -4.92 O1P AMP A 901s A 50 THR A 111 THR.? 10.09 O1P AMP A 901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 5.52 -51.71 -13.41 4.60 -53.19 -14.62 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.30 -55.49 -17.62 7.23 -55.73 -19.53 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU A 75 GLU^? -5.62 C2 AMP A 901s A 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 6.13 -35.02 -17.20 7.93 -35.29 -16.18 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU A 84 GLU~? 14.99 N1 AMP A 901 A 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 A 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU B 5 GLU.? 11.45 N6 AMP B 902 A 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 3.19 -19.09 -26.75 1.87 -17.61 -27.49 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU B 75 GLU^? -4.88 C2 AMP B 902s A 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 A 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 11.33 -24.73 -14.66 10.03 -26.36 -14.95 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU C 5 GLU.? 7.68 N6 AMP B 903 A 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o00 LYSOZYME user 8 3 # 8 A 35 GLU C 75 GLU^? -5.53 C2 AMP B 903s A 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 A 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 25.76 -33.90 -19.68 26.28 -32.22 -18.47 3hde_o00 source 3HDE LYSOZYME : 8 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 5 GLU.? 10.94 N7 AMP A 901 B 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 84 GLU~? 14.99 N1 AMP A 901 B 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU A 102 GLU^? 11.43 N1 AMP B 902 B 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 B 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 5 GLU.? 11.45 N6 AMP B 902 B 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 B 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 3.19 -19.09 -26.75 1.87 -17.61 -27.49 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 102 GLU^? 11.34 N1 AMP B 902 B 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 B 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU C 5 GLU.? 7.68 N6 AMP B 903 B 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o01 LYSOZYME user 7 3 # 7 B 35 GLU C 75 GLU^? -5.53 C2 AMP B 903s B 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 16.76 -34.80 -12.34 15.78 -32.94 -12.53 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o01 LYSOZYME user 8 3 # 8 B 35 GLU C 84 GLU~? 17.40 N6 AMP B 903 B 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o01 LYSOZYME user 9 3 # 9 B 35 GLU C 102 GLU^? 11.80 C2 AMP B 903 B 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 B 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 25.76 -33.90 -19.68 26.28 -32.22 -18.47 3hde_o01 source 3HDE LYSOZYME : 9 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 5 GLU.? 10.94 N7 AMP A 901 C 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 C 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 11.09 -49.01 -22.99 10.29 -50.88 -23.58 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 25.48 4.87 1.60 23.90 4.95 0.15 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 84 GLU~? 14.99 N1 AMP A 901 C 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 C 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 0.74 -32.42 -31.70 2.62 -32.20 -30.76 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 25.48 4.87 1.60 23.90 4.95 0.15 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU A 102 GLU^? 11.43 N1 AMP B 902 C 44 ASP A 78 ASP^? 5.94 N6 AMP A 901 C 50 THR A 9 THR^? 8.17 N6 AMP A 901 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 11.95 -31.02 -23.64 10.59 -30.59 -22.08 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 2.95 -40.37 -24.73 1.78 -42.09 -25.10 coo 25.48 4.87 1.60 23.90 4.95 0.15 8.99 -39.81 -27.46 9.32 -41.46 -26.10 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 5 GLU.? 11.45 N6 AMP B 902 C 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 C 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 3.19 -19.09 -26.75 1.87 -17.61 -27.49 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 25.48 4.87 1.60 23.90 4.95 0.15 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 102 GLU^? 11.34 N1 AMP B 902 C 44 ASP B 78 ASP^? 6.36 N6 AMP B 902 C 50 THR B 9 THR^? 7.58 N6 AMP B 902 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 16.67 -28.95 -21.61 16.44 -28.51 -19.56 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 12.15 -16.83 -20.34 11.30 -14.93 -20.75 coo 25.48 4.87 1.60 23.90 4.95 0.15 12.57 -20.91 -25.61 10.56 -20.92 -24.85 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU C 5 GLU.? 7.68 N6 AMP B 903 C 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 C 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 30.74 -27.65 -13.81 29.58 -28.42 -12.20 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 25.48 4.87 1.60 23.90 4.95 0.15 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU C 84 GLU~? 17.40 N6 AMP B 903 C 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 C 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 26.21 -46.33 -20.81 27.15 -45.80 -22.61 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 25.48 4.87 1.60 23.90 4.95 0.15 25.76 -33.90 -19.68 26.28 -32.22 -18.47 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU C 102 GLU^? 11.80 C2 AMP B 903 C 44 ASP C 78 ASP^? 6.25 N6 AMP B 903 C 50 THR C 9 THR^? 8.23 N6 AMP B 903 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 16.05 -34.46 -21.85 15.11 -35.34 -20.19 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.09 -37.43 -14.21 28.04 -37.58 -13.32 coo 25.48 4.87 1.60 23.90 4.95 0.15 25.76 -33.90 -19.68 26.28 -32.22 -18.47 3hde_o02 source 3HDE LYSOZYME : 8 hits 3hde_o02 naa= 3